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Abstract	
The Drosophila melanogaster fat body, analogous to mammalian adipose tissue and 
the liver, is the primary organ of fat and glycogen storage as well as being responsible 
for the humoral immune response following infection. Normal functioning of the fat 
body is of critical importance to the survival of the organism, but many molecular 
regulators of its function remain ill-defined. Here, for the first time, we demonstrate 
that the Drosophila bromodomain-containing protein fs(1)h is essential in the fat body 
for normal lifespan as well as metabolic and immune homeostasis. Under 
physiological conditions, flies lacking fs(1)h in the fat body exhibit a severely reduced 
lifespan, abnormally high expression of immune target genes including antimicrobial 
peptides (AMPs) and cytokines, an inability to utilise triglycerides following periods of 
starvation, and low basal AKT activity, mostly resulting from systemic defects in 
insulin signalling. Loss of fs(1)h in the fat body also results in hypoglycemia and a 
dysregulation of several fat body-derived signals, indicating a role for fat body fs(1)h 
in the regulation of various systemic endocrine signals. Removing a single copy of the 
AKT-responsive transcription factor foxo ameliorates almost all the observed 
phenotypes, restoring lifespan, metabolic function, uninduced immune gene 
expression, and AKT activity suggesting many of the in vivo effects of fs(1)h in the fat 
body are foxo-dependent. However, survival is not rescued and AMP expression is 
still elevated following bacterial infection in fs(1)h knockdown foxo heterozygous flies, 
indicating some of the phenotypes observed are independent of the FOXO 
hyperactivation. We propose that the promotion of systemic insulin signalling activity 
is a key in vivo function of fat body fs(1)h.  		 	
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RCC Renal cell carcinoma 
RCF Relative centrifugal force 
Rel Relish 
Rheb Ras homolog enriched in brain 
RIPA Radioimmunoprecipitation assay buffer 
RT Room temperature 
RT-qPCR Real time quantitative polymerase chain reaction 
rRNA Ribosomal ribonucleic acid 
RNA Ribonucleic acid 
RNA-seq RNA-sequencing 
RNAi Ribonucleic acid interference 
ROS Reactive oxygen species 
RPM Revolutions per minute 
RPMI Roswell Park Memorial Institute Medium 
S6K S6 Kinase 
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Sax Saxophone  
Scw Screw 
SDS Sodium dodecyl sulfate 
SEM Standard error of the mean 
SH2 Src Homology 2 
siRNA Small interfering ribonucleic acid 
SIRT6 Sirtuin-6 
SPE Spätzle-processing enzyme 
spz spätzle 
Socs36E Suppressor of cytokine signalling 36E 
Srp Serpent  
STAT Signal transducer and activator of transcription 
SWI/SNF SWItch/Sucrose Non-Fermentable 
TAF-1 TBP-associated factor-1 
TAG Triacylglycerol (also known as triglyceride) 
TAK1 Transforming growth factor β-activated kinase 1 
TBP TATA-binding protein 
tbrdp Testis-specifically expressed BCP 
TBS-T Tris-buffered saline + Tween20 
TE Tris-EDTA buffer 
TEP-1 Thiolester-containing protein-1 
Tg Transgenic 
TGF-β Transforming growth factor-β 
Tkv Thickvein 
TLC Thin layer chromatography 
tll tailless 
TLR Toll-like receptor 
TNF Tumour necrosis factor 
TNF-α Tumour necrosis factor alpha 
TNF-R Tumour necrosis factor Receptor 
TOR Target of rapamycin 
tou toutatis 
TotA Turandot peptide A 
Trbd trabid 
trx trithorax 
TSB Tryptic soy broth 
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TSC1/2 Tuberous sclerosis proteins 1/2 
UAS Upstream activation sequence 
Uba1 Ubiquitin-like modifier-activating enzyme 1 
UbcD1 (eff) Effete 
upd unpaired 
USP36 Ubiquitin-Specific Protease 36 
Utx Utx histone demethylase 
VEGF Vascular endothelial growth factor 
VNC Ventral nerve cord 
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1.1. Drosophila melanogaster as a model organism 
The fruit fly, Drosophila melanogaster, has been used as a model organism for over a 
century, with the first use being documented in 1901 at Harvard University. However, 
it was Thomas Hunt Morgan in the early 20th century who used Drosophila 
melanogaster to confirm the chromosomal theory of inheritance and showed that 
genes were located on chromosomes. He went on to receive the Nobel Prize in 
Physiology or Medicine in 1933 for identifying and characterising the role of 
chromosomes in heredity. In the early years, the fruit fly was used prominently for 
genetic investigation, however more recently this underlying knowledge of genetic 
mechanism has been used to further study development, behaviour, innate immunity 
and human disease (Jennings, 2011; Pandey and Nichols, 2011). Many biological 
properties are conserved between mammals and Drosophila, and the fly has become 
a powerful tool to model innate immunity along with neurological and metabolic 
diseases including Parkinson’s disease, obesity and diabetes (Alfa and Kim, 2016; 
Baker and Thummel, 2007; Trinh and Boulianne, 2013; Whitworth, 2011).  
 There are many technical advantages of using Drosophila in research; as a 
model organism in the laboratory they are easy and inexpensive to maintain, they 
have a short life cycle and can be genetically modified in many ways (Stocker and 
Gallant, 2008). The DNA of Drosophila, much like that of humans, is carried in 
chromosomal pairs, however, unlike humans they only have four pairs: a pair of sex 
chromosomes (XX in females and XY in males) along with three pairs of autosomes. 
This low number of chromosomes makes genetic analysis much easier compared to 
other organisms and therefore an extremely useful tool in scientific research, 
especially for genetic modifications (Hales et al., 2015). Interestingly, many of the 
genes and signalling pathways found in Drosophila are highly conserved in mammals, 
75% of all human disease genes have related sequences in Drosophila (Bier, 2005). 
Drosophila have been used to study homologous genes that cause a broad spectrum 
of human disease following disruption, including developmental, neurological and 
metabolic disorders (Yamamoto et al., 2014).  
1.1.1. Drosophila life cycle 
Drosophila undergo four life cycle stages; egg, larva, pupa and adult. The adult 
female can lay between 750-1500 eggs in a lifetime, and once the eggs are fertilised, 
the embryo develops within the egg before hatching into larva. The larva grows 
through three instars until it pupates and undergoes metamorphosis into an adult fly 
(Figure 1-1). Most embryonic and larval tissues are lost during metamorphosis and 
the adult tissues develop from imaginal disc cells that are present from early 
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embryonic development (Klebes et al., 2002). The timing of the Drosophila life cycle is 
dependent on the temperature in which they are raised, at 25°C their development 














Figure 1-1: The Drosophila life cycle 
Following mating, the female lays eggs and the embryos hatch giving rise to the 1st instar 
larvae. The larvae grow in two further instars (2nd and 3rd) until reaching pupal formation, and 
finally the adult’s eclose. 	
 Anatomically, Drosophila adults have an open circulatory system consisting of 
the hemolymph, a solution of water, inorganic salts and organic compounds that 
bathe the organs of the fly (Arrese and Soulages, 2010). They have a heart-like organ 
in the dorsal abdomen that consists of eight chambers in a tube-like structure, which 
are made up of pericardial cells and are closely surrounded by blood cells termed 
hemocytes (Grigorian and Hartenstein, 2013). The heart pumps the hemolymph 
through the organism and allows nutrients to distribute to all organs. They also have a 
respiratory system, trachea, a compartmentalised digestive system including the 
Malpighian tubules, which serve a similar function to the mammalian kidney, a liver-
like organ known as the fat body and a brain that is used extensively to study 
neurological development, function and disease (Jeibmann and Paulus, 2009). 
1.2. The Drosophila immune response 
Throughout the last thirty years, Drosophila has become an increasingly important 
model organism for immunological research. Mechanisms of the immune response 
have been well conserved throughout evolution, and many molecular pathways, 
including those involved in immunity, can be studied in vertebrates, invertebrates and 
















benefits due to the easily manipulated genome and the genetic tools available. In 
2011, Jules Hoffmann was awarded the Nobel Prize in Physiology or Medicine, he 
used Drosophila as a model system to study the first line of defence against microbes 
and showed that the gene ‘Toll’ was necessary for Drosophila to fight fungal infection 
(Lemaitre et al., 1996).  
 Insects, including Drosophila, have a complex immune system consisting of 
both cellular and humoral immunity. Cellular immunity consists of cells directly 
phagocytosing and killing invading pathogens or phagocytosing dead cells (Browne et 
al., 2013). The humoral immune response is able to secrete soluble molecules, such 
as antimicrobial peptides (AMPs), into the hemolymph to kill microbes that may not be 
in close proximity to the humoral response cells (Flatt et al., 2008a). The immune 
system of many organisms provides protection from a range of pathogens, many of 
which may be harmful to the host following infection. The ability for an individual to 
defend itself against pathogens and to distinguish between self and non-self is critical 
for survival (Akira et al., 2006). Studies in Drosophila and in mammals revealed highly 
conserved defence strategies at a molecular level (Lemaitre and Hoffmann, 2007).  
 Several different defence mechanisms have been shown to prevent microbes 
from harming the host (Figure 1-2). In many cases, the first line of defence includes 
physical barriers, including the exoskeleton or cuticle of insects as well as epithelial 
barriers of the trachea and gut (Reumer et al., 2010). If the first line of defence 
becomes breached, various specialised cells and tissues are responsible for the 
containment and eradication of the invading microbes. Drosophila lack an adaptive 
immune response, they rely solely on their innate immune system. Hemocytes are the 
cells that make up the cellular response in Drosophila by phagocytosing foreign 
intruders and dead cells, but also by providing encapsulation and melanisation 
responses in the fly (Vlisidou and Wood, 2015). The humoral response is 
characterised by the release of AMPs into the hemolymph, with the fat body being the 




Figure 1-2: Drosophila immune defence mechanisms 
Following septic injury or infection by bacteria, fungi or parasites, Drosophila can react by 
inducing the innate immune response via three main immune tissues; epithelia, hemocytes 
and the fat body. 
1.2.1. Drosophila immune pathways 
There are two major immune pathways characterised in Drosophila, the Toll pathway 
and the immune deficiency (Imd) pathway, which are the major pattern recognition 
pathways in the fly (Lemaitre and Hoffmann, 2007). The activation of these pathways 
are responsible for an upregulation of AMPs and cytokines in response to infection 
(Lemaitre and Hoffmann, 2007), and they control the majority of genes regulated by 
microbial infection (De Gregorio et al., 2002). The fat body, an organ analogous to the 
mammalian liver and adipose tissue, is the major site of the humoral immune 
response, being the main producer of AMPs following immune challenge (Imler and 
Bulet, 2005). Within these pathways, there are three NF-κB-like transcription factors 
that regulate Toll and Imd signalling, these are Dorsal-related immunity factor (Dif), 
dorsal and Relish (Dushay et al., 1996; Ip et al., 1993; Reichhart et al., 1993). It has 
been shown that Dif and dorsal are primarily associated with the Toll pathway, 
whereas Relish has been implemented in Imd pathway activation (De Gregorio et al., 
2002). Both the Toll and Imd pathways are activated by peptidoglycan recognition 
proteins (PGRPs), which are ubiquitously expressed innate immunity molecules 
conserved from insects to vertebrates (Dziarski and Gupta, 2006). Insects have 
multiple PGRP genes, which are classified into short or long transcripts and are found 
in the hemolymph, cuticle, fat body and in the epidermal cells of the gut where they 
can generate AMPs, induce phagocytosis and hydrolyse peptidoglycan (Royet and 
Dziarski, 2007). Interestingly, Lemaitre et al (1997) showed that different infectious 
agents mount significantly different AMP expression profiles in response to infection. 
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This suggests the Drosophila immune response has the capability to differentiate 
between various invading microorganisms (Lemaitre et al., 1997). 
 The Toll pathway (Figure 1-3) shows evolutionarily conserved similarities to 
the vertebrate interleukin 1 receptor (IL-1R) signalling pathway (Gay and Keith, 1991). 
However, unlike the mammalian Toll like receptors (TLRs), Toll in Drosophila does not 
act as a pattern recognition receptor (PRR) itself and does not directly sense invading 
microbes (Janssens and Beyaert, 2003), it is activated by the cytokine Spätzle (Spz). 
Toll relies on three pathogen recognition proteins in the hemolymph that detect the 
invading pathogens and trigger a serine protease cascade that activates the Spätzle-
processing enzyme (SPE), which in turn cleaves Spz into fragments (Stokes et al., 
2015). The precursor form of Spz has no signalling activity, but the cleaved C-terminal 
region, which forms a cysteine knot structure, can activate the receptor (Weber et al., 
2007). The pathway is activated by this cleavage event and the C-terminal of Spz can 
bind as a dimer to Toll, inducing dimerisation at the membrane, triggering the 
recruitment of three intracellular Death Domain-containing proteins, Myeloid 
differentiation primary response gene 88 (MyD88), tube and the kinase pelle. cactus, 
the vertebrate IκB homolog, builds a complex with two NF-κB family members, Dorsal 
and Dif, in the cytoplasm and prevents them from translocating into the nucleus. 
Following the activation of Toll and the recruitment of MyD88, tube and pelle, cactus 
is phosphorylated, prompting ubiquitination and degradation by the proteasome 
(Daigneault et al., 2013). As a consequence of cactus degradation, Dif and Dorsal are 
released and translocate into the nucleus (Belvin and Anderson, 1996). They are then 
able to bind to κB binding sites and activate the transcription of AMP target genes 
including Drosomycin (Drs) (Imler and Bulet, 2005).   
 The Imd pathway (Figure 1-3) is activated directly via the binding of 
monomeric or polymeric diaminopimelic acid (DAP)-type peptidoglycan (PGN) of 
Gram-negative bacteria. The main transmembrane (type II) receptor of the Imd 
pathway known as peptidoglycan recognition protein-LC (PGRP-LC) recruits the 
death-domain containing adaptor Imd, in turn interacting with Fas-associated death 
domain (FADD), which binds the Death related ced-3/Nedd2-like caspase (Dredd) 
(Ferrandon et al., 2007). Dredd has been shown to associate with the NF-κB family 
member Relish, and is cleaved following Relish phosphorylation (Guntermann and 
Foley, 2011). Following cleavage, Relish translocates to the nucleus and binds to κB 
binding sites, whereas the inhibitory domain of Relish, known as the ANKyrin repeats 
(ANK), remains stable in the cytoplasm (Meister et al., 2005). The recruitment of Imd 
can also lead to Relish phosphorylation via the MAPKKK transforming growth factor-β 
(TGFβ)-activated kinase 1 (TAK1) and the IKK signalling complex formed by the 
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catalytic subunit immune-response deficient 5 (IRD5, mammalian IKKβ) and a 
regulatory subunit known as Kenny, which is homologous to the mammalian IKKγ 
(Stokes et al., 2015). The translocation of Relish into the nucleus via FADD and 
Dredd or TAK1 leads to the activation of AMP target genes including Attacin (AttA), 
Cecropin (CeCA), Diptericin (Dipt) and Drosocin (Dro) (De Gregorio et al., 2002). 
 Negative regulation of the Imd pathway plays important roles in the restriction 
of signalling both outside and inside of cells and is critical for preventing unnecessary 
induction or hyperactivation of the immune response (Kim et al., 2006). Outside the 
cell, secreted catalytic PGRP proteins are able to reduce epithelial and systemic 
immune responses by scavenging peptidoglycan and PGRPs with amidase activity 
are able to down-regulate the Imd pathway following microbial sensing (Paredes et 
al., 2011). Within the cell, there are a number of negative regulators of the pathway 
including poor Imd response upon knock-in (pirk), which negatively regulates the 
PGRP-LC receptor (Kleino et al., 2008) whilst the Drosophila ubiquitin-specific 
protease, dUSP36, targets Imd itself to prevent constitutive immune signalling 
(Thevenon et al., 2009). Cylindromatosis (CYLD), a deubiquitinating enzyme, inhibits 
the IKK complex, which is made up of Kenny and IRD5 and defense repressor 1 
(dnr1) supresses the activity of DREDD (Guntermann et al., 2009). The immune 
suppressor, Caspar, inhibits the Imd pathway by blocking DREDD-dependent 
cleavage and nuclear translocation of Relish (Kim et al., 2006). Relish itself plays a 
crucial role in limiting signalling through proteosomal degradation of TAK1 (Park et al., 
2004). Furthermore, Trabid (trbd) a novel component of the Imd pathway is able to 
negatively regulate TAK1 (Fernando et al., 2014). Interestingly, mutations within 
intracellular regulators of the Imd pathway predispose flies to toxic levels of AMPs and 
compromised lifespan (Kounatidis et al., 2017). 
 Studies have also shown that the Toll and Imd pathways are not mutually 
exclusive, and the AMPs Defensin (Def) and Metchnikowin (Mtk) can be produced by 


































Figure 1-3: Drosophila Toll and Imd Pathways 
Antimicrobial peptide (AMP) production is induced by two signalling cascades; the Toll and 
Immune deficiency (Imd) pathways. Left: Toll is activated by Gram-positive bacteria and fungi. 
The Toll receptor is activated upon binding of the cleaved form of Spätzle, inducing 
dimerisation at the membrane and the recruitment of three intracellular Death domain-
containing proteins (MyD88, tube, pelle). cactus, the homolog of IκB, is phosphorylated and 
degraded by the proteasome. The transcription factors Dif and Dorsal are released, move into 
the nucleus and mediates the expression of antimicrobial peptides including Drosomycin. 
Right: PGRP-LC sense the presence of Gram-negative bacteria and activates the Imd 
pathway. Imd interacts with FADD and the caspase, Dredd. Dredd can then phosphorylate 
Relish, which is cleaved and Relish migrates to the nucleus to regulate expression of AMPs, 
while the ANK repeats remain in the cytoplasm. Relish can also be phosphorylated by the IKK 
signalling complex (Kenny and IRD5), which is activated through TAK1. The translocation of 
Relish to the nucleus mediates the expression of antimicrobial peptides including Attacin, 
Cecropin, Diptericin and Drosocin. The AMPs Defensin and Metchnikowin can be produced by 
both the Toll and Imd pathways. 
1.2.2. Drosophila antimicrobial peptides (AMPs) 
In Drosophila, 20 AMPs have been identified following immune induction that can be 
grouped into seven main classes of peptides; Attacin, Cecropin, Defensin, Diptericin, 




















































be further grouped into functional subgroups depending on their response to Gram-
positive bacteria, Gram-negative bacteria or fungi. AMPs, a hallmark of the systemic 
humoral immune response, are small molecules that can exhibit a range of activities 
following the invasion of bacteria and fungi (Imler and Bulet, 2005; Meister et al., 
1997). Elevated AMP expression levels can also be observed during times of stress, 
such as starvation or changes in temperature (Tsuzuki et al., 2012). AMPs are 
transcribed mainly in the fat body but also by epithelial cells and hemocytes (Ganesan 
et al., 2011). They are released into the hemolymph where they accumulate in high 
concentrations and circulate throughout the body (Lemaitre and Hoffmann, 2007). 
Insect AMPs, much like those of vertebrates, disrupt the integrity of membranes to kill 
the target microbes (Ganz, 2003). 	
1.2.3. Jak/STAT signalling in Drosophila innate immunity 
The Janus Kinase/Signal Transducer and Activator of Transcription (Jak/STAT) 
pathway is another evolutionarily conserved pathway across many species, with 
functions ranging from development to the immune response. In Drosophila, the 
Jak/STAT pathway plays a number of key roles in development, including sex 
determination and embryonic segmentation (Zeidler and Perrimon, 2000). During 
larval development, Jak/STAT signalling is important for the development of both the 
eye and wing imaginal discs (Hombría and Sotillos, 2013) and is shown to be crucial 
for hematopoiesis, hemocyte development and differentiation in the larval lymph gland 
(Krzemien et al., 2010; Morin-Poulard et al., 2013). Additionally, Jak/STAT signalling 
has well-characterised roles in stem cell maintenance in the midgut and the 
maintenance of hematopoietic stem cells (HSCs) in the lymph gland (Bausek, 2013; 
Singh et al., 2005). Studies have also shown that Jak/STAT signalling plays an 
important role in immunity, especially in the immune response following viral infection 
(Agaisse and Perrimon, 2004; Myllymäki and Rämet, 2014). Along with the Toll and 
Imd pathways, the interplay between these three immune pathways has been shown 
to trigger the appropriate response to combat injury and infection (Dostert et al., 
2005).  
 In Drosophila, the Jak/STAT pathway (Figure 1-4) consists of one Janus 
kinase, known as hopscotch (hop), and one STAT transcription factor, known as 
STAT92E (Hou et al., 1996; Yan et al., 1996). There are three known ligands for the 
pathway, unpaired (upd), unpaired 2 (upd2) and unpaired 3 (upd3) that can function in 
either an autocrine or paracrine manner (Agaisse et al., 2003; Harrison et al., 1998; 
Hombría and Sotillos, 2013). Interestingly, the upd proteins show similarity to that of 
type I cytokines of the IL-6 family in vertebrates (Panayidou and Apidianakis, 2013). 
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The pathway becomes activated when upd, upd2 or upd3 binds to the gp130-like 
receptor, domeless (dome), which becomes dimerised and activates hop leading to 
the phosphorylation of the cytoplasmic domain of dome (Binari and Perrimon, 1994). 
This phosphorylation event allows the recruitment of STAT92E via its Src Homology 2 
(SH2) domain, which can be recruited to dome and phosphorylated by hop (Hou et 
al., 1996). Upon phosphorylation, STAT92E dimerises and translocates as a 
homodimer to the nucleus, activating the transcription of its target genes, including 
Turandot A (TotA), thiolester-containing protein-1 (TEP-1) and Suppressor of cytokine 


















Figure 1-4: The Jak/STAT pathway in Drosophila 
The unpaired ligands (upd1, 2, 3) bind and activate the receptor dome on the cell surface. This 
results in the activation of hop, leading to the phosphorylation of dome. The phosphorylated 
domain of the receptor becomes a docking site for STAT92E (STAT). STAT becomes 
phosphorylated, producing an active STAT dimer that moves into the nucleus and binds to 
DNA to activate the transcription of target genes. upd; unpaired, dome; domeless, hop; 
hopscotch, Jak; Janus kinase, STAT; signal transducers and activators of transcription. 
1.2.4. Other pathways involved in the Drosophila immune response 
In addition to the Toll, Imd and Jak/STAT pathways there are also a number of other 
pathways involved in Drosophila immune response including the JNK pathway, p38 
pathway and TGF-β signalling. 
 The Jun-N-terminal Kinase (JNK) is a member of the mitogen-activated protein 






























numerous cellular responses including cellular proliferation, wound healing, apoptosis 
and inflammation (Weston and Davis, 2002). In Drosophila, there is a single JNK 
homolog, known as basket (bsk), and the pathway plays important roles in dorsal 
closure during embryonic development (Stronach and Perrimon, 2002) and for proper 
wound healing of the epidermis (Bosch et al., 2005). The Drosophila proteins eiger 
and wengen (wng) show similarities to mammalian tumour necrosis factor (TNF) and 
the TNF receptor (TNF-R), respectively (Moreno et al., 2002). eiger, the first 
invertebrate TNF superfamily ligand, is expressed predominantly in the nervous 
system and induces cell death by activating the JNK pathway through wng (Igaki et 
al., 2002). eiger has also been shown to trigger cell death and mediate pro-apoptotic 
function via JNK through grindelwald (grnd), another TNF-R family member 
(Andersen et al., 2015). Activation of both the JNK pathway and the NF-κB pathway, 
Imd, can be dependent on Tak1, which is homologous to mitogen-activated protein 
kinase kinase kinase (MAPKKK) in mammals. Interestingly, it has been shown that 
Tak1 can activate the JNK pathway in response to bacterial infection, but the 
activation does not lead to the transcription of AMPs (Silverman et al., 2003). 
Activation of the JNK pathway also results in the activation of the transcription factor 
activator protein-1 (AP-1) (Whitmarsh and Davis, 1996). AP-1 plays important roles in 
controlling expression of genes including Fos and Jun, but also the expression of 
AMP genes may require the activation of AP-1 function at the onset of immune 
response (Delaney et al., 2006) (Figure 1-5).   
 The p38 MAPK pathway is an evolutionarily conserved stress response and 
has been shown to play roles in the immune response of both plants and animals 
(Hommes et al., 2003). The signalling of the p38 pathway has also been described in 
Drosophila development, stress response and immunity. In Drosophila, there are 
three orthologues of p38, known as p38a, p38b and p38c (Chen et al., 2010), which 
have been shown to have various functional roles. Drosophila lacking the p38a gene 
are susceptible to environmental stresses such as starvation and heat shock (Craig et 
al., 2004). Whereas, p38b is involved in decapentaplegic (dpp) signal transduction 
during wing morphogenesis (Adachi-Yamada et al., 1999) and p38c is expressed in 
the gut, upregulated during intestinal infection and regulates lipid metabolism and 
immune homeostasis in the intestine (Chakrabarti et al., 2014). In response to stress, 
Drosophila p38 can directly phosphorylate Activating transcription factor-2 (Atf-2), a 
major transcriptional activator of stress-inducible genes that is critical for p38-





























Figure 1-5: The JNK and p38 pathway in Drosophila 
The conserved JNK pathway is activated by eiger, the TNF-superfamily ligand, which signals 
through two receptors, grindelwald and wengen. eiger binds to the receptors and activates 
TRAF2, which in turn activates JNK. The activation of JNK leads to the phosphorylation and 
activation of transcription factors including AP-1. The p38 pathway can be activated by the 
PGN of invading pathogens, which are sensed by PGRP-LC, triggering the Imd and p38 
mitogen-activated protein kinase pathways. The activation of p38 via the MEKK1/MKK3 
complex enhances the transactivating function of ATF2. PGN; peptidoglycan, PGRP-LC; 
peptidoglycan-recognition protein LC, TRAF2; tumour necrosis factor receptor-associated 
factors, Imd; immune deficiency, TAK1; TGF-β activated kinase 1, MKK3; MAP kinase kinase 
3, JNK; Jun amino-terminal kinase, AP-1; activator protein-1, ATF2; activating transcription 
factor 2, AMP; antimicrobial peptide. 
 
 The transforming growth factor-beta (TGF-β) superfamily are a large group of 
proteins that regulate many things including development and the immune response 
in both vertebrates and invertebrates (Raftery and Sutherland, 1999). Ligands of this 
superfamily signal through a type I/II receptor complex resulting in the 
phosphorylation and activation of specific SMAD transcription factors (Derynck and 
Zhang, 2003). SMAD transcription factors form complexes with Co-SMADs in the 
cytoplasm upon phosphorylation and translocate to the nucleus. Here, they can bind 
directly to DNA and activate or repress transcription to regulate target gene 
expression (Attisano and Tuen Lee-Hoeflich, 2001). In Drosophila, the TGF-β 
signalling pathway comprises of two main groups, the activin group and the bone 








































beta (Actβ), dawdle (daw) and myoglianin (myo), which all signal through the single 
baboon (babo) receptor (Ghosh and O’Connor, 2014). Conversely, the BMP group 
also consists of three different ligands, dpp, glass-bottom boat (gbb) and screw (scw), 
which can signal through two receptors known as thick veins (tkv) and saxophone 
(sax) (Nguyen et al., 1998). Both the activin and BMP groups can regulate different 
aspects of the innate immune response, for example dpp and daw both respond to 
immune challenge. However, dpp expression is increased during sterile injury and 
supresses unnecessary AMP expression, whereas daw expression is increased in 
response to infection and is an important inhibitor of inflammation following injury 
(Clark et al., 2011).	
1.3. The fat body  
The insect fat body plays many important roles in the humoral immune response, fat 
and glycogen storage, lipid metabolism and nutrient sensing (Arrese and Soulages, 
2010). Fat body tissue originates from the mesoderm during embryogenesis 
(Hoshizaki et al., 1994) and becomes immune competent in the early larval stage 
(Lemaitre and Hoffmann, 2007). The larval fat body is the main energy store during 
pupal development and during the first few days of adulthood following eclosion. After 
the first days of adulthood, the freely floating cells of the larval fat body undergo 
apoptosis and are replaced by newly developing adult fat body cells (Liu et al., 2009). 
The new fat body cells develop in the adult Drosophila and perform a similar energy 
storing function. In adult Drosophila, the fat body is distributed throughout the body, 
located mainly under the exoskeleton and surrounding the gut and reproductive 
organs (Arrese and Soulages, 2010). Structurally, the tissue is arranged in thin lobes, 
which allows maximal exposure to the hemolymph and rapid detection of changes in 
energy levels or circulating hormone levels (Arrese and Soulages, 2010). 
1.3.1. The fat body in metabolism 
The fat body is not only the main humoral immune response organ; it is also the 
primary metabolic tissue in Drosophila. Fat body cells are responsible for the 
synthesis and utilisation of lipids, carbohydrates and amino acids, as well as the 
synthesis of almost all the hemolymph proteins and metabolites (Arrese and 
Soulages, 2010). In recent years, the link between immunity and metabolism has 
been explored, with infections prompting metabolic dysregulation and dysfunction. 
Mef2, a transcription factor originally characterised for its role in muscle development, 
is required in the fat body for anabolic function and immune response, and is a critical 
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transcriptional switch between metabolism and immunity in the adult fat body (Clark et 
al., 2013). 
 Insulin/insulin-like growth factor (IGF) signalling (IIS) and target of rapamycin 
(TOR) signalling pathways (Figure 1-6) are central to metabolic regulation and 
controlling the uptake of nutrients into cells of Drosophila. Both these pathways can 
function either independently or together in an insulin/Akt/TOR-signalling network.  
 The insulin-signalling pathway has been shown to play roles in regulating 
lifespan, growth and metabolism via the insulin-like receptor (InR) (Goberdhan and 
Wilson, 2003). Following initiation of the insulin pathway by Drosophila insulin-like 
peptides (DILPs), chico, the insulin receptor substrate becomes activated leading to 
the phosphorylation of the pathway antagonist Akt (also known as protein kinase B) 
(Scanga et al., 2000). This phosphorylation event leads to the phosphorylation of the 
forkhead transcription factor FOXO leaving it inactive in the cytoplasm (Hay, 2011). 
When FOXO is not phosphorylated, it is able to move into the nucleus and activate 
the transcription of various genes including 4E-binding protein (4E-BP, also known as 
Thor in Drosophila), a known inhibitor of protein translation (Webb and Brunet, 2014). 
Insulin signalling controls a wide range of metabolic and physiological processes in 
the cell, ranging from autophagy to nutrient sequestration (Britton et al., 2002; Kim 
and Neufeld, 2015). Mutations in the insulin pathway can be detrimental to 
Drosophila, mutations in chico severely disrupts cellular proliferation and growth 
(Naganos et al., 2012) and insulin pathway mutant flies are significantly smaller, with 
higher lipid content compared to control flies (Murillo-Maldonado et al., 2011). 
 TOR is a highly conserved serine/threonine kinase that is involved in 
regulating cell growth, stress levels and metabolism (Inoki et al., 2005). The TOR 
pathway can be activated by insulin signalling, via the InR and AKT, or by sensing 
intracellular amino acids or various extracellular nutrients such as amino acid in the 
hemolymph (Miyamoto et al., 2013). Activated AKT is able to suppress the activity of 
the tuberous sclerosis complex genes 1 and 2 (TSC1/TSC2) complex, which 
inactivates the Ras homologue enriched in brain (Rheb) and results in TOR activation. 
Rheb promotes cell growth in a TOR and S6 Kinase (S6K)-dependent manner 
(Saucedo et al., 2003; Stocker et al., 2003). The activity of S6K, a p70 ribosomal 
protein, also leads to an increase in protein synthesis and cellular proliferation 
(Volarević and Thomas, 2001). However, Drosophila lacking the S6K gene show 
extreme delays in development and a severe reduction in body size, which is due to 
the flies having smaller cells, not fewer cells (Montagne et al., 1999). Whether TOR 
activation is insulin-dependent or via nutrient sensing, TOR phosphorylates targets 
such as S6K and 4E-BP to initiate translation (Miron et al., 2003). TOR mutant flies 
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show an increase in the lipid metabolism gene, brummer, and a decrease in fatty acid 
synthase (FAS) transcript levels, suggesting the activity of TOR regulates a balance 
between lipid anabolism and catabolism (Birse et al., 2010). 
 
 											
Figure 1-6: Insulin and TOR signalling in Drosophila 
The InR is activated by the binding of DILPs. Following activation, the InR transduces a signal 
from the DILPs to PI3K, through the single Drosophila insulin receptor substrate, chico. The 
major kinase AKT becomes phosphorylated and activated, which subsequently phosphorylates 
the transcription factor FOXO, leaving it inactive in the cytoplasm. The TOR pathway plays an 
important role in controlling amino acid sensing via amino acid transporters. Following the 
phosphorylation of TOR, the TOR kinase is able to activate S6 kinase and inhibit the activity of 
4E-BP. The insulin-signalling pathway and the TOR pathway interact at the level of AKT, the 
activation of AKT leads to the inhibition of the TSC1/2 complex and the activation of the TOR 
pathway. DILPs; Drosophila insulin-like peptides, InR; Insulin-like receptor, PI3K; 
Phosphoinositide 3-kinase, 4E-BP; 4E-binding protein, TSC1/TSC2; tuberous sclerosis 
complex genes 1 and 2, RHEB; Ras homologue enriched in brain, TOR; target of rapamycin, 

































1.3.2. Lipid and sugar metabolism in Drosophila 
Drosophila share most of the basic metabolic functions found in vertebrates, they are 
able to maintain energy stores in the form of lipids and glycogen as well as uphold the 
appropriate level of circulating sugars, trehalose and glucose (Rajan and Perrimon, 
2013). 
 Lipids have an important function in the composition of cellular membranes 
and in energy storage. In Drosophila, lipids in the form of triacylglycerol (triglycerides 
or TAG) and cholesterol ester are synthesised from dietary carbohydrates, fatty acids 
or proteins and are stored in the fat body as lipid droplets (LDs). The mobilisation of 
lipids is essential for growth, reproduction and energy requirements during times of 
non-feeding (Arrese and Soulages, 2010) and a balance between TAG storage and 
breakdown is crucial for the maintenance of energy homeostasis in both vertebrates 
and invertebrates (Trinh and Boulianne, 2013). In times of energy requirement, TAG 
stores are accessed by a number of lipases, which help orchestrate the breakdown of 
lipids via lipolysis (Figure 1-7). brummer (bmm), a homologue to mammalian 
adipocyte triglyceride lipase (ATGL), is an important lipid storage droplet-associated 
TAG lipase (Grönke et al., 2005). Studies show that during starvation or an over-
expression of bmm in Drosophila depletes lipid stores, whereas a loss of bmm can 
cause obesity in flies (Grönke et al., 2005). Hormone sensitive lipase (Hsl) mutant 
larvae have significantly larger LDs following starvation, however adult Hsl mutants 
have only slightly increased TAG stores than controls in fed conditions (Lee et al., 
2013). Additionally, in mammals ATGL and Hsl are thought to work in a synergistic 
manner to accomplish lipolysis at the LD surface (Grönke et al., 2007). Drosophila 
perilipin 1 and perilipin 2 (plin1 and plin2 or lipid storage droplet 1 and 2; Lsd1, Lsd2) 
associate with lipids, more specifically plin1 generally labels LDs of varying size and 
interacts closely with Hsl at the LD membrane to initiate the breakdown of LDs and 
begin the lipolysis of stored TAG. However, plin2 localises to smaller LDs, is involved 
in promoting lipid accumulation and acts as a barrier to lipases such as bmm and Hsl 
(Bi et al., 2012). Interestingly, plin1 locates exclusively to the surface of LDs while 


















Figure 1-7: Lipases involved in Drosophila lipid metabolism 
Stored lipid droplets become metabolically accessible by lipolysis; triglycerides are hydrolysed 
to monoglycerides and diglycerides. Lipases are shown in red and lipid droplet-associated 
proteins in blue. TAG; triacylglycerol/triglyceride, plin1; perilipin 1, plin2; perilipin 2, bmm; 
brummer, Hsl; Hormone sensitive lipase. 
 
 The glucagon-like adipokinetic hormone (Akh) family plays significant roles in 
stimulating the fat body to convert stored TAG into diglyceride and glycogen into 
trehalose, the principle sugar in insects (Matsuda et al., 2015). Trehalose is 
synthesised from glucose-6-phosphate synthase in the fat body of Drosophila and 
degraded back to glucose by the enzyme trehalase (Yasugi et al., 2017). Glucose 
from the diet can be stored as the carbohydrate glycogen in the fat body when it is not 
required for energy. Glycogen also provides a stored source of glucose for trehalose 
synthesis and the mobilisation of trehalose to glucose has been found to be critical for 
metabolic homeostasis (Yasugi et al., 2017). Interestingly, trehalose and glucose, the 
two circulating sugars in Drosophila, have been shown to play a direct role in the 
release of Akh by clusters of endocrine cells in the ring gland of the brain known as 
corpora cardiaca (Kim and Neufeld, 2015; Kim and Rulifson, 2004).  
 In addition to the fat body, hepatocyte-like cells known as oenocytes can 
enable lipid metabolism (Gutierrez et al., 2007) and express many lipid-synthesising 
and catabolising enzymes including Fas and acetyl-CoA carboxylase (Acc) (Parvy et 
al., 2012). In Drosophila, oenocytes are derived from ectoderm in two separate 
generations, one larval and one adult, with differing progenitors that are distinct with 
regards to cell number and size (Makki et al., 2014). During the larval stage 
oenocytes are much larger in size, however these cells breakdown and disappear 
before adult eclosion (Johnson and Butterworth, 1985). In adults, these cells are 
arranged in clusters in the abdominal segment and play important roles in 

























Figure 1-8: Metabolic homeostasis in Drosophila larvae 
Sugar homeostasis is maintained by IPCs in the brain and the ring gland, producing DILPs and 
Akh. Akh release from the ring gland can inhibit the storage of glycogen and TAG in the fat 
body to maintain lipid homeostasis. Upon starvation, the fat body releases lipids that are taken 
up by oenocytes for the production of energy. Amino acids and TAG in the gut can activate the 
TOR pathway and TAG storage in the fat body, respectively. IPC; insulin producing cells, 
DILPs; Drosophila insulin-like peptides, Akh; Adipokinetic hormone, TOR; target of rapamycin, 
TAG; triacylglycerol/triglycerides (Adapted from Leopold and Perrimon, 2007). 
1.3.3. Nutrient sensing by the Drosophila fat body  
Nutrition is a key regulator in developmental timing in both vertebrates and 
invertebrates (Layalle et al., 2008). As discussed above, nutrients, such as lipids and 
glucose, are detected and stored in the form of TAG and glycogen.  
 In the fat body of Drosophila, insulin signalling and TOR signalling play 
important roles in maintaining nutritional homeostasis, and as a result can regulate 
nutrient uptake, metabolism and storage (Zhang and Xi, 2014). The insulin-signalling 
pathway contributes to energy homeostasis by regulating carbohydrate storage (Slack 
et al., 2010). Insulin signalling is also the principle regulator of lipid accumulation 
(DiAngelo and Birnbaum, 2009). TOR signalling can also be activated in the fat body 
by free amino acids (Kim, 2009), amino acid transporters, such as slimfast, can 
function as nutrient sensors and regulate endocrine activity of the fat body via TOR 
(Reynolds et al., 2007). TOR also negatively regulates cell autonomous mechanisms 
such as autophagy, which can provide amino acids during conditions of limited 
nutrients (Jung et al., 2010). Interestingly, reducing InR or phosphoinositide 3-kinase 
(PI3K), an important family of signal transducer enzymes, in the fat body decreases 
growth rate whereas decreasing TOR activity in the fat body causes a reduction in 



















fat body, the steroid hormone 20-hydroxyedysone (20E, ecdysone) integrates with the 
insulin-signalling pathway to monitor nutritional status. 20E in the fat body has been 
shown to antagonise the insulin-signalling pathway, promote autophagy (Rusten et 
al., 2004) and weaken Myc activity to suppress peripheral insulin signalling and body 
growth (Colombani et al., 2005; Delanoue et al., 2010). Interestingly, 20E also 
controls the length of the larval stages and developmental transitions (Nijhout et al., 
2014).  
 The fat body is the major site for nutrient storage and mobilisation of lipids. 
Therefore, these processes have to be tightly regulated and communicated to other 
organs in larvae and adult flies to help maintain nutrient uptake and energy levels. 
One class of hormone peptides regulating these processes are the Drosophila insulin-
like peptides (DILPs). In Drosophila, there are eight of these peptides (DILP1-8) with 
varying expression patterns and function. DILP secretion can regulate energy balance 
and promote growth in response to dietary sugars and fats. In recent years, more and 
more studies implicate a major role for the fat body in communicating the nutrient 
status to the insulin producing cells (IPCs) in the brain and other organs via the 
release of hormonal and cytokine signals (Zhang and Xi, 2014). During both larval 
and adult stages, DILP6 is expressed extensively in the fat body and is induced by 
20E. In adult Drosophila, DILP6 transcript levels are regulated by FOXO and its 
expression represses DILP2 and DILP5 mRNA in the brain and the secretion of 
DILP2 into the hemolymph (Bai et al., 2012). The production of DILP2, 3 and 5 by the 
brain have also been shown to cross-talk with DILP6 in the fat body and removing 
DILP2, 3 and 5 increases the expression of DILP6 in the fat body.  
 The unpaired (upd) family are also thought to have important roles in nutrient 
sensing, along with their role in Jak/STAT activation in Drosophila. upd2, a functional 
analogue of leptin, is produced by the fat body and secreted into the hemolymph in 
response to dietary fat and sugar. upd2 activates the Jak/STAT pathway in 
GABAergic neurons, reducing their inhibitory effect on IPCs and in turn prompting the 
secretion of DILPs into the hemolymph (Rajan and Perrimon, 2012). This release of 
DILPs promotes uptake of nutrients, which results in growth and fat storage. 
Moreover, knockdown of upd2 in the fat body reduces adult body size by preventing 
DILP2 release from IPCs (Zhang and Xi, 2014). upd2 has been considered to serve a 
similar function to mammalian leptin, however, upd2 null flies do not show an obese 
phenotype (Rajan and Perrimon, 2012), whereas leptin deficient mammals show an 
increase in both fat storage and food intake (Friedman and Halaas, 1998). Recent 
studies have also shown upd1, another homolog of mammalian leptin, expression in 
the Drosophila brain but not fat body, increases food intake, weight and food cue 
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attraction (Beshel et al., 2017). Furthermore, the inflammatory cytokine upd3, which is 
released from hemocytes, specifically plasmatocytes upon excess of dietary lipids, 
was recently shown to play a detrimental role in reducing insulin sensitivity in various 
tissues (Agaisse et al., 2003; Woodcock et al., 2015). 
 Ecdysone-inducible gene L2 (ImpL2), the secreted insulin/IGF antagonist, is 
able to form protein complexes with DILP2 and DILP5 and inhibit insulin signalling in 
adult Drosophila (Alic et al., 2011). It is required for larval survival (Honegger et al., 
2008) and in times of nutritional stress is upregulated in the fat body, which leads to 
the suppression of insulin signalling and allows Drosophila to endure periods of 
starvation. Kwon et al (2015) and Figueroa-Clarevaga & Bilder (2015) also showed 
that ImpL2 is a critical factor involved in systemic organ wasting in Drosophila. 
 There is also another group of peptides that are known to regulate nutrient 
sensing in adult Drosophila. Firstly, Growth-blocking peptide 1 and 2 (Gbp1, Gbp2) 
are fat body-derived signals, synthesised in response to amino acids and the 
activation of TOR signalling. Both Gbp1 and Gbp2 stimulate DILP secretion from the 
brain and increase insulin signalling activity in Drosophila (Koyama and Mirth, 2016). 
Reducing expression of Gbp1 and Gbp2 in the fat body leads to reduced growth rate 
and a smaller body size. Gbp1 specifically has been further shown to regulate the 
immune response and the expression of Gbp1 is thought to be sensitive to starvation 
stress (Fujikawa et al., 2009). Secondly, the peptide hormone CCHamide2 (CCHa2) 
is expressed in the fat body and gut, binds to its receptor (CCHa2-R) in the brain and 
acts as a nutrient-dependent regulator of DILPs in Drosophila (Sano et al., 2015). 
Data has shown that CCHa2 and CCHa2-R form a direct signalling response between 
the brain and peripheral tissues (Sano, 2015). Moreover, transcriptional levels of 
CCHa2 are altered with changing nutrient levels, particularly sugars and genetically 
disrupting either CCHa2 or CCHa2-R causes defects in both larval growth and 
developmental timing (Sano et al., 2015).  
 Signalling from peripheral tissues, such as the fat body, to the brain is 
essential for regulating the growth and metabolism of Drosophila in response to 
nutritional availability. Mechanisms of nutrient sensing under normal physiological 




Figure 1-9: Nutrient-sensing mechanisms in Drosophila 
Drosophila nutrient sensing pathways carried out between the brain, fat body and hemolymph. 
IPCs; insulin producing cells, DILP; Drosophila insulin-like peptide, Gbp; Growth-blocking 
peptide, InR; Insulin-like receptor, PI3K; Phosphoinositide 3-kinase, EcR; ecdysone receptor, 
TOR; target of rapamycin, S6K; S6 kinase, Akh; Adipokinetic hormone, AKH-R; adipokinetic 
hormone receptor, PKA; cAMP-dependent protein kinase, Glucose-6-P; glucose-6-phosphate, 
upd2; unpaired 2, CCHa2; CCHamide 2, ImpL2; Ecdysone-inducible gene L2.	
1.3.4. Regulation of metabolism in fed and starved states  
Regulating metabolism under physiological conditions is important to maintain the 
homeostasis of many organisms. During a stress response or environmental change, 
such as starvation, specific mechanisms are required to help aid survival 
(Schwasinger-Schmidt et al., 2012). Drosophila can regulate their metabolic pathways 
to trigger an accurate response in fed or starved states.  
 In the fed state, Drosophila IPCs in the brain release DILPs into the 
hemolymph. IPCs sense systemic glucose levels in the hemolymph in a cell 
autonomous manner and an uptake of glucose results in a depolarisation event in the 
IPCs. This depolarisation event activates voltage-sensitive calcium channels and 
triggers the release of DILPs (Nässel and Vanden Broeck, 2016). The circulating 
DILPs can then bind to the InR inducing downstream phosphorylation of AKT, in turn 
this can lead to the phosphorylation of FOXO and the activation of TOR signalling. 
FOXO phosphorylation prevents its movement from the cytoplasm to the nucleus 
therefore promoting growth and nutrient storage in the fat body. Nutrient signals, 
particularly cellular levels of amino acids, and insulin signalling via the InR can 












































found on the membrane of cells and can interact with both TSC1 of the TSC1/2 
complex upstream of TOR and FOXO to recruit proteins to the cell membrane 
(Teleman et al., 2005a). Melted mutants have reduced lipids, a reduction in TOR 
signalling and an increase in foxo activation (Reis and Hariharan, 2005). Slimfast, an 
amino acid transporter, signals through TOR to regulate metabolism and growth in 
response to amino acid levels, it can also override insulin signalling in peripheral 
tissues by inhibiting PI3K activity (Baker and Thummel, 2007). The TOR pathway is 
made up of two multiprotein complexes: TORC1 and TORC2. TORC1 regulates 
growth and translation via the phosphorylation of S6K to drive protein synthesis or 
inhibit 4E-BP activity to increase translation (Bjedov et al., 2010). Under favourable 
conditions, such as an amino acid-rich fed state, TORC1 is active and S6K can work 
as a positive mediator of the TOR pathway to promote growth and alter metabolism 
(Montagne et al., 1999; Um et al., 2006). TORC1-dependent phosphorylation of 4E-
BP disrupts its association with translation initiation factor 4E (eIF4E) allowing eIF4E 
to promote cap-dependent translation (Richter and Sonenberg, 2005). Additionally in 
the fed state, fatty acids are rapidly taken up by the fat body and incorporated into 
glycerides, including TAG and phospholipids. Following feeding, TAG, glycogen and 
protein granules occupy most of the intracellular space within the fat body (Arrese and 
Soulages, 2010).  
 Upon starvation, DILP expression levels can vary dramatically in response to 
the reduction in nutrients available. Studies have shown levels of DILP3 and DILP5, 
but not DILP2, are reduced in starved Drosophila (Ikeya et al., 2002). In contrast, 
DILP6 transcript levels are increased under nutritional deprivation and FOXO has 
been shown to modulate this response in larvae (Slaidina et al., 2009). Interestingly, 
an increased accumulation of DILP2 and DILP5 is shown in the IPCs of the 
Drosophila brain following starvation, whereas DILP2 transcript levels in the whole fly 
remain unchanged (Kannan and Fridell, 2013). During the starvation state, the activity 
of both the insulin and TOR signalling pathways is reduced. Without the 
phosphorylation of FOXO by the insulin pathway, it is able to freely translocate into 
the nucleus, induce transcription of starvation response genes, reduce protein 
synthesis and restrict Drosophila growth (Baker and Thummel, 2007). A reduction in 
TOR activity following starvation leads to a reduction in S6K activity and a decreased 
ability to carry out translation via 4E-BP (Tettweiler et al., 2005). The activity of 4E-
BP, which can be controlled by TOR, has been shown to work as a metabolic brake 
that is activated under conditions of environmental stress, including starvation, to 
control fat metabolism (Teleman et al., 2005b). Adipokinetic hormone (Akh), which 
plays a similar role to mammalian glucagon, binds to the Akh-receptor (Akh-R) and 
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promotes the breakdown of TAG and glycogen in the fat body during starvation. Akh 
also activates the enzyme glycogen phosphorylase, which reduces the amount of 
glycogen in the fat body and increases circulating sugar levels (Baker and Thummel, 
2007). During periods of starvation, the lipase bmm, which acts in parallel with Akh to 
regulate lipolysis, plays a crucial role in the mobilisation of TAG and glycogen in the 
fat body to promote energy release (Grönke et al., 2005). The fat body signalling 
pathways in both the fed and starved states are shown in Figure 1-10. Additionally, 
Drosophila oenocytes are thought to be critical to mount an effective starvation 
response, they are able to promote lipid and carbohydrate breakdown following fat 























































Figure 1-10: Metabolic pathways in fed and starved states 
A. Drosophila metabolic pathways in the fat body in a fed state and B. Drosophila metabolic 
pathways in the fat body in the starved state. Solid lines represent active signalling pathways, 
and dotted lines represent regulatory mechanisms that become active when signalling is not 
active. InR; Insulin-like receptor, TAG; triacylglycerol/triglyceride, TOR; Target of rapamycin, 
S6K; S6 Kinase, Akh; Adipokinetic hormone, Akh-R; Adipokinetic hormone receptor, PI3K; 
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Hemocytes, the collective term for the blood cells of Drosophila, originate from 
mesodermally derived stem cells (Lavine and Strand, 2002) and can differentiate into 
three main blood cell types, plasmatocytes, crystal cells and lamellocytes, which 
function in embryonic, larval and adult Drosophila.  
 Plasmatocytes make up ~95% of circulating hemocytes in the adult fly and are 
most similar to mammalian leukocytes, particularly the monocyte and macrophage 
lineage (Holz et al., 2003). In Drosophila larvae, hemocytes circulate throughout the 
body, however in adults, much like mammalian macrophages, plasmatocytes are 
sessile cells and become resident cell populations following terminal differentiation 
(Elrod-Erickson et al., 2000). They have been shown to play important roles as 
professional phagocytes and in cytokine production (Agaisse et al., 2003; Charroux 
and Royet, 2009). Interestingly, adult plasmatocytes are not a homogenous 
population of cells as they exhibit differential expression of signalling molecules 
including dpp and daw in response to wounding and infection (Clark et al., 2011). 
Furthermore, adult plasmatocytes seem to be post-mitotic, and no cellular proliferation 
has been seen under steady state or in inflammatory conditions (Honti et al., 2014). 
Crystal cells contain crystalline inclusions of prophenoloxidase that function in the 
melanisation immune response of Drosophila (Gajewski et al., 2007), and play 
important roles in wound healing and encapsulation. The production of melanin also 
leads to the production of cytotoxic free radicals that may participate in the killing of 
invading pathogens (Meister and Lagueux, 2003). In larvae, lamellocytes are stress-
response cells, which do not usually appear in healthy individuals (Avet-Rochex et al., 
2010). They are able to specifically differentiate and encapsulate foreign bodies that 
are too large to be phagocytosed by plasmatocytes (Wood and Jacinto, 2007), such 
as the parasitoid wasp eggs laid in Drosophila larvae by the parasitoid wasp. 
Lamellocytes have not been yet been detected in adult Drosophila. 
1.4.1. Hematopoiesis in Drosophila 
Embryonic hematopoiesis in Drosophila is thought to be reminiscent of early 
hematopoiesis in vertebrates (Figure 1-11). During Drosophila development, two 
hematopoietic waves have been described: embryonic and lymph gland 
hematopoiesis (Evans et al., 2003). The embryonic and larval stages of 
hematopoiesis lead to the formation and expansion of self-renewing tissue-resident 
macrophages that emerge from the embryonic head mesoderm around embryonic 
stage 7 (Gold and Brückner, 2014). These new tissue-resident macrophages can 
colonise local microenvironments in peripheral tissues and can self-renew in the 
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differentiated state (Makhijani et al., 2011). The majority of these cells migrate 
throughout the larvae and a small number remain localised around the anterior part of 
the gut known as the proventriculus (Wood and Jacinto, 2007). 
	
Figure 1-11: Early hematopoiesis in Drosophila and vertebrates 
A. Insect blood, vascular and excretory cells derived from a common precursor. During 
development many different cell types stay in close contact, and the lymph gland and 
pericardial nephrocytes line up next to the dorsal vessel. B. In vertebrates, the AGM gives rise 
to endothelial and blood precursors that migrate within the embryo to assemble blood vessels 
and differentiate into individual hematopoietic lineages. Orange; blood, purple; excretory, blue; 
muscle, green; mesoderm, pink; endothelial, AGM; aorta-gonad-mesonephros (Adapted from 
Evans et al., 2003). 
 
 The second wave of hematopoiesis is initiated by a cluster of cells that lines 
the dorsal vessel, known as the lymph gland (Wood and Jacinto, 2007) (Figure 1-12). 
The lymph gland is a specialised organ formed during embryogenesis and its 
progenitors share a common origin with the cells of the vascular (dorsal vessel) and 
excretory (pericardial nephrocytes) lineages, which all develop from cardiogenic 
mesoderm (Evans et al., 2003). The development of the cardiogenic mesoderm is 
reliant on signalling input by dpp, fibroblast growth factor (FGF), Wingless (Wg) and 
Notch (Frasch, 1995; Gisselbrecht et al., 1996; Wu et al., 1995). The hemocytes 
produced in the lymph gland are capable of giving rise to all three differentiated cell 
types that are released during the 3rd instar of larval development, however lymph 
gland hematopoiesis appears to be time-restricted as the organ disintegrates during 
metamorphosis (Shim, 2015). During this disintegration, the remaining lymph gland 
hemocytes are released into circulation. Interestingly, insulin/TOR signalling has been 



















controlling the fate of prohemocytes (Benmimoun et al., 2012). In extreme 
environmental conditions or following immune challenge, larval tissue-resident 
macrophages can be supported by the newly differentiated hemocytes in the lymph 
gland (Gold and Brückner, 2014). The sudden release of hemocytes from the lymph 
gland during larval stages is due to the lymph gland bursting (Krzemien et al., 2007). 
 In adult Drosophila, the production of new blood cells has not been identified 
to date. It is thought hemocytes produced during the two waves of hematopoiesis 
















Figure 1-12: The lymph gland of Drosophila larvae 
A schematic of the 3rd instar larval lymph gland. The lymph gland borders the dorsal vessel 
and pericardial cells separate each lobe. The primary lobe consists of three main regions; a 
cortical zone, where differentiated hemocytes are found, a medullary zone, where 
hematopoietic progenitors (prohemocytes lacking differentiation markers) are found and a 
PSC, which contains a specialised population of hemocytes. The secondary lobe usually 
consists of immature hemocytes. PSC; posterior signalling centre. (Adapted from Jung et al., 
2005).   
1.4.2. Transcriptional regulation of hematopoiesis 
During hematopoiesis the differentiation of hemocytes subsets is reliant on lineage 
specific transcription factors (Figure 1-13). The Drosophila gene serpent (srp), a 
transcription factor of the GATA family is required for the formation of prohemocytes 
in the Drosophila embryo (Williams, 2007). During embryogenesis, early populations 
of prohemocytes in the head mesoderm express srp, which gives rise to two classes 
of blood cells, the plasmatocytes and crystal cells (Lebestky et al., 2000). Srp is also 
required later in development during hemocyte maturation. The receptor tyrosine 
kinase PVR, and its three ligands, PVF1, 2 and 3, control the survival and migration of 
hemocytes in the tissues (Wood et al., 2006) as well as hemocyte proliferation in the 
















transcription factors known as glial cells missing (gcm) and glial cell missing 2 (gcm2) 
(Alfonso and Jones, 2002). The differentiation of crystal cells is triggered by the 
expression of transcription factor, lozenge (lz) (Fossett et al., 2003). lz is also required 
in the embryo for the specification of crystal cells in the larval lymph gland (Wood and 
Jacinto, 2007) and the expression of lz in larvae also appears to be under the control 
of Notch signalling (Lebestky et al., 2003). The molecular control for the differentiation 
of lamellocytes remains widely unknown. However, it is thought that the transcription 
factor collier, also known as knot (kn), may be required in larvae development for the 
production of lamellocytes during parasitisation (Crozatier et al., 2004). The Jak/STAT 
pathway and Toll signalling pathways are also though to be implemented in 
lamellocyte proliferation and differentiation. The hyperactivation of hopscotch, the only 
Jak homolog, induces plasmatocyte proliferation, the differentiation of lamellocytes 
and the formation of melanised tumours (Agaisse and Perrimon, 2004). Disruption of 
Toll function within the lymph gland of Drosophila larvae can lead to hemocyte over-













Figure 1-13: Regulation of hematopoiesis via transcription factors 
Serpent is needed for hemocyte specification in the embryo. PVR and its ligands PVF1, 2 and 
3, are important for hemocyte survival in the embryo and proliferation in the lymph gland. 
Differentiation of crystal cells requires the transcription factor Lozenge, which is under the 
control of Notch in Drosophila larvae. Plasmatocytes require the transcription factors GCM and 
GCM2. Lamellocytes need the transcription factor Collier, Jak/STAT and Toll signalling have 
also been implicated in lamellocyte differentiation and proliferation. PVF; platelet-
derived/vascular endothelial growth factor, PVR; platelet-derived/vascular endothelial growth 
factor-receptor related, GCM; glial-cells missing, Jak; Janus kinase, STAT; signal transducers 














1.4.3. Hemocytes in Drosophila immune function 
Drosophila hemocytes have two main cellular response mechanisms, phagocytosis 
and encapsulation.  
 Phagocytosis is carried out by the plasmatocytes and these cells are 
responsible for the removal of foreign intruders, apoptotic cells and cell debris 
(Williams, 2007). During Drosophila development, significant cell death occurs and 
hemocytes play an important role in the disposal of these apoptotic cells via the 
scavenger receptor Croquemort (crq) (Franc et al., 1999). The attachment of the 
phagocyte to the particle of interest is the first step of the phagocytosis process, 
followed by modifications to the cytoskeleton, internalisation and the destruction of the 
particle within phagosomes (Meister and Lagueux, 2003). Several receptor proteins 
have been shown to be involved in the process of phagocytosis including proteins 
related to CD36 and Eater. Eater, an epidermal growth factor (EGF)-domain protein, 
is expressed exclusively on prohemocytes and plasmatocytes where it can bind and 
internalise a vast range of bacteria (Kocks et al., 2005).  
 Encapsulation is an important defence mechanism against invading parasites, 
which is mediated by lamellocytes in the larvae of Drosophila (Sorrentino et al., 2002). 
The encapsulation response is most often induced when the parasite is too big to be 
phagocytosed by plasmatocytes, for example following infection with the eggs of a 
parasitic wasp (Small et al., 2012). The invading parasite is detected by 
plasmatocytes that send signals to the lymph gland leading to increased proliferation 
and mass differentiation of lamellocytes from prohemocytes in the secondary lobes 
(Jung et al., 2005). The lamellocytes released from the lymph gland form a multi-
layered case around the invading parasite, which becomes melanised by crystal cells 
and is eventually killed (Vlisidou and Wood, 2015).  
 Hemocytes have the ability to store defence molecules that can be released 
upon infection. For example, plasmatocytes can express immune molecules such as 
the blood clotting factor, hemolectin, or the Toll activating ligand Spätzle (Lemaitre 
and Hoffmann, 2007). Hemocytes are also able to play important signalling roles 
between immune tissues, produce cytokines, such as upd3, and AMPs following 
bacterial infection (Clark et al., 2011; Péan et al., 2017; Shia et al., 2009; Yang and 
Hultmark, 2016).  
1.5. Epigenetic regulation and histone modifications 
Since the early 1960s it has been known that histones, proteins that associate with 
DNA and package it into nucleosomes, are subject to post-transcriptional modification 
(Allfrey et al., 1964), such as methylation and ubiquitination, and play key roles in 
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epigenetic regulation. The core histones H2A, H2B, H3 and H4 join to form the 
nucleosome (Portela and Esteller, 2010). H1 is known as the linker histone, which 
does not form part of the nucleosome, but binds to the DNA linking two histone 
complexes and seals off the nucleosome where the DNA enters and leaves (Daujat et 
al., 2005). Epigenetic regulators can be divided into three main groups, based on their 
function: the epigenetic ‘writers’ place epigenetic marks onto DNA or histones and 
these marks can then be recognised by epigenetic ‘readers’ or removed by epigenetic 
‘erasers’ (Falkenberg and Johnstone, 2014). Epigenetic marks are able to directly 
influence histone-DNA or histone-histone interactions and serve as a docking site for 
epigenetic readers (Bowman and Poirier, 2015). The binding of epigenetic reader to 
post-transcriptional modifications dictates the location and timing of recruitment of 
transcription factors and catalysis complexes (Andrews et al., 2016). Epigenetic 
mechanisms can modify gene expression and alter chromatin without changing the 
DNA sequence, and these epigenetic events are fundamental in maintaining normal 
cellular processes and development (Handy et al., 2011). Many human diseases, 
including cancer, have been implemented by the addition of the wrong type of 
epigenetic mark, or an epigenetic mark being added at the wrong time or in the wrong 
location (Sharma et al., 2010). Modifications to DNA or chromatin-associated proteins, 
such as histones, have important influences on chromatin structure and gene 
expression (Cedar and Bergman, 2009). These modifications can be grouped into two 
main categories: DNA modifications and histone modifications.  
1.5.1. DNA modifications 
DNA modifications have been best characterised by the methylation of cytosine at the 
5-position of the cytosine ring, producing 5-methylcytosine (5mC). This deposition of 
the methyl group on cytosine is predominately carried out by a family of enzymes 
known as DNA methyltransferases (Tough et al., 2016) and is usually associated with 
gene repression. DNA methylation can regulate gene transcription by altering 
recognition sites of proteins that bind DNA or by disrupting transcription factor binding 
sites within gene promoters. Other newly identified DNA modifications include 5-
hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxycytosine (5caC) 
which can be formed following the oxidation of 5mC (Plongthongkum et al., 2014). 
1.5.2. Histone modifications  
Histones are subject to many types of modification, most occur on amino acids within 
the histone tails, which protrude from the nucleosome and provide an exposed 
surface for protein interactions (Jenuwein and Allis, 2001). These modifications play 
important roles in DNA repair and replication, transcriptional regulation and alternative 
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splicing (Portela and Esteller, 2010). Acetylation and methylation of histones are the 
most well studied modifications and many families of proteins are involved in adding, 
removing, or recognising these epigenetic marks, which are also known as writers, 
erasers and readers respectively. Acetylation of core histones occurs most frequently 
on multiple lysine residues, and is typically associated with gene expression. Histone 
acetylation is thought to alter the net charge of the histone and weaken its interaction 
with DNA, leading to the chromatin becoming more accessible to gene expression 
machinery and transcription factors (Hong et al., 1993). However, acetylated lysine 
residues can also act as recognition signals for reader proteins, predominantly to 
those containing acetyllysine recognition domains, to recruit proteins able to modify 
chromatin structure and gene transcription (Zeng and Zhou, 2002). The methylation of 
histones is more complex than that of acetylation as both lysine and arginine residues 
can be methylated (Alban et al., 2014) and the effects of methylation on gene 
transcription are far more varied. Interestingly, lysine residues can be mono-, di-, or 
tri-methylated (Martin and Zhang, 2005), whereas arginine can only be mono- or di-
methylated (Bedford and Richard, 2005). Unlike acetylation, the process of 
methylation does not alter the charge of the histone, however it does recruit reader 
proteins to the DNA (Musselman et al., 2012). Methylation patterns can have diverse 
effects on transcriptional states, for example tri-methylation (Me3) of lysine (K) 4 in 
histone H3 (H3K4Me3) near the transcriptional start site is associated with gene 
expression, while H3K27Me3 further from the start site is usually associated with 
repression (Tough et al., 2016).  
1.6. Bromodomain-containing proteins 
Bromodomain-containing proteins (BCPs) can recognise acetyllysine residues on the 
tails of histones (Figure 1-14), specifically of histone H3 and H4, and regulate 
chromatin structure and gene expression (Fujisawa and Filippakopoulos, 2017). As 
BCPs recognise acetyllysine residues many of them are classed as epigenetic 
readers. The bromodomain (BD) family of proteins are comprised of a wide range of 
chromatin-associated proteins, including histone acetyltransferases (HATs) and 
chromatin-remodeling factors (Barbieri et al., 2013). BDs have been identified in a 
number of proteins with varying domain architecture and functions (Muller et al., 
2011). The first BD was identified in the Drosophila brahma (brm) gene as a protein 
domain of approximately 110 amino acids (Haynes et al., 1992). In more recent years, 
these proteins have been divided into three main families, histone acetyltransferases, 
chromatin-remodeling complexes and bromodomain and extraterminal domain (BET) 




















Figure 1-14: Bromodomain-containing protein (BCP) mechanism 
The bromodomain (BD; green) of BCPs are able to recognise and bind acetyllysine resides 
(Ac; purple) on histone tails. 
1.6.1. Histone acetyltransferases (HATs) 
Histone acetyltransferases (HATs) are enzymes that acetylate conserved lysine 
amino acids in histones, they include Gcn5 and p300 cAMP-response-element 
binding (CREB)-binding protein associated factor (PCAF) in mammals. The 
bromodomain of the HAT complex is generally responsible for anchoring the HAT 
complex to acetylated chromatin, leading to acetylation of adjacent nucleosomes 
(Josling et al., 2012). Although some BCPs regulate gene expression only through 
their HAT activity, others can also regulate transcription directly through interactions 
with transcription factors (Bannister and Miska, 2000). In yeast, Gcn5 contains both a 
HAT and a bromodomain that usually bind to acetylated histone H3, and to a lesser 
extent histone H4 (Sterner and Berger, 2000). The Gcn5 protein is a component of 
the SAGA (Spt-Ada-Gcn5 acetyltransferase) complex which is enriched on promoters 
of active genes and positively regulates transcription by RNA polymerase II (Robert et 
al., 2004). The mammalian p300 protein also has a bromodomain and a HAT domain, 
as well as other domains involved in protein binding. The bromodomain of p300 binds 
to all core histones (preferentially H3), and is required for p300 to bind to chromatin. 
p300 also has several other domains which allows them to bind a large number of 
proteins including TATA-binding proteins (TBP), RNA helicase A and RNA 
polymerase II, and this interaction allows them to act as transcriptional co-activators 
(Swope et al., 1996). It has also been shown that p300 can regulate gene expression 
not just on acetylated histones, but also by recruiting RNA polymerase II and 










1.6.2. ATP-dependent chromatin-remodeling complexes  
ATP-dependent chromatin-remodeling complexes utilise energy generated from ATP 
hydrolysis to locally alter and disrupt the association of histones with DNA, allowing 
nucleosome movement (Vignali et al., 2000). These complexes include brm, 
SWItch/Sucrose Non-Fermentable (Swi2/Snf2) and Bramha-related gene 1 (Brg1). 
The bromodomain components within these complexes are critical for the recruitment 
of the complex to the genes that they regulate, and subsequent chromatin remodeling 
complexes can influence gene expression by mechanisms such as improving access 
to the promoter region for the transcriptional machinery (Hassan et al., 2001). The 
chromatin remodeling SWI/SNF complex regulates a subset of genes in yeast, 
Drosophila and mammals (Tang et al., 2010); it is found in the promoter region of 
these genes, and its chromatic remodeling activities allow for greater access for the 
transcriptional machinery (Peterson and Workman, 2000). The complex remains 
associated with RNA polymerase II during elongation and can play a role in 
transcriptional repression (Sudarsanam and Winston, 2000).This complex contains a 
catalytic ATP-dependent helicase component, known as Swi2/Snf2, which contains a 
bromodomain that preferentially binds to acetylated histone H3, particularly H3K14ac 
(Chatterjee et al., 2011). Swi2/Snf2 show similarities to the human proteins BRG1 and 
the Drosophila protein brahma (Elfring et al., 1998). The transcriptional activator, 
Brg1, encodes a 205K nuclear protein and contains extensive homology to Swi2 in 
humans (Khavari et al., 1993). Deletion of the bromodomain of Swi2/Snf2 shows 
reduced binding to acetylated histones and as a result leads to a reduction in 
chromatin remodeling (Awad and Hassan, 2008). 
1.6.3. Bromodomain and extraterminal (BET) proteins 
The BET family is a novel class of transcription regulators (Loyola and Almouzni, 
2004) including Brd2, Brd3 and Brd4 (De Riick et al., 2013). These proteins contain 
two bromodomains at their amino-terminal end as well as a conserved extraterminal 
(ET) domain at the carboxyl end that serves as a protein-protein interaction module 
(Josling et al., 2012). Similarly to other bromodomain proteins, BET proteins are 
primarily involved in regulating transcription through their interactions with a range of 
other proteins and retroviruses including murine leukemia virus (MLV). Members of 
the BET family have been recognised as essential genes in mediating inflammatory 
response, but also for the replication of viruses (Filippakopoulos et al., 2010). 
Interestingly, BET proteins are involved in gene regulation via a number of different 
mechanisms. Brd2 (also known as RING3) is a mammalian BET protein with kinase 
activity that is associated with the promoters of a subset of cell cycle genes including 
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cyclins. Brd2 binds as a dimer to acetylated residues in histone H4; its first 
bromodomain binds to H4K12ac and strongly to H1K74ac, and the second 
bromodomain binds as a dimer to H4K5ac and H4K8ac (Josling et al., 2012). Brd2 
functions as part of a complex, and much like many other bromodomain proteins, it is 
involved in the activation of cell cycle genes regulated by the cellular E2 factor (E2F) 
transcription factors and forms complexes with them. Brd2 is also required to recruit 
the general transcription factor TATA binding protein (TBP) to the E2F complex (Peng 
et al., 2007). Mutations within both bromodomains in human embryonic kidney (HEK) 
293 cells leads to an inhibition of transcription (LeRoy et al., 2008), suggesting Brd2 
plays a critical role in regulating transcription by facilitating the recruitment of 
transcription factors to target genes. A number of polymorphisms in Brd2 have been 
linked to rheumatoid arthritis (Mahdi et al., 2009) and Brd2 knockout mice show 
severe obesity and a reduction in an inflammatory response (Wang et al., 2009). Brd4 
(also known as MCAP) has a similar structure to Brd2, with an additional C-terminal 
motif that is involved in interacting with other proteins (Crowe et al., 2016). Brd4 binds 
to acetylated histone H3 and H4, with the first bromodomain predominantly binding to 
acetylated H3 including H3K56ac but also H2AK85ac (Filippakopoulos et al., 2012), 
whereas the second bromodomain has a higher affinity for acetylated histone H4 
(Vollmuth et al., 2009), but will bind strongly to various acetylated H2, H3 and H4. It is 
also able to bind to the active form of the positive transcription elongation factor b 
(PTEFb) complex (Schroder et al., 2011), an over-expression of Brd4 causes PTEFb 
to increase phosphorylation of RNA polymerase II leading to increased transcription 
(Jang et al., 2005), showing Brd4 is important for regulating transcription. 
 The human genome encodes 61 BCPs in 46 different proteins (Junwei and 
Vakoc, 2014) and some have now been implicated in disease processes (Sanchez 
and Zhou, 2009). Brd4 plays an important role in various biological processes 
including functioning within the inflammatory response as a co-activator for the 
transcriptional activity of NF-κB and controlling viral gene transcription (Yang et al., 
2005). Brd2 has exhibited histone chaperone activity, in mice it is thought to be 
essential for embryonic development, and furthermore an association between Brd2 
and epilepsy in humans has also been described (Pal et al., 2003). p300 has also 
been suggested to play a role in the IL-6 signalling pathway, via an interaction 
between STAT3 amide-terminal domain and p300, stabilising the STAT3-p300/CREB-
binding protein (CBP) complex (Hou et al., 2008). Recent studies have suggested 
BCPs may have functional roles in cancer cell survival and proliferation (Sanchez and 
Zhou, 2009). Research also demonstrated an important role for BET proteins in 
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modulating T-cell differentiation in vitro, therefore reducing the inflammatory response 
by transferred cells in vivo (Bandukwala et al., 2012).  
1.6.4. Bromodomains as therapeutic targets 
The development of novel pharmaceutical approaches that target inflammatory gene 
expression by interfering with the recognition of acetylated histones by BET proteins 
has become a main focus as a potential treatment for cancer and a number of 
inflammatory diseases including rheumatoid arthritis (Klein et al., 2016). A synthetic 
compound, known as I-BET has been shown to mimic acetylated histones and disrupt 
the chromatic complex responsible for the expression of inflammatory genes in 
activated macrophages (Nicodeme et al., 2010). The small molecule, JQ1 is a 
synthetic BET inhibitor and has been shown to suppress inflammatory responses in 
the brain of the 3xTg mouse model of Alzheimer’s disease (Magistri et al., 2016). In 
the murine periodontitis model, systemic administration of JQ1 also significantly 
inhibits inflammatory cytokine expression (Meng et al., 2014). 
1.7. Jumonji domain-containing proteins 
Jumonji (Jmj) domain-containing proteins (JDCPs) are a family of proteins with 
functional roles in a number of biological processes including transcriptional 
repression and DNA/RNA repair through the demethylation of N-methylated nucleic 
acids (Figure 1-15) (Upadhyay et al., 2011). The jumonji family contains four distinct 
clusters: JMJD2A-D and JARID1/2, JMJD3 and UTX/UTY, JMJD1A-C and Hairless, 
and finally FBXL10/11 and PHF2/8 (Cloos et al., 2008). The jumonji protein has a 
DNA binding domain (ARID), and two conserved jmj domains (jmjN and jmjC) 
(Takeuchi et al., 2006). In many species, there are known jumonji family proteins that 
have only the jmjC domain or both the jmjN and jmjC domains (Takeuchi et al., 2006). 
Several members of the jumonji family demethylate lysine residues in histones and 
are involved in chromatin regulation and/or transcription regulation (Klose et al., 
2006). The function of the jmjN domain is widely unknown, however the jmjC domain 
is thought to play an essential role in histone demethylation and targets the removal of 
all three histone lysine methylation states (mono-, di- and trimethylation), most JmjC 
histone demethylase proteins characterised so far are capable of demethylating 
trimethylated lysines, and in many circumstances favour a trimethylated substrate 
(Tsukada et al., 2006). Drosophila Jmj shares high homology with the mammalian Jmj 
in the JmjN, JmjC and AT-rich interaction domains (Sasai et al., 2007). Data suggests 
Jmj in Drosophila play an important role in transcriptionally inactive chromatin and 
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controlling the expression of important developmental genes by modifying chromatin 
into silent transcriptional states (Sasai et al., 2007).  
 Jmj proteins, particularly JmjC-driven demethylase reactions have been 
identified in various biological processes, such as posterior development (Lan et al., 
2007), prostate cancer (Xiang et al., 2007a), rRNA expression (Frescas et al., 2007), 
and androgen nuclear receptor-mediated gene expression (Yamane et al., 2006). It 
has also been shown as a transcriptional repressor and represses cyclin D1 
transcription in the embryonic heart, which is required for normal cardiogenesis 
(Willems and Mercola, 2013), along with important roles in the development of 
multiple tissues. It has also been shown that H3K27 demethylation, specifically by 
JMJD3 catalytic activity, is critical for pro-inflammatory gene expression in human 


















Figure 1-15: Jumonji domain-containing protein (JDCP) mechanism 
The jumonji protein (Jmj; red) demethylates mono-, di- and tri-methylated residues (Me; 
orange) on histone tails. 











1.8. Thesis outline 
1.8.1. General hypothesis 
female sterile (1) homeotic (fs(1)h), the sole bromodomain and extraterminal domain 
(BET) protein in Drosophila, plays an essential role in immunity and metabolism in the 
Drosophila fat body.  
1.8.2. Thesis structure 
Chapter 1 provided an overview of Drosophila melanogaster, the model organism 
used in this study, along with a detailed description of the Drosophila immune 
response and its regulation of metabolism in both fed and starved states. Chapter 1 
also introduced two families involved in epigenetic regulation known as the 
bromodomain-containing proteins (BCPs) and jumonji domain-containing proteins 
(JDCPs). The materials and methods used throughout the course of this thesis are 
described in Chapter 2.  
 Chapter 3 investigates the roles of BCPs and JDCPs in Drosophila immune 
cells following bacterial infection. This includes the use of tissue-specific RNAi 
knockdowns of BCPs and JDCPs and infecting the flies with Listeria monocytogenes 
or Francisella novicida, one Gram-positive and one Gram-negative intracellular 
bacteria. This chapter describes the survival screens that were carried out using two 
fat body drivers (c564-Gal4 and r4-Gal4) and two hemocyte drivers (HmlΔGal4, UAS-
2xeGFP and crq-Gal4). The survival screens led to the identification of female sterile 
(1) homeotic, fs(1)h, being short-lived following fat body knockdown. fs(1)h is a 
bromodomain-containing protein, and the survival screens suggested it is essential in 
the fat body for Drosophila survival.  
 Chapter 4 further describes the immune role of fs(1)h when it is knocked down 
in the Drosophila fat body, following on from the data obtained in Chapter 3. This 
chapter also investigates the novel role fs(1)h has in Drosophila immunity, 
metabolism, insulin signalling and nutrient sensing. Much of the data obtained in this 
chapter suggests many of the phenotypes observed are foxo-dependent and that 
fs(1)h in the fat body has a key in vivo function in promoting and regulating systemic 
insulin signalling activity. 
 The data obtained from Chapter 4 shows that knocking down fs(1)h in the 
Drosophila fat body leads to a range of phenotypes, mainly due to FOXO 
hyperactivation. Chapter 5 aims to investigate the role of FOXO in the flies with fs(1)h 
knocked down in the fat body. The data in this chapter shows that removing one copy 
of foxo in flies lacking fs(1)h in the fat body can rescue many of the phenotypes 
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observed, confirming much of it is foxo-dependent. However, data in Chapter 5 also 
shows some of the phenotypes, particularly following bacterial infection, can not be 
rescued by foxo heterozygosity, suggesting there is also a foxo-independent role for 
fs(1)h in the fat body. Furthermore, Chapter 5 begins to investigate potential physical 
or transcriptional interactions between fs(1)h, FOXO and AKT.  
 Chapter 6 investigates the effects of the pharmacological inhibitor, I-BET151, 
and siRNAs for mammalian BET proteins in the human cell line, THP-1, on insulin 
signalling. The first part of this chapter uses the small-molecule inhibitor, I-BET151, to 
treat THP-1 cells and investigate any changes in the insulin-signalling pathway by 
measuring protein levels of activated AKT and FOXO3a. The second part of this 
chapter uses small interfering RNAs (siRNAs) to individually knockdown three of the 
mammalian bromodomain and extraterminal domain (BET) proteins known as 
bromodomain-containing protein 2, 3 and 4 (Brd2, 3, 4), in THP-1 cells. This part 
includes checking the efficiency of each siRNA knockdown and measuring activated 
AKT and FOXO3a protein levels. 
 Chapter 7 includes a detailed discussion of the data shown in this thesis in 
relation to the known literature in both Drosophila and mammals, as well as an 
outlook on future work.  	 	
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Chapter 2  		
Materials and Methods 	 	
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2.1. Maintenance of Drosophila melanogaster 
2.1.1. Fly stock maintenance 
Drosophila stocks and experimental flies were kept in incubators at 18°C, 25°C, or 
29°C, with 60% humidity. They were housed with a running 12hour light: 12hour dark 
cycle to help maintain the flies’ natural circadian rhythm. Individual fly stocks that were 
not being used experimentally, were kept in duplicate in vials containing 
approximately 8ml of fly food in the 18°C incubator until required, at which point they 
were expanded and placed at 25°C. Fly stocks were checked at regular intervals to 
ensure stocks were healthy and of the correct phenotypic characterisations. Stocks 
were also transferred to fresh food vials every 3-4 weeks without CO2 anaesthesia.   
2.1.2. Fly food preparation 
Flies were kept on food containing 10% weight to volume Brewer’s yeast, 2% polenta 
and 0.8% agar (MP Biomedicals), 8% fructose (Sainsbury’s supermarkets Ltd), 0.5% 
nipagin (Methyl 4-hydroxybenzoate, Sigma-Aldrich) in 15% ethanol, and 0.75% 
propionic acid (Sigma-Aldrich). 
 Agar and polenta was added to three-quarters of the total water, brought to the 
boil and simmered for 2 minutes whilst being stirred constantly to prevent burning. 
The heat was then reduced before adding yeast and fructose, along with the 
remaining water allowing the food to cool down. Once the temperature had cooled to 
below 70°C, the nipagin (in 15% ethanol) and propionic acid were added as 
antimicrobial and antifungal agents. Approximately 8ml of food was pumped into each 
vial, and sealed immediately with a cotton bung to prevent any contamination. 
Following cooking, the sealed vials were kept at room temperature or 4°C until 
required, if kept at 4°C the vials were left to warm up at room temperature before 
placing flies on it.  
2.1.3. Identifying males and females  
Adult Drosophila were anaesthetised under a light microscope on a porous CO2 gas 
pad, moving and separation of flies was carried out using a soft bristled paintbrush to 
prevent damaging the flies. The identification of males and females was distinguished 
by a number of physical characteristics: 
(i) Females tend to be larger than males. 
(ii) Males show darker abdominal pigmentation and genitalia than females.  
(iii) Male flies have sex combs, which are located on the first pair of legs and 
used to attach to the female during mating. The sex combs can be 
identified under a light microscope as thick black hairs.   
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2.1.4. Virgin collection 
Fly vials containing hatching pupae were cleared of any adults and left for new flies to 
eclose. Virgin females were collected up to 6 hours post eclosion, as during this 
period they will not have mated. Virgin female can be visually identified through their 
pale colouring and a dark spot in the abdomen, known as the meconium, which 
consists of waste products remaining from pupation. Collected virgin females were 
kept in separate vials at 25°C for three days before carrying out any crosses, to 
ensure the collected females were virgins. Any vials seen to contain eggs or larvae 
and consequently not virgins, were discarded.  
2.2. Drosophila Stocks 
During this thesis a number of Drosophila melanogaster lines were used to carry out 
experiments that are described below. 
2.2.1. Wild type stocks 
The w1118, white eyed, wild type fly line (with isogenic X, second and third 
chromosomes), was the predominant control fly line used. These flies carry an 
insertion in the white allele leading to white-eye colour. The w1118 flies were also used 
when crossing experimental flies to generate heterozygote controls.  
2.2.2. The Gal4-UAS system 
The Gal4- upstream activating sequence (UAS) system, developed by Brand and 
Perrimon in 1993, is commonly used in Drosophila to achieve spatially and temporally 
restricted gene expression (McGuire et al., 2004). In this system, a P element carrying 
the transcriptional activator in yeast, Gal4, leads to the expression under the control of 
endogenous tissue-specific enhancers that allows tissue-specific expression of Gal4. 
Gal4 can recognise and bind UAS sequences in the DNA and facilitate transcription of 
the target transgene that has been cloned downstream of the UAS leading to tissue-
specific expression or knockdown (Figure 2-1).  
 The Gal4-UAS system was used throughout this thesis, most frequently for 
tissue-specific knockdown of target genes in the Drosophila fat body and hemocytes. 




Figure 2-1: The Gal4-UAS system 
The yeast transcription factor, Gal4, activates transcription of its target gene by binding to the 
UAS. The driver line provides tissue-specific Gal4 expression (left) and the gene of interest is 
under UAS control allowing expression or knockdown of the gene of interest (right). UAS; 
upstream activating sequence.   
2.2.3. Temperature sensitive Gal80 (Gal80ts) system 
Temperature sensitive Gal4-repressor Gal80 (Gal80ts) uses alterations in temperature 
to regulate the Gal4-UAS system. Ubiquitously expressed Gal80ts in Drosophila binds 
to the carboxy-terminal of Gal4 and represses transcriptional activation at 18°C. 
However, when shifted to 29°C the Gal80ts is degraded and the Gal4 can activate the 
expression or knockdown of the specific transgene downstream (Figure 2-2).  
 
Figure 2-2: Temperature sensitive Gal80 in the Gal4-UAS system 
At 18°C, Gal80 binds to the Gal4 repressing transcriptional activation (top). At 29°C, Gal80 is 
released allowing Gal4 to activate transcription (bottom).  
2.2.4. RNA interference (RNAi)  
To investigate the roles of specific genes in detail, RNAi lines of various genes of 
interest were obtained. The RNAi lines used in this thesis are shown in Table 2-2. The 
RNAi lines were linked to upstream activating sequences (UAS) and when used in 
combination with a Gal4 driver tissue-specific knockdown of the target gene is 
achieved. The Gal4-UAS system drives the expression of a hairpin RNA (hpRNA), 
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which is in turn cut by Dicer, an enzyme that produces small interfering RNAs 
(siRNAs). The siRNAs bind to mRNA and lead to sequence-specific degradation of 
the target mRNA, which results in the loss of translation of the gene of interest in a 
specific tissue of interest (Figure 2-3).  
 	 	
Figure 2-3: RNA interference (RNAi) in Drosophila using Gal4-UAS 
The Gal4-UAS system is used to drive the expression of a hairpin RNA (hpRNA), the double-
stranded RNAs are processed by the enzyme Dicer into small interfering RNAs (siRNAs) 
which sequence specifically degrades the mRNA of the target gene. This degradation leads to 
a loss of translation of the target gene ubiquitously or in a specific cell type such as hemocytes 
or the fat body (Adapted from VRDC, 2017). 
2.2.5. Balancer Chromosomes 
Balancer chromosomes are an essential tool when working with Drosophila; they are 
used to prevent recombination, maintain deleterious mutations in stocks and allow the 
tracking of chromosomes following Drosophila crosses (Rubin and Lewis, 2000). A 
number of fly lines used in the thesis have the addition of balancer chromosomes in 
order to prevent lethal or sterile mutations being lost from a Drosophila population 
(Muller, 1918) and stop multiple alleles on the same chromosome from being 
separated by meiotic recombination (Miller et al., 2016). Balancer lines used in this 
thesis are shown in Table 2-3. 
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2.2.6. Experimental flies and crosses 
Flies required for experiments were crossed and kept at 25°C, whereas stocks were 
maintained at 18°C. Unless stated otherwise, male flies were used for all experiments. 
 Fly crosses were carried out in standard vials, containing standard fly food. 
Approximately 5 virgin females of the required tissue-specific Gal4 driver line and 4 
males of the w1118 line as the driver line control or the necessary UAS responder line 
was crossed for each experiment carried out. Gal4 crosses were maintained at 25°C, 
with progeny being ready to collect approximately 10 days following the setup of the 
cross. An example of the control and experimental crosses are shown in Figure 2-4. 
 
Figure 2-4: An example of the Drosophila crosses set in this thesis 
A. For each experiment a control cross was set up, virgin females of each tissue-specific Gal4 
driver were crossed to w1118 male flies. The male offspring from these crosses were aged for 5-
7 days and used for the required experiments. B. The experimental crosses were set up along 
side the control crosses, but this time the virgin females of each tissue-specific Gal4 driver 
were crossed to each of the UAS-RNAi lines or other required lines. The male offspring from 
the crosses with the required genotype were aged for 5-7 days and used for the required 
experiments. 	  
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2.3. Drosophila stocks used in this thesis 
The transgenic fly lines used in this thesis are listed in Table 2-1 below. 
Fly Stock Chromosomal 
Location 
Purpose 
w1118;c564-Gal4 II Fat body expressed Gal4 line. 




expressed Gal4 line. Can also be 
used to visualised hemocytes (2x 
eGFP). 
w1118;;crq-Gal4/Tm6c Sb1 III Hemocyte/plasmatocytes 
expressed Gal4 line. 
Table 2-1: List of transgenic Gal4 driver lines 







Gene Name Chromosome 
Location 
VDRC 22108 UAS-CG5383-IR Phosphatidyl-serine 
receptor (PSR) 
III 
VDRC 22689 UAS-CG5383-IR Phosphatidyl-serine 
receptor (PSR) 
III 
VDRC 24740 UAS-CG32346-IR Enhancer of bithorax 
(E(bx)) 
III 
VDRC 33446 UAS-CG1966-IR ATP-dependent 
chromatin assembly 
factor large subunit 
(ACF) 
I 
VDRC 33447 UAS-CG1966-IR ATP-dependent 
chromatin assembly 
factor large subunit 
(ACF) 
III 
VDRC 35962 UAS-CG8569-IR - II 







VDRC 37720 UAS-CG5942-IR brahma (brm) III 
VDRC 37721 UAS-CG5942-IR brahma (brm) III 
VDRC 46645 UAS-CG32346-IR Enhancer of bithorax 
(E(bx)) 
I 
VDRC 100383 UAS-CG42799-IR dikar II 
VDRC 100735 UAS-CG10897-IR toutatis (tou) II 




VDRC 101737 UAS-CG5206-IR bonus (bon) II 






VDRC 102885 UAS-CG15319-IR nejire (nej) II 
VDRC 103830 UAS-CG9088-IR little imaginal discs 
(lid) 
II 
VDRC 104121 UAS-CG5653-IR - II 
VDRC 104879 UAS-CG14514-IR Bromodomain- 
containing 8 (Brd8) 
II 
VDRC 105115 UAS-CG15319-IR nejire (nej) II 
VDRC 105986 UAS-CG5640-IR Utx histone 
demethylase (Utx) 
II 
VDRC 106119 UAS-CG17603-IR TBP-associated 
factor 1 (TAF-1) 
II 
VDRC 107312 UAS-CG42799-IR dikar II 
VDRC 107321 UAS-CG1815-IR - II 






VDRC 107819 UAS-CG2982-IR - II 





VDRC 107992 UAS-CG7154-IR - II 
VDRC 108618 UAS-CG11375-IR polybromo II 
VDRC 108662 UAS-CG2252-IR female sterile (1) 
homeotic (fs(1)h) 
II 
VDRC 108848 UAS-CG10133-IR - II 




VDRC 109290 UAS-CG3654-IR Jumonji, AT rich 
interactive domain 2 
(Jarid2) 
II 
VDRC 109294 UAS-CG43320-IR - II 




VDRC 109417 UAS-CG7200-IR - II 




VDRC 110485 UAS-CG7460-IR - II 
VDRC 110808 UAS-CG31132-IR BRWD3 II 
VDRC 51227 UAS-CG2252-IR female sterile (1) 
homeotic (fs(1)h) 
III 

















w1118 Fm7a X  Bar eyes 
w1118; If/Sm6a II Bar eye (If), Curly 
(Sm6a) 
w1118;; TM2/Tm6c Sb1 III Ebony (TM2) Stubble 
(Tm6c Sb1) 
w1118; If/Sm6a; TM2/Tm6c Sb1 II and III  
 
Bar eye, Curly, ebony 
and Stubble 
Table 2-3: Balancer lines used in this thesis 
Other lines used in this thesis are shown below in Table 2-4. 
Fly Line Chromosomal Location Purpose 
w1118; FOXOGFP II GFP-tagged FOXO 
fusion protein 
w1118;; foxoΔ94/Tm6c Sb1 III foxo mutant flies 
Table 2-4: Other fly lines used in this thesis 
2.4. Life span assays 
There were a number of different types of life span assays used in this thesis. The life 
span of the flies was measured under normal physiological conditions, following 
infection and following starvation. 
2.4.1. Physiological Survival  
Male flies were collected following eclosion for 3-4 days to obtain between 20-30 age-
matched flies per genotype and placed onto new fly food. All survival experiments 
were carried out at room temperature, 25°C or 29°C.  
 In all survival assays carried out, each vial was checked daily for any fly 
deaths that may have taken place and numbers were recorded. Food vials were also 
kept horizontally during the assay to prevent the flies getting stuck in the food.   
2.4.2. Starvation survival 
For starvation survivals, male flies were collected from the relevant crosses and 
maintained for 5-7 days on standard fly food at 25°C. Following this time, groups of 
approximately 20 flies per genotype were transferred onto vials of new, standard fly 
food as a control or vials of agar (with 1% PBS), allowing the flies to have access to 
water and prevent desiccation. These experiments were usually carried out at room 
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temperature or 25°C. Each vial was checked every two hours during the day for any 
fly deaths that had taken place and numbers were recorded. 
2.4.3. Infection survival 
Male flies were collected following eclosion for 3-4 days to obtain enough flies per 
genotype and then aged for between 5-7 days at 25°C. For all infection survivals, flies 
were put into groups of 20-30 individuals, one group was an uninjected control, and 
the other groups of flies were injected into the abdomen with sterile PBS as a 
wounding control, or infected with Listeria monocytogenes (L. monocytogenes) or 
Francisella novicida (F. novicida). All infection survival experiments were carried out 
at 25°C or 29°C.	
2.5. Injection assays 
2.5.1. Calibration for injection 
Fly injections were carried out with microinjection needles that were produced from 
borosilicate glass capillaries (Kwik-Fil) and a needle puller (Model PC-10, Narishige). 
Injections were performed using a PicospritzerR III, and the injection volume was 
calibrated by expelling a drop of liquid from the needle into a pot of mineral oil and 
halocarbon oil (both Sigma). The expelled drop was measured using the microscope 
graticule to obtain a final injection volume of 40 nanolitres (nl). 
2.5.2. Bacterial culture and infection 
The bacterial stocks of L. monocytogenes and F. novicida (U112 strain) were stored 
at -80°C. Small quantities of these stocks were removed using a plastic scraper and 
dipped into the selected media, L. monocytogenes was placed in Tryptic Soy Broth 
(TSB, Sigma Aldrich) and F. novicida in Brain, Heart Infusion (BHI, Oxoid) media. The 
individual cultures were grown over night at 37°C, either still (L. monocytogenes) or 
shaking (F. novicida). The following day, the cultures were centrifuged at 12,000g for 
10 minutes and the supernatant was discarded. The bacterial pellets were re-
suspended in sterile PBS (Corning) and the optimal density (OD) was measured at 
the wavelength of 600nm (OD600), the bacterial stocks were diluted to an OD of 0.1 
prior to injections. Once the needle was calibrated (see 2.5.1) flies were 
anaesthetised on CO2 and injected into their abdomen with 40nl of liquid. 
 Following bacterial infection, flies were placed back into vials at 29°C, counted 
daily for survival assays or six hours post infection the flies were homogenized in 
100µl TRIzol (TRI reagent, Sigma) and stored at -20°C ready for the generation of 
cDNA and RT-qPCR analysis. The flies were homogenized six hours post infection in 
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order to observe maximum AMP induction. For some experiments, infected flies (and 
controls) were also kept at 29°C for 24 hours and then homogenized in 75µl 2x 
Laemmli loading buffer (100mM Tris [pH6.8], 20% glycerol, 4% SDS, 0.2M DTT). The 
samples were stored at -80°C until required for Western blot analysis. 
2.5.3. Insulin injection 
Male flies of the appropriate genotypes were collected and aged for 5-7 days at 25°C. 
Flies were starved for 1 hour prior to injections, and using the microinjection needles 
the flies were injected into the abdomen with 40nl of PBS or human insulin (Sigma) 
resuspended in PBS at a low dose (1.28µg/ml) or a high dose (6.4µg/ml). The flies 
were homogenised 10 minutes post-injection in 75µl 2x Laemmli loading buffer. The 
samples were stored at -80°C until required for Western blot analysis. 
2.5.4. 2-NBDG injection 
Male flies of the appropriate genotypes were collected and aged for 5-7 days at 25°C. 
Using the microinjection needles, the flies were injected into the abdomen with 40nl of 
PBS or 2-NBDG (50mM, Cayman chemical) resuspended in sterile PBS and placed at 
29°C for 1 hour prior to imaging. Images were acquired using a Leica SP5 
microscope. Images were obtained using the Leica LAS-AF software with either the 
10x numerical aperture (NA) 0.4 objective or the 20x Dry NA 0.5 objective. All images 
had the resolution of 1024 x 1024 pixels, at a scan speed of 400Hz. There was a 4 
line average carried out during imaging to obtain the highest quality images. Tile 
scanning was used in order to image whole flies, as it was not possible to image a 
whole fly in a single tile. Following imaging, the Leica LAS software automatically 
merged the two image tiles, producing one image of a whole fly. 	
2.6. Fat body dissection 
Male flies of the appropriate genotypes were aged for 5-7 days prior to fat body 
dissection. Flies were anaesthetised on CO2, then one at a time moved onto the 
dissecting plate and secured by placing a fine dissecting pin (Austerlitz Insect Pins, 
Size 1) through the thorax. The legs and wings were removed using dissection 
scissors, and the abdomen was secured by placing a second dissecting pin through 
the genital segment. The fly was covered in chilled sterile PBS, and any bubbles were 
removed using a plastic pipette. Two pairs of forceps were used to open the abdomen 
along the ventral midline, and the guts and gonads were removed. The cuticle 
connecting the thorax and abdomen was cut and any heart or tracheal tissue still 
attached to the abdomen section was removed and discarded. The abdominal 
cuticular surface, which is internally covered in a layer of fat body, was taken for RT-
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qPCR analysis. The dissected fat body samples were stored with 3 dissected flies in 
100µl TRIzol (Sigma) for RT-qPCR analysis. All samples were stored at -20°C until 
required. This dissection technique was adapted from Krupp and Levine (2010). 
2.7. RT-qPCR (Real Time-quantitative Polymerase Chain Reaction) 
2.7.1. Generation of cDNA from whole flies and dissected fat body samples 
RNA extractions were carried out using TRIzol (Sigma), three flies per sample were 
homogenised in 100µl of TRIzol and left to sit at room temperature for 5 minutes. 
Chloroform (20µl, VWR) was added to each sample for washing. Samples were mixed 
thoroughly and left at room temperature for 3 minutes, the samples were then 
centrifuged at 12,000rpm for 15 minutes at 4°C. The upper aqueous phase was 
removed from each of the microfuge tubes and placed into new tubes; the lower, 
organic phase was discarded. Once each sample had been transferred into new 
tubes, 50µl isopropanol (VWR) was added and mixed well in order to precipitate the 
RNA. The tubes were left for 10 minutes at room temperature, and then spun at 4°C 
for 10 minutes at 12,000rpm. The supernatant was removed and the RNA pellets 
were washed in 200µl of 75% ethanol (VWR). The samples were centrifuged for 5 
minutes at 13,000rpm and the ethanol was removed and discarded. The RNA pellets 
were re-suspended in 40µl DNAse1 mix (Table 2-5).  
DNAse 1 Components Quantity per sample Manufacturer 
RNAse-free water 34µl Ambion 
10x DNA buffer  
(Buf. DNAse1 + MgCl2) 
4µl Thermo Scientific  
DNAse1, RNAse-free 2µl Thermo Scientific 
Table 2-5: DNAse1 Mix Components 
Each RNA sample was then incubated for 30 minutes at 37°C to remove any residual 
genomic DNA. Following incubation, 4µl 25mM EDTA (Thermo Scientific) was added 
to each sample to bind magnesium ions and samples were incubated at 68°C for 10 
minutes. Reverse transcription was carried out by incubating 10µl of the DNAse-
treated RNA with 1µl Random Hexamers (Thermo Scientific) at 68°C for 5 minutes 
and then incubated on ice for 5 minutes. Following the 5-minute incubation, 9µl of the 
reverse transcription mix (Table 2-6) was added to each sample. Samples were left to 
incubate at room temperature for 10 minutes and then for 1 hour at 37°C. Finally, the 
samples were heated at 68°C for 10 minutes to inactivate the enzymes. The 20µl of 






Quantity per sample Manufacturer 
M-MuLV buffer (Buf RT) 4µl Thermo Scientific 
10mM dNTPs 
(deoxyribonucleotides) 
2µl Thermo Scientific 
RNAse inhibitor (Ribolock) 1µl Thermo Scientific 
Reverse Transcriptase 
(RevertAid) 
1µl Thermo Scientific 
RNAse-free water 1µl Ambion 
Table 2-6: Reverse Transcription Mix Components 
2.7.2. RT-qPCR 
Following the production of the cDNA (20µl), half of each sample was taken from each 
tube and combined to make the first of eight standards in a 1:3 dilution series. The 
remaining 10µl of cDNA was mixed in a 1:40 dilution with 1x TE buffer (10mM Tris, 
1mM EDTA). The RT-qPCR was run using 4.8µl diluted cDNA along with 5µl 2x 
Sensimix SYBR green no-ROX (Bioline) and 0.2µl of a 10µM primer pair mix of 
choice, with a total reaction volume of 10µl. The primer stocks were stored at a 
concentration of 100mM in TE buffer at -20°C, and further diluted to 10µM working 
stocks containing both left and right primer pairs (Table 2-7). 
 A Corbett Rotor-Gene 6000 was used to run the RT-qPCR, and the cycle 
settings used were: Hold 95°C for 15 minutes, then 40 cycles of 95°C for 15 seconds, 
57°C for 30 seconds, 72°C for 30 seconds, and finally a melting curve from 72°C to 
95°C.  
The primer sets used in this thesis are shown below in Table 2-7. 
Primer  Left Right 
α-tubulin GATTCCGGTGACGGTGAG GATGCACACCTATCCGCTCT 
Rpl1 TCCACCTTGAAGAAGGGCTA TTGCGGATCTCCTCAGACTT 
Gal4 GCAGCATTCTGGAACAAAGA GGACAATTGGATCTCCCAAG 
fs(1)h GAAAAAGCAGAAACTGGAGAA TGCTCGAAGCGGACTCAT 
AttA CACAATGTGGTGGGTCAGG GGCACCATGACCACCATT 
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CecA1 TCTTCGTTTTCGTCGCTCTC CTTGTTGAGCGATTCCCAGT 
Def TTCTCGTGGCTATCGCTTTT GGAGAGTAGGTCGCATGTGG 
Dipt ACCGCAGTACCCACTCAATC CCCAAGTGCTGTCCATATCC 
Dro CCATCGAGGATCACCTGACT CTTTAGGCGGGCAGAATG 
Drs GTACTTGTTCGCCCTCTTCG CTTGCACACACGACGACAG 
Mtk TCTTGGAGCGATTTTTCTGG TCTGCCAGCACTGATGTAGC 
Hsl CTTGGAAATACTTGAGGGGTTG AGATTTGATGCAGTTCTTTGAGC 
bmm GTCTCCTCTGCGATTTGCCAT CTGAAGGGACCCAGGGAGTA 
plin1 GCGTTCTATGGTAGCCTTCAG GCGTCCGGATAGAAAGCTG 
plin2 GCAGAATGGCAAGAGTTCTGA ACTGTGTGTAGGACTGGATCCTC 
InR GCACCATTATAACCGGAACC TTAATTCATCCATGACGTGAGC 
DILP2 ATCCCGTGATTCCAAGAGAA GCGGTTCCGATATCGAGTTA 
DILP3 CCGAAACTCTCTCCAAGCTC TGAGCATCTGAACCGAACT 
DILP5 GCCTTGATGGACATGCTGA AGCTATCCAAATCCGCCA 
DILP6 CCCTTGGCGATGTATTTCC CACAAATCGGTTACGTTCTGC 
ImpL2 GCCGATACCTTCGTGTATCC TTTCCGTCGTCAATCCAATAG 
foxo ACTTTCCCGTGGGCAATC CGCCGTAGCTCATCTCCT 
Pepck GGATAAGGTGGACGTGAAG ACCTCCTGCGACCAGAACT 
Thor CAGGAAGGTTGTCATCTCGGA GGAGTGGTGGAGTAGAGGGTT 
dpp CCTTGGAGCCTCTGTCGAT TGCACTCTGATCTGGGATTTT 
eiger CGACGAGTTCCAAAAGGAGT GTCGTCGTCCTCCTCATC 
upd1 GCACACTGATTTCGATACGG GCACACTGATTTCGATACGG 
upd2 CGGAACATCACGATGAGCGAAT TCGGCAGGAACTTGTACTCG 
upd3 ACTGGGAGAACACCTGCAAT GCCCGTTTGGTTCTGTAGAT 
	 75 
CCHa2 TGCTACTGGTCGTTATCTGCAC TAGGCCTGGCATCCCTTT 
Gbp1 CAGCACAGAACAGATCACCAG GCAGCACAGTGGTGTTTTCA 
Gbp2 AAACGGCGGACATGGATA TGGAAAACGACCGAAGACA 
Table 2-7: RT-qPCR primer sequences used in this thesis 
2.8. Western blot  
Samples of three flies per microcentrifuge tube were homogenised in 75µl of 2x 
Laemmli loading buffer (100mM Tris [pH 6.8], 20% glycerol, 4% SDS, 0.2 M DTT) and 
the samples were stored at -80°C until required. Samples were left to defrost at room 
temperature, then along with the protein ladder (Blue Protein Standard, Broad Range; 
New England Biolabs) heated to 85°C for 5 minutes and vortexed. The protein ladder 
and sample lysate was loaded at 5µl per lane in a 4-12% polyacrylamide gel 
(Invitrogen, Life Technologies). The gel was run using 1x MES SDS Running buffer 
(20x: 50mM MES, 50mM Tris base, 0.1% SDS, 1mM EDTA) at room temperature for 
35 minutes at 300mAmps, 200 volts and 50 watts. The protein from the gel was 
transferred onto nitrocellulose (Amersham Protran, GE Healthcare) or polyvinylidene 
difluoride (PVDF; Immobilon Transfer Membrane, Millipore) membrane. The 
membrane and filter paper (Chromatography paper, Whatman) was cut to 8cm x 7cm 
and soaked in transfer buffer (25mM Tris, 192mM glycine, 20% (v/v) methanol) along 
with the sponges to keep the gel, membranes and filter paper held in place. The 
PVDF membrane was soaked in 100% methanol (VWR) prior to being soaked in 
transfer buffer. The methanol hydrates the hydrophobic PVDF membrane and 
improves transfer and protein binding. Once soaked in transfer buffer, the transfer 
equipment was assembled, the red plastic was placed on the bottom, as the 
negatively-charged proteins run towards the positive charge, then the sponge, 
followed by the filter paper, membrane, gel, a second piece of filter paper, a second 
sponge and finally the top, black plastic. The gels were then placed into the transfer 
cell, containing ice cold transfer buffer and the transfer was ran out at 4°C for 1 hour 
20 minutes, at 300 mAmps, 400 volts and 50 watts. 
 Once the transfer was complete, the membranes were removed from the 
transfer equipment and placed in a container of blocking solution of milk (Non fat dry 
milk, Cell Signalling) and put on a rocker at room temperature for 1 hour. The 
membranes were washed 5 times, each for 3 minutes using TBS-T (Tris buffered 
saline, 0.1% Tween20) and incubated with the required primary antibody. The primary 
antibodies were added at 1:1,000 in bovine serum albumin (BSA; Albumin Fraction V, 
AppliChem), and the membranes were left at 4°C on the rocker overnight. Following 
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membrane washing with TBS-T (5 times, 3 minutes each), the secondary antibodies 
were added at 1:5,000 in milk and the membranes were placed on the rocker at room 
temperature for 2 hours. Membranes were then washed again in TBS-T (5 times, 5 
minutes each) and the proteins were detected with either Supersignal West Pico- or 
Femto- Chemiluminiscent Substrate (both Thermo Scientific) depending on the 
primary antibody used. A BioRad Molecular Imager was used to expose the images, 
and the band densities were analysed using BioRad Image Lab software. 
The primary antibodies used for Drosophila work in this thesis were as followed:  
Antibody Manufacturer Concentration Used 
Anti-S505-phosphorylated 
Drosophila Akt 
Cell Signalling, #4054 1:1,000 
Anti-p70 S6 Kinase Cell Signalling, #9206 1:1,000 
Anti-GFP D5.1 XP Cell Signalling, #2956 1:1,000 
Anti-Relish-C Developmental Studies 
Hybridoma Bank, 21F3 
1:1,000 
Ubiquitin (P4D1) Cell Signalling, #3936 1:1,000 
Anti-α-tubulin Developmental Studies 
Hybridoma Bank, 12G10 
1:10,000 
Table 2-8: Primary antibodies used for Drosophila Western blots 
 
The secondary antibodies used for Drosophila work in this thesis were as followed: 
Antibody Manufacturer Concentration Used 
HRP anti-rabbit IgG Cell Signalling, #7074 1;5,000 
 
HRP anti-mouse IgG Cell Signalling, #7076 1:5,000 
 
Table 2-9: Secondary antibodies used for Drosophila Western blots 
2.9. Coomassie staining 
Samples of three flies were homogenised in 75µl of 2x Laemmli loading buffer and ran 
on a 4-12% polyacrylamide gel, as described above in section 2.8. Once the gel had 
run, it was fixed in Fixing Solution (Table 2-10) for 30 minutes on the rocker at room 
temperature. The gel was then stained in Coomassie Working Solution (Table 2-11) 
for 45 minutes on the rocker at room temperature. After 45 minutes, the gel was 
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destained using Destaining Solution (Table 2-10) for 2-3 hours on the rocker and then 
imaged using an Epson Scanner. 





Methanol 50ml 45ml VWR 
Acetic Acid 10ml 10ml VWR 
H2O 40ml 45ml  
Table 2-10: Fixing and destaining solution quantities for Coomassie  
Coomassie Working Solution Manufacturer Quantity 
Methanol VWR 250ml 
Coomassie stain (concentrated) See Table 2-12 15ml 
Acetic Acid VWR 50ml 
H2O  200ml 
Table 2-11: Coomassie working solution quantities 
Coomassie Concentrated Stain Manufacturer Quantity 
Brilliant Blue R-250 Dye (BBR) Thermo Scientific 12g 
Methanol VWR 300ml 
Acetic Acid  VWR 60ml 
Table 2-12: Coomassie concentrated stain quantities 
2.10. Thin layer chromatography (TLC)  
Thin layer chromatography (TLC) was used to quantify stored triglyceride levels in 
whole flies. Groups of 10 flies, in quadruplicate per genotype were anaesthetised 
using CO2 and placed in 100µl of 3:1 ratio of chloroform:methanol (both VWR). The fly 
samples were centrifuged at 13,000rpm at 4°C for 3 minutes and then homogenised. 
In order to generate a standard curve and quantify the whole fly triglycerides, a set of 
standards were prepared using lard (Sainsbury’s supermarkets Ltd) dissolved in 3:1 
chloroform:methanol. Standards (2µl) and samples (20µl) were then loaded onto a 
silica gel (Merck) as show in Figure 2-5. A 4:1 ratio of hexane: ethyl ether (both VWR) 
was used for the mobile phase of the TLC. Gels were then stained using the general 
oxidising stain, ceric ammonium heptamolybdate (CAM; cerium (V) sulphate hydrate 
(Sigma-Aldrich), ammonium molybolate tetrahydrate (Honeywell) and Sulphuric acid 
(H2SO4, VWR), left to dry and baked at 80°C for approximately 20 minutes. Once the 
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gel had baked, it was imaged using an Epson Scanner and triglyceride levels were 
analysed using the ImageJ software.	
 
Figure 2-5: TLC plate layout 
A TLC silica gel. All standards and samples were loaded at the bottom of the gel (as indicated 
by the arrow). The lard standards are shown on the left hand side with the micrograms (µg) of 
lard, the box on the right shows the triglycerides present in the samples. The standards and 
triglyceride bands were quantified using ImageJ.NLC; no lard control.  
2.11. LipidTOX staining 
Whole flies of the required genotypes were fixed for 1 hour in 4% paraformaldehyde 
(PFA, Sigma) and 0.1% Triton X-100 (Sigma), the flies were then pulled apart and 
fixed for a further 30 minutes in 4% PFA and 0.1% Triton X-100. Samples were then 
washed 3 times with 1x PBS (Corning) and 0.1% Triton X-100. During the last wash, 
DAPI (Life Technologies, 1:1,000) was added and incubated for 10 minutes at room 
temperature. The samples were washed 3 times with 1x PBS, and incubated with 
HCS LipidTOX Deep Red (Life Technologies, 1:200) in 1x PBS for 2 hours at room 
temperature in the dark. Finally, the samples were mounted on glass cover slips in 
Fluoromount-G (eBioSciences). Images were acquired using a Leica SP5 
microscope. Images were obtained using the Leica LAS-AF software using the 10x 
numerical aperture (NA) 0.4 objective and all images had the resolution of 1024 x 
1024 pixels, at a scan speed of 400Hz. There was a 4 line average carried out during 
the imaging to obtain the highest quality images. 
2.12. Glucose, trehalose and glycogen quantification 
Circulating sugars (glucose and trehalose) and stored carbohydrate (glycogen) levels 
in Drosophila were quantified using a colorimetric assay with a glucose reagent 
containing glucose oxidase and peroxidase. The amount of glucose in each sample 
was assumed to be proportional to the development of a red compound detected after 
oxidisation of the glucose by glucose oxidase in the presence of peroxidase. Flies 
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were starved for 1 hour and then homogenised in 75µl TE + 0.1% Triton X-100 in 
groups of three flies per genotype, at least 5 samples per genotype were prepared 
and samples were frozen at -80°C until required. When required the samples were 
removed from the -80°C, left to thaw and then heated for 20 minutes at 90°C to 
inactivate the fly enzyme, trehalase. Samples were loaded at 5µl into flat bottom 96-
well tissue culture plate (Greiner bio-one).	
 Each fly sample was run four times, firstly alongside water for the calculation 
of fly background absorbance, secondly with glucose reagent (Sentinel diagnostics), 
thirdly with glucose reagent plus trehalase (from porcine kidney, Sigma, 1:100) to 
allow for the measurement of both glucose and the glucose released from trehalose. 
Finally, glucose plus glycogen levels were measured by adding glucose reagent plus 
amyloglucosidase (Sigma Aldrich, 1:100). Samples were treated with trehalase or 
amyloglucosidase in order to take into account any trehalose or glycogen present 
along with glucose in whole flies. In order to analyse the sugar levels, glucose 
standards were also prepared (1:2 dilution, 10-series dilution) and loaded along with 
the samples. Each lane was also run with H2O in order to control for 
spectrophotometer detection differences. The 96-well plate layout is shown in Figure 
2-6. Plates were incubated at 37°C for 10 minutes before reading with a Wallac 
spectrophotometer at a wavelength of 490nm.   
Figure 2-6: 96-well plate layout for trehalose, glucose and glycogen analysis 
To measure circulating sugars and stored carbohydrate levels, 96-well plates were set up as 
shown. See text for details.   
5µl sample, 195µl Glucose 
5µl sample,  
195µl amyloglucosidase:glucose 
5µl sample, 195µl water 
200µl water alone 
5µl 1:2 Standards, 195µl Glucose x2 rows 






Flat bottom, 96-well plate 
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2.13. Genomic DNA preparation 
Following the collection of flies, three flies per sample were homogenised in 150µl 
Buffer A (100mM Tris-HCl, 100mM EDTA, 100mM NaCl, 0.5% SDS). Each sample 
was incubated at 65°C for 30 minutes. Following incubation, 300µl LiCl/KAc (6M LiCl, 
5M KAc) was added and the samples were placed on ice for 10 minutes. Samples 
were centrifuged at 12,000rpm at room temperature for 15 minutes. The supernatant 
was moved into new microcentrifuge tubes and 240µl of isopropanol was added, 
mixed and samples were centrifuged at 12,000rpm at room temperature for 15 
minutes. The supernatant was discarded; the pellets were washed with 200µl 70% 
ethanol and then removed, the pellets left to dry and resuspended in 150µl TE. The 
samples were stored at -20°C until required for PCR. 
2.13.1. Genomic DNA PCR 
Following the generation of genomic DNA, 1µl of each sample was taken and mixed 
with 2µl Standard Taq buffer (New England Biolabs), 0.4µl 10mM dNTPs (New 
England Biolabs), 2µl 16S ribosomal DNA primers (Sigma, Table 2-13), 0.4µl Taq 
(New England Biolabs) and 14.7µl distilled H2O. The PCR was run on the following 
programme: 94°C for 10 minutes, 35 cycles at 94°C for 1 minute, 54°C for 1 minute 
and 72°C for 2 minutes, and finally 72°C for 5 minutes. The samples were run on a 
1% gel with 3µl of SYBR Safe DNA Dye (Life Technologies) at 110 volts for 35 
minutes and DNA bands were visualised using a Safe Imager Transilluminator gel 
documentation system (Thermo Scientific). 
Primer Left Right 
16S  AGAGTTTGATCCTGGCTCAG GGTTACCTTGTTACGACTT 
Table 2-13: 16S ribosomal DNA PCR primers 
2.14. Smurf assay 
Flies were maintained on standard fly food until the day of the Smurf assay. Standard 
fly food was dyed using Blue dye no.1 (SPS Alfachem) at a concentration of 2.5% 
(wt/vol). Flies were maintained at 29°C on the dyed food for a 2-hour time period 
starting from 9am. A fly was classed as a ‘Smurf’ when the dye coloration could be 
observed outside of the digestive tract. Flies with a blue digestive tract were classed 
as ‘eaten’ and flies with no internalised blue colouration were classed as ‘not eaten’. A 
minimum of 20 flies was used per genotype, per experiment.  
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2.15. In vitro experiments 
2.15.1. Cell culture 
The human monocytic cell line, THP-1 (BioCat, 140554) was maintained in complete 
Roswell Park Memorial Institute (RPMI) 1640 medium (Life Technologies), 
supplemented with 2mM Glutamine (Life Technologies), 10mM Hepes (Life 
Technologies), 10% Fetal Bovine Serum (FBS, Life Technologies) and 1% 
penicillin/streptomycin (Life Technologies) at 37°C in 5% CO2, at a concentration 
range of 0.5-1 x 106 cells per ml. The cell line was sub-cultured every three days.  
2.15.2. Treating THP-1 cells with I-BET151 
The THP-1 cells were seeded in 6-well plates at a density of 0.5 x 106 per 2ml of 
RPMI media (Life Technologies) supplemented as shown above. Unstimulated cells 
were treated with 2µl of 1µM GSK1210151A (I-BET151) compound (in DMSO) or with 
DMSO alone (as the control), with a final DMSO concentration of 0.1%. Following 24-
hour treatment with the inhibitor or DMSO alone, the THP-1 cells were harvested by 
moving the cell media from the appropriate wells into microcentrifuge tubes and spun 
for 1 minute at 13,000rpm. The supernatant was removed and the pellet was re-
suspended in 100µl Radioimmunoprecipitation assay (RIPA) lysis and extraction 
buffer (ThermoFisher Scientific). Samples were then frozen at -80 oC until required for 
Western blot analysis. 
2.15.3. Western blot of samples from the THP-1 cell line samples 
Cells were harvested and placed into 100µl LDS Sample Buffer and NuPage 
Reducing Agent. Samples were heated to 85oC for 5 minutes, vortexed briefly and 5µl 
of cell samples and 5µl SeeBlue Plus2 Pre-stained ladder (Thermo Scientific) were 
loaded into 4-12% polyacrylamide gels (Invitrogen, Life Technologies) and run in MES 
buffer (NuPage MES SDS Running Buffer) for 40 minutes at 200 volts. Following 
electrophoresis, the transfer was prepared with the following set-up of the transfer: 
blotting pads (x3), filter paper (Invitrogen), gel, nitrocellulose transfer membrane 
(Invitrogen, Pore Size 0.45µl), filter paper, blotting pads (x3). Blotting pads, 
membranes and filter paper were all soaked in 1x transfer buffer (Invitrogen Transfer 
Buffer, 20x) prior to use. The transfer was run out at room temperature, for 1 hour at 
30 volts. Membranes were blocked in 3% Bovine Serum Albumin (BSA; Sigma) on the 
rocker for 2 hours at room temperature. The primary antibodies (Table 2-14) were 
added to BSA and left on the rocker overnight at 4oC. The membranes were washed 3 
times, 10 minutes each with TBS-T and the secondary antibodies (Table 2-15) were 
added in Odyssey blocking buffer (Li-Cor, 927-40000), wrapped in tin foil to protect 
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from the light, and placed on the rocker at room temperature for 1 hour. The 
membranes were washed in TBS-T 3 times for 10 minutes each time. Excess TBS-T 
was removed and the membrane was laid face down on the imager. The membranes 
were imaged using the Odyssey imaging system (Li-Cor) to identify the bands.  
The primary antibodies used for the THP-1 cell line work were as followed:  
Antibody Manufacturer Concentration Used 
Phospho-AKT (Ser473) Cell Signalling, #9271 1:1,000 
FoxO3a (D19A7) Cell Signalling, #12829 1:1,000 
β-Actin Sigma Aldrich, A5316 1:10,000 
BRD2 Bethyl, A302-583A-M 1:1,000 
BRD3 Bethyl, A302-368A 1:1,000 
BRD4 Cell Signalling, #13440 1:1,000 
Table 2-14: Primary antibodies used for THP-1 cell line Western blots 
The secondary antibodies used for the THP-1 cell line work were as followed:  
Antibody Manufacturer Concentration Used 










Table 2-15: Secondary antibodies used for THP-1 cell line Western blots 
2.15.4. Small interfering RNA (siRNA) 
Small interfering RNA (siRNA), an RNAi tool, was used to induce short term silencing 
of bromodomain-containing proteins 2, 3 and 4 (Brd2, 3, 4) in the THP-1 human cell 
line. THP-1 cells were placed into 6-well plates at 0.5 x 106/ml in RPMI media and left 
overnight. The cells were removed from each well and placed into 15ml falcon tubes 
and centrifuged at 400rcf for 4 minutes at room temperature and resuspended in 
1.8ml RMPI media per falcon tube.  
2.15.4.1. siRNA Preparation 
Before transfecting the THP-1 cells, the siRNA reagents were prepared as shown in 
Figure 2-7. Viromer GREEN (Lipocalyx, VG-01BL-00), the transfection reagent used, 
binds small oligonucleotides to efficiently knockdown the gene of interest in a number 
of cell lines, including THP-1 cells. 
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Figure 2-7: siRNA tube preparation 
To start the siRNA protocol, Tube 1 contained the required siRNA (Brd2, 3 or 4), Tube 2 
contained the non-targeting siRNA, which was used as the control treatment and Tube 3 
contained Viromer, the polymer-based transfection reagent (Lipocalyx, 2017). 
 
The reagents used for siRNA preparation are shown below in Table 2-16.  
siRNA Stock Information 
BRD2 ON-TARGETplus SMARTPool, Dharmacon, Human 
BRD2, cat# L-004935-00 
BRD3 ON-TARGETplus SMARTPool, Dharmacon, Human 
BRD3, cat# L-004936-00 
BRD4 ON-TARGETplus SMARTPool, Dharmacon, Human 
BRD4, cat# L-004937-00 
Non-targeting siRNA ON-TARGETplus Non-targeting Pool, Dharmacon, #D-
001810-10-05 
Table 2-16: siRNA stock information 
2.15.4.2. Transfection 
The transfection step was carried out in triplicate in RNAse/DNAse free, sterile tubes 
(Figure 2-8). Each complexation was incubated at room temperature for 15 minutes 
and 200µl from each complexation tube was added to the respective wells for a final 





•  10µM BRD2, 3 or 4 siRNA solution from 20µM BRD2, 3 or 4 stock 
•  buffer GREEN (1:2 dilution) 	
•  10µM non-targeting siRNA from the 20µM non-targeting siRNA stock 









•  12µl Viromer GREEN pipetted onto the wall of a sterile RNAse free tube  
•  1080µl buffer GREEN  
 Note: vortex for 3-5 seconds 
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Figure 2-8: siRNA transfection set up 
The tubes from Figure 2-6 above were used to set up the correct siRNAs to treat the THP-1 
cells. Top: Complexation (1) indicates the non-targeting siRNA, as the negative control. 
Bottom: Complexation (2) indicates the siRNA to knockdown the required gene.  
2.15.4.3. Cell harvest and Western blot 
Following the three-day incubation time with the siRNA, the THP-1 cells were taken 
from each well and put into 15ml Falcon tubes, each well was washed with 1ml sterile 
PBS, and the wash-out was added to each respective Falcon tube. Each tube was 
centrifuged at 400rcf for 4 minutes and the cell pellet was resuspended in 1ml sterile 
PBS (Gibco) and transferred into 1.5ml microcentrifuge tubes. The tubes were 
centrifuged at 1,500rcf for 2.5 minutes, the PBS was removed and the cell pellets 
were resuspended in 40µl RIPA buffer. The cell lysates were incubated on ice for 30 
minutes, with vortexing taking place every 10 minutes; the supernatants were 
transferred to new centrifuge tubes and stored at -80oC. Western blots were carried 
out as described above in 2.15.3.  
 The primary antibodies and secondary antibodies used for the human cell line 
Western blots are shown above in Table 2-14 and Table 2-15, respectively. 
2.16. Statistical analysis 
2.16.1. Survival analysis 
All survival experiments included approximately 20-30 flies per genotype. From the 
initial infection survival screen, percentage survival and median survival for each 
genotype was calculated and graphs were plotted in GraphPad Prism (GraphPad 
Software). For any of the phenotypes that showed large variation (two days or more) 
away from the control genotypes the survival experiment was repeated. Lifespan 















BRD2, 3 or 4 
siRNA 
Note: ‘Tube 1’ may contain BRD2, BRD3 




2.16.2. RT-qPCR analysis 
The gene expression concentrations were obtained using a standard curve that was 
generated for each primer set used (Figure 2-9A) and a melt curve was used to 
indicate the presence of cDNA in each sample (Figure 2-9B). The expression levels of 
individual samples were normalised to the expression level of the housekeeping gene 
α-tubulin. RT-qPCR data was analysed when the R2 value for standard linearity was 
0.99 or above, and if each primer had an efficiency of 0.75 or above. Each experiment 
included at least four samples, with three flies per sample, and individual experiments 
were repeated three times. Data analysis using unpaired t-tests or 2-way ANOVAs 
were carried out using GraphPad Prism to determine statistical significance. 
Figure 2-9: Standard curve and melt curve for RT-qPCR 
An example of a cDNA standard curve and melt curve. A. The standards are indicated by the 
red lines and the multi-coloured lines indicate the samples. B. The melt curve shows the 
presence of cDNA in each of the standards and samples. dF/dT: derivative of fluorescence vs. 
derivative temperature, which shows the changes in fluorescence caused by temperature 
changes leading to double stranded DNA melting to single stranded DNA. 














































2.16.3. Western blot analysis 
For all Western blots, 3 flies were taken per sample. Following Western blot, the 
image was opened in ImageJ and the rectangle tool was used to draw a box around 
each band of interest to obtain the density of each band. The background was 
removed and ImageJ calculated the relative area and density. The same process was 
carried out to obtain the density of the loading control bands (α-tubulin or actin) and 
the amount of protein was calculated relative to the loading control. Each experiment 
was repeated at least three times, graphs were generated and data was analysed 
using unpaired t-tests in GraphPad Prism. 
2.16.4. Thin Layer Chromatography (TLC) gel analysis 
A total of 10 flies were included in each sample, in quadruplicate for each of the TLCs, 
each TLC was also repeated at least three times to confirm findings. Using the set of 
standards that were prepared using lard, a standard curve was generated from the 
known concentrations of lard in order to calculate the approximate amount of lard (in 
µl) in each fly sample. In samples where no lard could be detected, graphs were 
annotated with non-detected (n.d). The TLC analysis was carried out using Bio-Rad 
Image Lab software and an unpaired t-test was preformed to identify statistical 
significance in GraphPad Prism. 
2.16.5. Glucose, trehalose and glycogen colorimetric assay analysis 
Glucose, trehalose and glycogen data was exported from the spectrophotometer in 
excel files showing the absorption at 490nm. Unpaired t-tests were used to identify 
statistical significance. A standard curve was generated from levels of standard 
absorbance minus the background absorbance of the glucose reagent alone. The 
absorbance levels from water alone were subtracted from the absorbance levels for 
fly and water, leaving the level of fly background for each sample. This value was then 
subtracted from each individual sample as ‘background’. The absorbance value of the 
glucose reagent alone (without fly sampled added) was subtracted from each sample, 
leaving the levels of glucose, and glucose released from trehalose or glycogen per 
sample. The addition of trehalase, allows for the measurement of glucose released 
from trehalose, a major fly sugar. The addition of amyloglucosidase allowed for the 
measurement of glycogen, the polymeric form of stored glucose, also present in each 
of the fly samples. The quantities (in µg) of glucose, glycogen and glucose released 
from trehalose were calculated from the standard curve equation, which was 
produced from the glucose standards. Each experiment included at least five 
samples, each containing three flies, per genotype and the assay was repeated at 
least three times. 
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2.16.6. Statistical significance and error bars 
All error bars included in the experimental figures are represented as standard error of 
the mean (SEM), as stated in the figure legends. Statistical significance stars indicate 
the p values being less than or equal to the following; *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001. Any values greater than or equal to p≥0.05 were classed as non-
statistically significant results.  	  
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Chapter 3  		
BCP and JDCP RNAi line survival screen following 




Epigenetic modifications are important for normal development and disruption to 
these changes can lead to unwanted alterations in gene expression (Handy et al., 
2011). In recent years, these modifications have been linked to a number of diseases 
including cancer and autoimmune disease (Bayarsaihan, 2011). The changes in gene 
expression observed when epigenetic modifications occur are, in most cases, due to 
alterations in the structure of chromatin, making the DNA more or less accessible 
(Narlikar et al., 2002). Epigenetic modifications including DNA methylation or histone 
modifications affect gene regulation by repressing or enhancing the binding of 
transcription factors (Moore et al., 2013). 
 The bromodomain is a 110 amino acid motif, originally discovered in 
Drosophila as an important chromatin-modifying factor (Tamkun et al., 1992). The 
bromodomain sequence is highly conserved between yeast, Drosophila and humans 
(Haynes et al., 1992). In Drosophila, the bromodomain has been shown to play a wide 
range of functions in histone modification, chromatin remodelling and as 
transcriptional activators or repressors (Denis et al., 2010). A range of proteins have 
been shown to contain bromodomains and serve a range of functions in Drosophila. 
female sterile (1) homeotic (fs(1)h), the only bromodomain and extraterminal domain 
(BET) family member in Drosophila, is thought to be most closely related to Brd2 and 
Brd4 in mammals (Belkina and Denis, 2012; Berkovits and Wolgemuth, 2013). 
Functionally, fs(1)h has transcriptional repression functions that are essential for 
proper differentiation in the early embryo (Denis et al., 2010; Florence and Faller, 
2008). Testis-specific bromodomain-containing protein, tBRD-1, in Drosophila is 
expressed in primary spermatocytes, is essential for male fertility (Theofel et al., 
2014) and is required for proper differentiation of the immature male sex cells known 
as spermatids (Leser et al., 2012). tBRD-1 acts as a reader of acetylated residues of 
histones at the promoters of unknown target genes (Leser et al., 2012). Bromodomain 
and WD repeat domain-containing protein 3 (BRWD3), which contains tandem 
bromodomains, has been genetically linked to the Jak/STAT pathway in Drosophila 
although little else is known about its biological function (Müller et al., 2005). 
Post-translational modification of histones are essential for cellular regulation, 
for example, acetylation of histone residues plays a key role in the regulation of 
transcription (Zhao et al., 2010). The addition of an acetyl group to lysine residues 
leads to the neutralisation of the charge, which impacts on protein-protein interactions 
and protein conformation causing differences in protein assembly and enzyme activity 
(Kouzarides, 2000; Muller et al., 2011). Bromodomain-containing proteins (BCPs) are 
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well-characterised regulators of transcription and well-known epigenetic modifiers 
(Denis et al., 2010). The bromodomain (BD), originally described in the Drosophila 
brahma (BRM) protein, is able to recognise and bind acetylated lysine residues 
(Dhalluin et al., 1999; Tamkun et al., 1992). Bromodomains bind acetylated lysines, 
predominantly in histone tails, to facilitate the recruitment of transcription factors and 
other chromatin-binding proteins (Wu and Chiang, 2007). This recognition of the 
acetylated lysine residues by the bromodomain generally leads to transcriptional 
activation, and due to this, BCPs are associated with a wide range of biological 
processes (Berkovits and Wolgemuth, 2013; Guan and Xiong, 2011; Houzelstein et 
al., 2002; Wang et al., 2009). In the human genome, there are 46 proteins that contain 
bromodomains with a wide variety of functions including co-regulators (Yang et al., 
1996), co-activators (Venturini et al., 1999), mediators (Jacobson et al., 2000), 
chromatin modifying enzymes and scaffolding proteins (Xue et al., 2000). The 
bromodomain and extra-terminal domain (BET) family of proteins are characterised by 
two bromodomains (BD1 and BD2) and an extraterminal (ET) domain. BET proteins 
can recognise mono-, di- or tri- acetylated histones, however, BD1 has greater affinity 
for acetylated histone H4 and the recognition of acetylated H3 by the bromodomain 
has been implicated in chromatin remodelling (Padmanabhan et al., 2016). The BET 
family have various functional roles including transcriptional regulation, genome 
structure and viral replication (Weidner-Glunde et al., 2010; Wu and Chiang, 2007). In 
recent years, pharmacological inhibitors of the BET family of proteins, including IBET-
151 and JQ1, have been used as treatment for cancer, inflammation and autoimmune 
disease (Bandukwala et al., 2012; Jung et al., 2015; Mele et al., 2013). However, the 
broader in vivo roles of BET proteins in metabolism and immunity are still not 
completely clear. 
 Similarly to the bromodomain, jumonji domains are also associated with 
chromatin modification and epigenetic regulation. Unlike other histone modifications, 
which are usually transient, methylation was thought to be a permanent modification, 
until the recent discovery of the first demethylases (Shi and Tsukada, 2013). Histone 
methylation states are dynamically regulated by a number of different groups of 
methyltransferases and demethylases (Bannister and Kouzarides, 2011; Shi and 
Whetstine, 2007). Much like other histone modifications, histone demethylation plays 
important roles in regulating gene expression and cell fate, therefore the methylation 
status of histones needs to be tightly controlled (Dambacher et al., 2010). Jumonji 
domain-containing proteins (JDCPs) play an important role in the removal of methyl 
groups from histones (Klose et al., 2006). The Jumonji N (JmjN) and Jumonji C 
(JmjC) domains are two domains that have been identified in the jumonji family of 
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transcription factors. It was originally suggested that the JmjN and JmjC domains 
always occur together, however the JmjC domain was later found without a JmjN 
domain in many organisms from bacteria to humans (Tsukada et al., 2006). The 
catalytic JmjC domain is a family of histone demethylases (KDMs) encoded by 30 
genes in humans (Klose et al., 2006; Tsukada et al., 2006). The highly conserved 
JmjC domain is the largest class of demethylase enzymes that catalyse lysine 
demethylation of histones through a reaction that requires iron and α-ketoglutarate 
(Xiang et al., 2007b). The JmjC domain-containing histone demethylase can remove 
mono-, di- or tri-methylated states in histones (Klose et al., 2006). JmjC proteins have 
been associated with various human diseases including cancer and developmental 
and neurological disorders (Klose et al., 2006), its detrimental role in demethylation 
would suggest these histone demethylating enzymes may regulate a wide variety of 
cellular processes (Cloos et al., 2008). In vertebrates, Jumonji domain-containing-3 
(Jmjd3) is a H3K27 demethylase that catalyses the demethylation of H3K27me2/3 
(Burchfield et al., 2015). The regulation of Jmjd3 is highly gene- and context- specific, 
and is involved in development, cell plasticity, the immune system, neurodegenerative 
disease and cancer. Interestingly, Jmjd3 can enhance both pro- and anti- 
inflammatory responses involved in infection and wound healing (Salminen et al., 
2014). In cytokine-stimulated human leukemic monocytic cells (THP-1), Jmjd3 
knockdown reduces the expression of key inflammatory markers (Das et al., 2013). 
Changes in these pro- and anti-inflammatory markers are involved in NF-κB, 
chemokine and CD40 signalling, and knocking down Jmjd3 inhibits a number of NF-
κB-regulated inflammatory genes (Das et al., 2010). JMJD3 also responds to bacteria, 
parasites and viruses; following the addition of lipopolysaccharide (LPS) to 
macrophages in culture, JMJD3 is recruited to the start sites of over 70% of LPS 
inducible genes (De Santa et al., 2007, 2009). Deletion of lysine-specific demethylase 
3B (KDM3B) can induce myeloid leukemia (Kim et al., 2012) and breast cancer 
(Paolicchi et al., 2013), whereas deletion of KDM5D is found in 50% of prostate 
cancer (Perinchery et al., 2000) and mutations associated with KDM7B has been 
identified in individuals with autism spectrum disorder (Shalaby et al., 2017).  
In Drosophila, much like in humans, jumonji domain-containing proteins 
influence gene expression and chromatin organisation by demethylating histones 
(Klose et al., 2006). The demethylation process plays an important role in regulating 
gene activity across the genome (Bannister and Kouzarides, 2011). There are 13 
JmjC genes in Drosophila, ten of the genes do not critically regulate development 
(Shalaby et al., 2017). The three other genes have detrimental roles in Drosophila 
development. Little imaginal discs (Lid) and Utx histone demethylase (Utx) are 
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currently the best studied members of the JmjC family in Drosophila (Shalaby et al., 
2017) However, Utx and Jumonji, AT rich interactive domain 2 (Jarid2) null mutants 
exhibit lethality, whilst a third mutant, Lid, displays semi-lethality (Gildea et al., 2000; 
Herz et al., 2010; Lloret-Llinares et al., 2008). Mutations in KDM4A and KDM4B 
interfere with transcriptional activation of the ecdysone receptor (Tsurumi et al., 2013) 
and mutations in different JmjC domain genes modify hippo signalling causing an 
overgrown eye phenotype (Shalaby et al., 2017) and hedgehog pathway 
dysregulation leading to a wing vein phenotype (Shalaby et al., 2017). Additionally, a 
number of JmjC genes, JMJD5, JMJD7 and NO66 have been found to function as 
hydroxylases, not as histone demethylases (Chowdhury et al., 2014; Ge et al., 2012). 
  Many aspects of innate immunity are conserved between insects and 
mammals. As Drosophila are easily manipulated genetically, they are a powerful 
model for studying immune function, infection and disease (Dionne and Schneider, 
2008). Drosophila are also able to detect and discriminate between distinct classes of 
microorganisms (Lemaitre et al., 1997). The Imd pathway, activated predominantly by 
peptidoglycan (PGN) of Gram-negative bacteria, can control host defence against 
these infections (Gottar et al., 2002). Following the detection of Gram-positive 
bacteria and fungi, the Toll pathway is activated following the cleavage of Spätzle, the 
ligand for the receptor, Toll. Drosophila infections are complex and almost every 
microbe can cause a different type of pathology (Dionne and Schneider, 2008). As in 
humans, some of the tissue damage that occurs during infection is due to an over-
aggressive immune response rather than the microbe itself (Dionne and Schneider, 
2008).  
The Gram-positive bacterium, Listeria monocytogenes, is an abundant, 
intracellular pathogen and the causative agent of a number of food-borne diseases in 
humans (Farber and Peterkin, 1991). In Drosophila, L. monocytogenes is a lethal 
infection that causes infection-induced anorexia (Chambers et al., 2012). The 
infection activates the Toll pathway and alters energy metabolism and the infected 
flies gradually lose energy stores in the form of triglycerides and glycogen (Chambers 
et al., 2012). Following L. monocytogenes infection, Drosophila show a reduction in 
metabolites and enzymes involved in the two main energy pathways, β-oxidation and 
glycolysis (Chambers et al., 2012). Furthermore, mutations in dif, the NF-κB-related 
factor, leads to an increased susceptibility to L. monocytogenes infection than that of 
wild-type flies (Mansfield et al., 2003).  
The Gram-negative intracellular bacterium, Francisella novicida, is closely 
related to F tularensis, a pathogen known to cause tularaemia, a severe infection in 
humans characterised by ulcers, fever and weight loss (Pechous et al., 2009). Human 
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infection with F. novicida is extremely rare and the cases that do occur are usually 
associated with immunocompromised individuals or those with underlying health 
issues (Brett et al., 2012). However, F. novicida is highly virulent in mice and other 
rodents (Sjödin et al., 2012). When Drosophila are infected with F tularensis, a highly 
virulent species closely related to F. novicida, the bacteria resided both inside 
hemocytes and extracellularly in the open circulatory system (Vonkavaara et al., 
2008). The production of AMPs during Francisella infection is shown to be under the 
control of the Imd pathway (Vonkavaara et al., 2008) and the Imd pathway, not the 
Toll pathway, is also essential for combating F. novicida infections (Moule et al., 
2010). In this study Drosophila were infected with F. novicida strain U112, a wild type 
strain that causes virulent infections in its natural mouse and rabbit host but it is not 
pathogenic to humans (Moule et al., 2010).  
 Little is known about the roles of bromodomain-containing proteins (BCPs) or 
jumonji domain-containing proteins (JDCPs) in the regulation of immunity or 
metabolism in Drosophila. In order to identify the roles of BCPs and JDCPs in 
immunity, we performed an RNAi survival screen knocking down each of the 
described BCPs or JDCPs in the fat body or hemocytes of Drosophila (see Table 2-2). 
Following tissue-specific knockdown, the flies were infected with Listeria 
monocytogenes or Francisella novicida (Ahlund et al., 2010; Mansfield et al., 2003). 
Both L. monocytogenes and F. novicida were injected directly in the body cavity, 
bypassing epithelial barriers and the gut, allowing us to focus on systemic infection. 
For each RNAi knockdown, two fat body drivers and two hemocyte drivers were used 
to test the validity of the tissue-specific drivers and the reproducibility of the results. 
3.1.1. Objective and aims  
The objective of this chapter is to identify whether BCPs or JDCPs have important 
roles in the fat body or hemocytes following bacterial infection. 
 
The aims of this chapter are: 
1. To knockdown each of the known BCPs and JDCPs in Drosophila using RNAi 
lines and tissue-specific driver lines for the fat body or hemocytes. 
2. To infect each of the knockdown lines with Listeria monocytogenes or 
Francisella novicida and record survival effects. 	  
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3.2. Survival screen following bacterial infection using fat body drivers 
The fat body, an organ analogous to adipose tissue and the liver in mammals, is the 
main site of the humoral immune response and metabolic homeostasis (Arrese and 
Soulages, 2010). Following infection, the fat body produces antimicrobial peptides 
(AMPs) via two immunoregulatory pathways, known as Toll and Imd to help 
Drosophila defend themselves (De Gregorio et al., 2002). The Toll pathway is 
activated by the detection of Gram-positive bacteria and fungal glycans, whereas the 
Imd pathway is usually mediated by the detection of Gram-negative peptidoglycan 
(Hoffmann, 2003). To investigate the role of BCPs or JDCPs in the fat body, we used 
two fat body specific drivers, c564-Gal4 and r4-Gal4 to knockdown each of the RNAi 
lines. 
3.2.1. c564-Gal4 
c564-Gal4 is a Gal4-driver line expressed in the fat body, salivary glands, imaginal 
discs, gut and brain, along with the lymph gland of Drosophila larvae (Harrison et al., 
1995). 
 In the survival screen performed, flies that showed a median survival time 
either two or more days longer or shorter than the driver only control (c564-Gal4 
crossed to w1118; c564>0) were considered to show a biologically significant survival 
phenotype following bacterial infection in fat body knockdowns using c564-Gal4 
(Figure 3-1). Each RNAi line, in all experiments was run at 29°C with two control 
groups, an uninjected group and PBS injected group as a wounding control (data not 
shown).  
 Following the knockdown of RNAi lines using c564-Gal4, we found one short-
lived RNAi line following infection with both L. monocytogenes and F. novicida, which 
was KK108662. KK108662 knockdown in the fat body reduced the median survival 
time from both L. monocytogenes and F. novicida infections to below 2 days, whereas 
the driver only control showed a median survival time of 5-7 days depending on the 
bacteria. KK108662 is an RNAi line specific for CG2252, also known as female sterile 
(1) homeotic, fs(1)h. fs(1)h is a bromodomain-containing protein that plays a role as a 
negative regulator of transcription (Florence and Faller, 2008) and dendrite 
morphogenesis (Bagley et al., 2014). We also found a number of long-lived RNAi 
lines following infection with L. monocytogenes including KK107378, KK108943 and 
KK107819. These lines showed a prolonged median survival time of 9 days following 
L. monocytogenes infection compared to the control, which had a median survival 
time of 7 days. KK107378 is an RNAi line specific for CG30417, a testis-specifically 
expressed bromodomain-containing protein-3 (tbrd-3). tbrd-3 is a bromodomain-
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containing protein, but little is known about its function (Theofel et al., 2014). 
KK108943 is an RNAi line specific for CG4107, also known as Gcn5 acetyltransferase 
(Gcn5). Gcn5 is a bromodomain-containing protein involved in histone H3 and H4 
acetylation (Guelman et al., 2006; Suganuma et al., 2008), chromatin remodelling 
(Suganuma et al., 2008) and muscle development (Parrish et al., 2006). KK107819 is 
an RNAi line specific to CG2982, a jumonji domain-containing protein, currently with 
no name or known function. The prolonged survival was not observed following F. 
novicida infection (Figure 3-1). 
3.2.2. r4-Gal4 
r4-Gal4, an insertion on the third chromosome, directs reporter gene expression 
specifically in the Drosophila fat body (Lee and Park, 2004).  
 In the survival screen performed, flies that showed a median survival time of 
two or more days longer or shorter than the driver only control (r4-Gal4 crossed to 
w1118; r4-Gal4>0) were considered to show a survival phenotype following bacterial 
infection in fat body knockdowns using r4-Gal4. Each RNAi line, in all experiments 
was run at 29°C with two control groups, an uninjected group and PBS injected group 
as a wounding control (data not shown).  
 Using the r4-Gal4 driver (Figure 3-2), we observed three short-lived 
phenotypes following infection with L. monocytogenes including KK106119, GD37720 
and KK108662, the latter was found to be short-lived following infection with both L. 
monocytogenes and F. novicida. KK106119 is an RNAi line specific to CG17603, also 
known as TBP-associated factor 1 (Taf1). Taf1 is a bromodomain-containing protein 
involved in histone acetylation (Mizzen et al., 1996), regulation of Jak/STAT signalling 
(Kallio et al., 2010), and a positive regulator of Notch signalling (Xie et al., 2014). 
GD37720 is an RNAi line specific to CG5942, known as brahma. brahma is a 
bromodomain-containing protein involved in histone acetylation (Tie et al., 2012), 
phagocytosis (Stroschein-Stevenson et al., 2005) and regulation of the immune 
response (Bonnay et al., 2014). After L. monocytogenes infection, KK108662 showed 
a median survival time of 5 days, whereas the control had a median survival time of 7 
days. KK108662 was the only RNAi line that showed a significant reduction in median 
survival following infection with F. novicida, which was below 2 days compared to the 
control group, which had a median survival of 5 days. A number of RNAi lines were 
also long-lived following L. monocytogenes infection, including KK104879, KK107312, 
KK110158 and GD22108. KK104879 is an RNAi line specific to CG14514, also known 
as Bromodomain-containing 8 (Brd8). Brd8 plays roles in histone acetylation, histone 
exchange (Kusch et al., 2004) and a negative regulator of gene expression (Lu et al., 
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2007). KK107312, is an RNAi line specific to CG42799, also known as dikar. dikar is a 
bromodomain-containing protein involved in Drosophila long-term learning (Akalal et 
al., 2011) and olfactory learning (Dubnau et al., 2003). KK110158 is an RNAi line 
specific to CG33182, known as Lysine (K)-specific demethylase 4B (Kdm4B). Kdm4B 
is a jumonji domain-containing protein involved in the demethylation of H3K36 and 
H3K9 (Lin et al., 2008; Lloret-Llinares et al., 2008). GD22108 is an RNAi line specific 
to CG5383, also known as phosphatidylserine receptor (PSR). PSR is a jumonji 
domain-containing protein shown to play roles in the negative regulation of JNK 
signalling and apoptotic processes (Krieser et al., 2007). There were no long-lived 
RNAi lines with the r4-Gal4 driver line following F. novicida infection. 
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Figure 3-1: RNAi survival screen using c564-Gal4 
5-7 day old male of each RNAi line, knockdown was driven by c564-Gal4 in the fat body and 
flies were infected with Listeria monocytogenes (circles) and Francisella novicida (squares).  
Graph shows median survival of each RNAi line. w1118 was used as the control (c564-Gal4>0), 
n=20 per group. 	  
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Figure 3-2: RNAi survival screen using r4-Gal4  
5-7 day old male of each RNAi line, knockdown was driven by r4-Gal4 in the fat body and flies 
were infected with Listeria monocytogenes (circles) and Francisella novicida (squares). Graph 
shows median survival of each RNAi line. w1118 was used as the control (r4-Gal4>0), n=20 per 
group.	  
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3.3. Survival screen following bacterial infection using hemocyte drivers 
The cellular arm of the Drosophila innate immune system is made up predominantly 
of hemocytes, phagocytotic cells that engulf bacteria and encapsulate large foreign 
particles (Lavine and Strand, 2002). 
3.3.1. HemolectinΔ-Gal4 
Hemolectin (Hml) is a plasmatocyte specific protein involved in a number of functions 
including wound healing, hemolymph coagulation and hemostasis (Lesch et al., 
2007). Hml shares homology with Von Willebrand factor (VWF), a blood-clotting factor 
found in mammals. The expression of Hml is found in both plasmatocytes and crystal 
cells, but has not been found in lamellocytes (Goto et al., 2003). Hml expression in 
plasmatocytes begins at stage 17 of embryogenesis and continues all the way 
through to adult flies (Goto et al., 2003). It has also been shown that the expression of 
antimicrobial peptides is not significantly affected by Hml RNAi (Goto et al., 2003).  
 The first hemocyte reporter line used in this thesis was w;HmlΔGal4, UAS-
2xeGFP (Sinenko and Mathey-Prevot, 2004), it has been shown to have the greatest 
plasmatocyte specificity. Furthermore, HmlΔ shows robust and specific expression in 
the larval lymph gland and circulating hemocytes (Sinenko and Mathey-Prevot, 2004). 
Here, the yeast transcription factor Gal4 is expressed under the control of an 
upstream Hml promoter sequence. These flies were also crossed with UAS-eGFP 
transgenic flies to visualise Hml expression with GFP if necessary (Goto et al., 2003). 
Flies that showed a median survival time of two or more days longer or shorter than 
the driver only control (HmlΔGal4 crossed to w1118; HmlΔGal4>0) were considered to 
show a survival phenotype following bacterial infection in hemocyte knockdowns 
using HmlΔGal4 (Figure 3-3). We combined HmlΔGal4 with each RNAi line and 
infected them with L. monocytogenes or F. novicida. Each RNAi line, in all 
experiments was run at 29°C with two control groups, an uninjected group and PBS 
injected group as a wounding control (data not shown).  
 Using the HmlΔGal4 driver, we found three RNAi lines to be short-lived 
following infection with F. novicida; these were KK100383, KK110485 and GD33446. 
KK100383 is a specific RNAi line for CG42799, known as dikar, a bromodomain-
containing protein. Functional information regarding dikar is shown above, where we 
also found a phenotype with another dikar RNAi line (KK107312) in the fat body. Even 
though both RNAi lines were targeting the same gene, there were no consistent 
phenotypes observed. KK110485 is a specific RNAi line for CG7460, which has no 
gene name or known function yet. GD33446 is a specific RNAi line for CG1966, also 
known as ATP-dependent chromatin assembly factor large subunit (Acf). Acf is a 
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bromodomain-containing protein involved in chromatin assembly (Fyodorov and 
Kadonaga, 2002), nucleosome assembly, mobilisation and positioning (Eberharter et 
al., 2001; Ito et al., 1997, 1999) and is also a negative regulator of transcription (Liu et 
al., 2008). All three of these lines showed a reduced median survival time of 4 days 
compared to the median survival time of the controls at 6 days following F. novicida 
infection. However, these lines showed no phenotype with L. monocytogenes 
infection. We also found a number of long-lived RNAi lines following L. 
monocytogenes infection; these were KK109294, KK107819, KK108662, KK109295 
and KK100735. KK109294 is a specific RNAi line for CG43320, a jumonji domain-
containing protein, with no gene name or functional information yet. As described 
above, KK107819 is a specific RNAi line for CG2982, which is also a jumonji domain-
containing protein, with no gene name or known function and KK108662 is specific for 
fs(1)h and its functional information is found above. Interestingly, when we used the 
HmlΔGal4 driver we found a long-lived phenotype with the fs(1)h RNAi line following L. 
monocytogenes infection, but not following F. novicida infection. KK109295, a specific 
RNAi line for CG11033, also known as Lysine (K) specific demethylase 2 (Kdm2) is a 
jumonji domain-containing protein involved in histone H3K36 demethylation (Lagarou 
et al., 2008), histone H3K4 demethylation, specifically trimethyl-H3K4 (Kavi and 
Birchler, 2009) and histone H2A ubiquitination (Lagarou et al., 2008). KK100735, a 
specific RNAi line for CG10897, also known as toutatis (tou), is a bromodomain-
containing protein involved in ATP-dependent chromatin remodelling (Emelyanov et 
al., 2012) and nervous system development (Vanolst et al., 2005). Even though these 
five RNAi lines were shown to be long-lived following L. monocytogenes infection, we 
did not detect the same phenotype following F. novicida infection. 
3.3.2. Croquemort-Gal4 
Croquemort (crq), a member of the CD36 superfamily, is expressed by hemocytes 
and in the gut during larval and pupal development of Drosophila (Evans et al., 2014). 
In mammals, CD36 is a membrane glycoprotein found on platelets, phagocytes, 
adipocytes, monocytes and some epithelia (Silverstein and Febbraio, 2009). It 
functions as a scavenger receptor on phagocytic cells, which recognise and 
eliminates foreign intruders, such as bacteria, parasites and viruses, during infection 
(Platt et al., 1999). It is a negative regulator of angiogenesis (Dawson et al., 1997) 
and due to this, it plays roles in inflammation, wound healing and tumour growth 
(Silverstein and Febbraio, 2009). CD36 inhibits growth factor-induced angiogenic 
signals mediating cell proliferation and migration (Chu et al., 2013). Drosophila crq is 
a CD36 ortholog, present on hemocytes and is involved in the recognition, engulfment 
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and promoting the clearance of apoptotic cells by embryonic plasmatocytes (Franc et 
al., 1999). It is also involved in phagosome maturation for the clearance of neuronal 
debris (Han et al., 2014). Much like hemolectin, crq is expressed on plasmatocytes 
through the lifespan of Drosophila (Guillou et al., 2016). Therefore, we used w;;crq-
Gal4, where crq is under the control of Gal4, as a second hemocyte driver line for the 
survival screen in this study. Flies that showed a median survival time of two or more 
days longer or shorter than the driver only control (crq-Gal4 crossed to w1118;;crq-
Gal4>0) were considered to show a survival phenotype following bacterial infection in 
hemocyte knockdowns using crq-Gal4 (Figure 3-4). Each RNAi line, in all experiments 
was run at 29°C with two control groups, an uninjected group and PBS injected group 
as a wounding control (data not shown).  
 Using the crq-Gal4 driver, we observed no long-lived phenotypes in any of the 
RNAi lines with either L. monocytogenes or F. novicida infection. We found a number 
of short-lived lines following F. novicida infection with the HmlΔ-Gal4 driver, but we 
were unable to phenocopy them with the crq-Gal4 driver. However, we did find a 
number of RNAi lines to be long-lived following L. monocytogenes infection. These 
lines were: KK110485, KK108662, KK109295, KK100735, KK101311, KK105986, 
KK108618, GD35962 and GD37720. All of these RNAi lines showed an increased 
median survival time of 8 days following L. monocytogenes infection compared to the 
median survival time of 6 days in the control group. The RNAi lines identified in this 
survival screen, when using crq-Gal4 have a range of functions in Drosophila.  
KK110485 is a specific RNAi line to CG7460, which has no name or functional 
information as discussed above. We previously identified KK108662 (fs(1)h), 
KK109295 (Kdm2) and KK100735 (tou) to be long-lived following L. monocytogenes 
infection with the HmlΔ-Gal4 driver and the functional information is described above. 
KK101311 is a specific RNAi line to CG1845, also known as Bromodomain-containing 
protein, 140kD (Br140). Br140 has shown to play roles in histone H3 acetylation 
(Huang et al., 2006) and dorsal/ventral axon guidance (Berger et al., 2008). 
KK105986 is a specific RNAi line to CG5640, known as Utx histone demethylase 
(Utx), which is a jumonji domain-containing protein involved in the negative regulation 
of H3K27 trimethylation (Denton et al., 2013; Zhang et al., 2013), along with wound 
healing (Campos et al., 2010) and autophagy regulation (Denton et al., 2013). 
KK108618 is a specific RNAi line to CG11375, also known as polybromo (PB) or 
bap180. PB is a bromodomain-containing protein involved in imaginal disc-derived leg 
morphogenesis and is a negative regulator of chromatin silencing (Chalkley et al., 
2008). GD35962 is a specific RNAi line to CG8569, a bromodomain-containing 
protein, with no gene name or known function, other than a predicted role in 
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chromatin binding. We also identified GD37720, a specific RNAi line for brahma, 
which has been functionally described above. We were unable to replicate the 
phenotypes with both hemocyte drivers in the rest of the RNAi lines.    
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Figure 3-3: RNAi survival screen using HmlΔGal4 
5-7 day old male of each RNAi line, knockdown was driven by HmlΔGal4 in the hemocytes and 
flies were infected with Listeria monocytogenes (circles) and Francisella novicida (squares). 
Graph shows median survival of each RNAi line following infection. w1118 was used as the 
control (HmlΔ-Gal4>0), n=20 per group. 
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Figure 3-4: RNAi survival screen using crq-Gal4 
5-7 day old male of each RNAi line, knockdown was driven by crq-Gal4 in the hemocytes and 
flies were infected with Listeria monocytogenes (circles) and Francisella novicida (squares). 
Graph shows median survival of each RNAi line. w1118 was used as the control (crq-Gal4>0), 
n=20 per group. 
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3.4. Chapter 3 overview  
Bromodomain-containing proteins (BCPs) and jumonji domain-containing 
proteins (JDCPs) both play important roles in chromatin remodelling and 
transcriptional modifications (Zhang et al., 2016a). However, the roles they play in 
Drosophila immunity are currently relatively unknown. To evaluate if they play a role in 
immunity and defence mechanisms against bacterial infection, we knocked down 
each of the known BCPs or JDCPs in the immune cells of Drosophila. There are two 
main types of immune cells in the fly that make up both the cellular and the humoral 
defence following infection (Buchon et al., 2014). The cellular defence is reliant on the 
hemocytes, similar to monocytes and macrophages in mammals; they play important 
roles in identifying and phagocytosing invading microorganisms (Vlisidou and Wood, 
2015). The fat body makes up the humoral response in the fly, analogue to the 
mammalian adipose tissue and the liver; it produces the bulk of antimicrobial peptides 
(AMPs) which are able to destroy invading pathogens (Imler and Bulet, 2005). 
We carried out a survival screen looking into the roles BCPs and JDCPs may 
have during bacterial infection, the initial screen led to the identification of a number of 
BCP and JDCP knockdowns in the fat body or hemocytes that were short-lived or 
long-lived following bacterial infection with L. monocytogenes or F. novicida (Table 3-
1). Using RNAi lines for BCP or JDCP knockdowns in the fat body specifically, with 
the two driver lines c564-Gal4 or r4-Gal4, we identified three RNAi lines (Gcn5, tbrd-3 
and CG2982) to be long-lived following L. monocytogenes infection when using the 
c564-Gal4 driver. However, this long-lived phenotype was not shown for these three 
lines using the second fat body driver (r4-Gal4). In addition, we identified four lines 
(brd8, dikar, Kdm4B, PSR) to be long-lived following L. monocytogenes infection 
when using the r4-Gal4 driver, but these observations were not phenocopied by the 
initial fat body driver. Also using the r4-Gal4 driver, we identified two RNAi lines (Taf1 
and brahma) to be short-lived following L. monocytogenes infection. We also 
identified one RNAi line (KK108662, fs(1)h) that was short-lived following infection 
with both L. monocytogenes and F. novicida, when the line was knocked down 
specifically in the fat body using both drivers (c564-Gal4 and r4-Gal4).  
Following knockdown of BCPs or JDCPs in the hemocytes, using HmlΔ-Gal4, a 
number of RNAi lines were shown to live longer post-infection with L. monocytogenes 
than the control flies (Kdm2, tou, CG43320 and CG2982). Additionally, we observed a 
reduction in survival in three of the RNAi lines (dikar, Acf, and CG7460) tested 
following infection with F. novicida, however these results were not shown using the 
second hemocyte driver, crq-Gal4. Using the crq-Gal4 driver, we also identified a 
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number of long-lived RNAi lines following infection with L. monocytogenes (Brd140, 
polybromo, utx, brahma, CG8569 and CG8569) but these results were not repeated 
using the original hemocyte driver. However, knocking down Kdm2 and tou in the 
hemocytes using both hemocyte drivers extended the lifespan following infection with 
L. monocytogenes. Interestingly, the RNAi line, KK108662 (fs(1)h), which was shown 
to be short-lived following knockdown with both fat body drivers, was longer lived 
following L. monocytogenes infection when it was knocked down in the hemocytes 
using both driver lines. These data together suggest that following bacterial infection, 
knocking down fs(1)h may play an important and tissue-specific role in the fat body of 
Drosophila.  
 Using the RNAi lines that we had identified to have a survival phenotype, we 
repeated each of the crosses, and carried out the infections with L. monocytogenes 
and F. novicida for a second time. However, although we had identified a number of 
RNAi lines from the initial screen, to be long-lived or short-lived following bacterial 
infection, there was only one RNAi line that provided a consistent result in the follow-
up experiments. The RNAi line was KK108662, which is specific for female sterile (1) 
homeotic, fs(1)h. This line was extremely short-lived following bacterial infection when 
it was knocked down specifically in the fat body. Due to this finding, we wanted to 






c564-Gal4 r4-Gal4 HmlΔ-Gal4 crq-Gal4 
KK108662 
(fs(1)h) 
Short (L.m/F.n) Short (L.m/F.n) Long (L.m) Long (L.m) 
KK107378 
(tbrd-3) 
Long (L.m) / / / 
KK108943 
(Gcn5) 
Long (L.m) / / / 
KK107819 
(CG2982) 
Long (L.m) / / / 
KK106119 
(Taf1) 
/ Short (L.m) / / 
GD37720 
(brahma) 
/ Short (L.m) / Long (L.m) 
KK104879 
(Brd8) 
/ Long (L.m) / / 
KK107312 
(dikar) 
/ Long (L.m) / / 
KK110158 
(Kdm4B) 
/ Long (L.m) / / 
GD22108 
(PSR) 
/ Long (L.m) / / 
KK100383 
(dikar) 
/ / Short (F.n) / 
KK110485 
(CG7460) 
/ / Short (F.n) Long (L.m) 
GD33446 
(Acf) 
/ / Short (F.n) / 
KK109294 
(CG43320) 
/ / Long (L.m) / 
KK107819 
(CG2982) 
/ / Long (L.m) / 
KK109295 
(Kdm2) 
/ / Long (L.m) Long (L.m) 
KK100735 
(toutatis) 
/ / Long (L.m) Long (L.m) 
KK101311 
(Br140) 
/ / / Long (L.m) 
KK108618 
(polybromo) 
/ / / Long (L.m) 
KK105986 
(utx) 
/ / / Long (L.m) 
GD35962 
(CG8569) 
/ / / Long (L.m) 
Table 3-1: RNAi lines showing a phenotype following bacterial infection 
A summary of the survival phenotypes (short or long-lived compared to the Gal4 controls) 
observed following infection with Listeria monocytogenes (L.m) or Francisella novicida (F.n). 
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Chapter 4  
 
 
The immune and metabolic roles of female sterile (1) 
homeotic in the Drosophila fat body 	 	
	 109 
4.1. Introduction 
The female sterile (1) homeotic gene was isolated based on its embryonic 
phenotypes. These phenotypes include maternal mutations that cause segmental 
defects or deletions and thoracic homeotic transformation, while zygotic mutations 
cause lethality at larval or pupal stages or female sterility (Florence and Faller, 2008). 
Drosophila females lacking the function of the fs(1)h protein do not lay eggs (Perrimon 
et al., 1984). The homeotic defects in fs(1)h are similar to those caused by mutations 
in trithorax (trx), a key regulator of Hox genes (Florence and Faller, 2008). Hox genes 
are an important group of transcriptional regulators involved in vertebrate and 
invertebrate body planning (Mallo and Alonso, 2013). It has been shown that fs(1)h is 
critical for the activation of Ultrabithorax (Ubx), a Hox gene that controls the 
differential development between wings and haltere (Weatherbee et al., 1998). Ras 
signalling, which affects many cellular functions including proliferation, migration, 
apoptosis and differentiation (Olson and Marais, 2000), has been linked with the 
modulation of gene expression including that of fs(1)h (Florence and Faller, 2008). 
Additionally, during early stages of embryogenesis, fs(1)h is required for the 
regulation of Ras targets tailless (tll) and hückebein (hkb). Furthermore, fs(1)h 
encodes a tll repressor, which functions to down-regulate TOR signalling (Florence 
and Faller, 2008).  
 The female sterile (1) homeotic, fs(1)h, gene encodes two chromatin-binding 
isoforms, a short form, fs(1)hS (120kDA), and long form, fs(1)hL (210kDA) (Figure 4-
1) (Florence and Faller, 2008). The short isoform of fs(1)h, contains two 
bromodomains (BD1 and BD2) and an extraterminal (ET) domain at its C-terminal, 
which is necessary for protein-protein interactions (Lygerou et al., 1994). The long 
isoform is identical to the short form with an additional carboxy-terminal motif (CTM) 
that was shown to be essential for normal Drosophila development (Kellner et al., 
2013). fs(1)h is the sole Drosophila member of the bromodomain and extraterminal 
domain (BET) family, and is homologous to mammalian bromodomain-containing 
proteins (BCPs), BRD2/3/4/T (Florence and Faller, 2008). However, its closest 
orthologues are thought to be Brd2 and Brd4, which regulates transcription by 
recruiting Positive Transcription Elongation Factor b (PTEFb) at promoter regions of 
various genes in mammals (Kellner et al., 2013). Much like other BCPs, fs(1)h is able 
to recognise and bind acetylated lysine resides, as well as interact with and function 
as scaffolding for molecules involved in gene transcription (Sanchez and Zhou, 2009).  
 The fat body is analogous to adipose tissue and the liver in mammals and 
plays important roles in the humoral immune response and in metabolism. It produces 
the majority of antimicrobial peptides (AMPs) to help fight infection and control the 
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anabolism and catabolism of carbohydrates, lipids and sugars via a number of 
nutrient sensing mechanisms. Interestingly, the physiological roles of fs(1)h in the 
Drosophila fat body had not previously been explored. 
 
Figure 4-1: Long and short isoforms of Drosophila fs(1)h 
Schematic of the fs(1)h proteins showing the functional modules. fs(1)hS indicates the short 
isoform and fs(1)hL indicates the long isoform. BD1 and BD2 are the first and second 
bromodomains, respectively. The C-terminal motif (CMT) is unique to fs(1)hL. ET; 
extraterminal domain.  
4.1.1. Objective and aims 
In Chapter 3, we demonstrated that the loss of fs(1)h in the fat body dramatically 
reduced lifespan following infection with Listeria monocytogenes or Francisella 
novicida. Interestingly, fs(1)h was also the only BCP in the Drosophila fat body to 
affect survival following bacterial infection. The objective of this chapter is to better 
understand the role fs(1)h is playing in the fat body of Drosophila. 
 
The aims of this chapter are: 
1. To further investigate the immune role of fs(1)h in the fat body of Drosophila 
2. To explore the role of fat body fs(1)h in Drosophila metabolism 
4.2. Confirming the knockdown of fs(1)h in the fat body using c564-Gal4  
Following the RNAi survival screen and identifying that fs(1)h knockdown in the fat 
body caused the flies to be short-lived following bacterial infection (Figure 3-1 and 3-
2), we firstly wanted to ensure fs(1)h was efficiently being knocked down by the main 
fat body driver, c564-Gal4. Gene expression analysis showed that knocking down 
fs(1)h specifically in the fat body was not detected at transcript level in whole fly 
samples (Figure 4-2A). However, when the transcript level of fs(1)h was measured in 
dissected fat body tissue it was significantly reduced (Figure 4-2A’). The expression of 
Gal4 was also assayed and showed that Gal4 was significantly enhanced in fs(1)h 
knockdown flies in both whole fly and dissected fat body samples (Figure 4-2B and B’ 
respectively). 
  







































Figure 4-2: fs(1)h expression was reduced in dissected fat body samples following 
knockdown 
RT-qPCR analysis of 5-7 day old fly samples following knockdown of fs(1)h in the fat body 
(c564>fs(1)h-IR, grey bars) and control samples (c564>0, white bars). All RT-qPCR data was 
normalised to the housekeeping gene, α-tubulin. Normalised transcript levels of A. fs(1)h 
expression in whole fly samples with fs(1)h knocked down in the fat body and controls. 
Unpaired t test, data shown as mean + SEM, **p<0.01 A’. fs(1)h expression in dissected fat 
body samples with fs(1)h knocked down in the fat body and controls. Unpaired t test, data 
shown as mean + SEM, **p<0.01, n=8-10 per genotype. B. Gal4 expression in whole fly 
samples with fs(1)h knocked down in the fat body and controls. Unpaired t test, data shown as 
mean + SEM, ***p<0.001 B’. Gal4 expression in dissected fat body fly samples with fs(1)h 
knocked down in the fat body and controls. Unpaired t test, data shown as mean + SEM, 





































































4.3. Knockdown of fs(1)h in the fat body reduced lifespan 
Following the RNAi screen, experimental flies were found to be short-lived following 
knockdown of fs(1)h in the fat body. At both 25°C and 29°C and when uninfected, the 
flies had a severely reduced lifespan when fs(1)h was knocked down in the fat body 
using c564-Gal4 (c564>fs(1)h-IR) compared to the control group. At 25°C, 50% of the 
fs(1)h knockdown flies were dead by day 8 post-eclosion (Figure 4-3A), and this was 
reduced further still to day 5 post-eclosion when the flies were maintained at 29°C 
(Figure 4-3B), whereas the control genotype (c564>0) showed no reduction in lifespan 
at 25°C or 29°C.  
 Following bacterial infection with Listeria monocytogenes, a Gram-positive 
intracellular bacterium, or Francisella novicida, a Gram-negative intracellular 
bacterium, fs(1)h knockdown flies were shown to have a further reduced survival 
compared to the controls (Figure 4-3C and Figure 3-1, 3-2). fs(1)h knockdown flies 
infected with L. monocytogenes were all dead by day 6 post-infection, whereas the 
control flies survived until day 9 post-infection. F. novicida infected fs(1)h knockdown 
flies were all dead by day 4 post-infection, unlike the controls that were all dead at day 
6. The effect of c564>fs(1)h-IR flies also resulted in a decreased survival time 
following wounding, whereas the controls lived much longer. These data from the 
lifespan analysis and infection survivals showed that c564>fs(1)h-IR flies were 
dramatically short-lived compared to controls following infection, but also when 
injected with PBS, as a wounding control or completely uninjected.  
 To verify the specificity of the target tissue, we used a second fat body driver, 
r4-Gal4, and found the same dramatic reduction in survival following bacterial 
infection (Figure 3-2). The reduced lifespan under physiological conditions could also 
be replicated with the r4-Gal4 fat body driver with all of the uninjected fs(1)h 
knockdown flies dead by day 10 post-eclosion, whereas the controls showed no 
reduction in survival (Figure 4-3D).  
 We can conclude from these data that the loss of fs(1)h in the fat body 
resulted in a reduction in physiological lifespan, indicating a detrimental role for fs(1)h 
in the Drosophila fat body. The role of fs(1)h during infection remains unclear as the 
flies were very short-lived even in the absence of infection, for this reason the role of 
fs(1)h under physiological conditions was predominantly investigated. 	  
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Figure 4-3: Knocking down fs(1)h in the fat body reduced life span 
Flies were observed daily for the number of deaths and percent survival was calculated over 
time following knockdown of fs(1)h in the fat body. A. Survival was carried out comparing 
newly eclosed fs(1)h fat body knockdown flies (c564>fs(1)h-IR, squares) and control samples 
(c564>0, circles) at 25°C. n=20 per genotype. B. Survival was carried out comparing newly 
eclosed fs(1)h fat body knockdown flies (c564>fs(1)h-IR, squares) and control samples 
(c564>0, circles) at 29°C. n=20 per genotype. C. Survival was carried out on 5-7 day old male 








































































D. Survival at 29OC
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flies following bacterial infection in fs(1)h fat body knockdown (c564>fs(1)h-IR, grey lines) and 
control samples (c564>0, black lines). Uninjected flies (circles), PBS injected (squares), 
Listeria monocytogenes infected (triangles, OD 0.1) or Francisella novicida infected 
(diamonds, OD 0.1) flies at 29°C, n=20 per genotype. D. Survival was carried out between 
newly eclosed fs(1)h fat body knockdown flies using a second fat body driver (r4-Gal4>fs(1)h-
IR, squares) and control samples (r4-Gal4>0, circles) at 29°C. n=20 per genotype. 
4.4. Antimicrobial peptide expression was increased following fs(1)h 
knockdown in the fat body  
The fat body, an organ analogous to the liver and adipose tissue in mammals, is the 
principal site of the humoral response in Drosophila (Arrese and Soulages, 2010). 
Antimicrobial peptides (AMPs) are predominantly produced in the fat body and then 
secreted into the hemolymph (Lemaitre and Hoffmann, 2007). The AMPs are 
transcriptionally induced following infection by the two known peptidoglycan-
responsive signalling pathways, known as the Toll and Imd pathways. Recognition of 
Gram-positive bacteria and fungi activate the Toll pathway, whereas the Imd pathway 
is triggered by the detection of Gram-negative bacteria (Lemaitre et al., 1997).  
 Seven AMPs produced by the Toll and Imd pathways were assayed in order to 
investigate the immune function of the fat body when fs(1)h was removed. The AMPs 
assayed included Attacin A, Cecropin A1, Defensin, Diptericin, Drosocin, Drosomycin 
and Metchnikowin. Transcript levels of each AMP were increased following the 
knockdown of fs(1)h in the fat body relative to the control flies (Figure 4-4 A-G). 
However, this transcriptional increase was only significantly upregulated compared to 
controls in AttA, Dro and Drs (Figure 4-4 A, E, F). Following fat body dissection in 
both fs(1)h fat body knockdown flies and control flies, the AMP transcript levels 
became increasingly upregulated compared to the control group (Figure 4-5 A-G).  
 Following bacterial infection with Listeria monocytogenes or Francisella 
novicida there was a further increase in the transcript levels of each of the seven AMP 
described previously when fs(1)h was knocked down in the fat body compared to the 
control group (Figure 4-6 A-G). Even though the control group showed an expected 
induction of AMP expression following both bacterial infections. The fs(1)h fat body 
knockdown flies (c564>fs(1)h-IR) showed an even more pronounced expression. 
Furthermore, there was no prominent induction of AMPs detected in the PBS injected 
control flies but fs(1)h knockdown flies also showed an increased AMP expression 
after wounding, which almost reached the expression levels of AMPs following 
infection of the control genotype (Figure 4-6 A-G). These data together indicated that 
the loss of fs(1)h in the fat body resulted in an upregulation of all the AMPs analysed. 
Therefore, fs(1)h may play a role as an endogenous negative regulator of AMP 
expression in the presence or absence of bacterial infection. 
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Figure 4-4: AMP transcript levels were increased following fs(1)h knockdown in the fat 
body 
RT-qPCR analysis of 5-7 day old whole fly samples following knockdown of fs(1)h in the fat 
body (c564>fs(1)h-IR, grey bars) and control samples (c564>0, white bars). All RT-qPCR data 
was normalised to the housekeeping gene, α-tubulin. Data shown on a log10 scale. 
Normalised transcript levels of A. Attacin, B. Cecropin A1, C. Defensin, D. Diptericin, E. 
Drosocin, F. Drosomycin and G. Metchnikowin. Unpaired t tests, *p<0.05, **p<0.01, no stars 
indicate lack of statistical significance. Data represented as mean of n=8 biological repeats per 





































































































































Figure 4-5: AMP transcript levels were increased in dissected fat body samples 
following fs(1)h knockdown in the fat body 
RT-qPCR analysis of 5-7 day old dissected fat body samples following knockdown of fs(1)h in 
the fat body (c564>fs(1)h-IR, grey bars) and control samples (c564>0, white bars). All RT-
qPCR data was normalised to the housekeeping gene, α-tubulin. Data shown on a log10 
scale. Normalised transcript levels of A. Attacin, B. Cecropin A1, C. Defensin, D. Diptericin, E. 
Drosocin, F. Drosomycin and G. Metchnikowin. Unpaired t tests, **p<0.01, ***p<0.001. Data 
represented as mean of n=10 biological repeats per genotype (3 flies per sample), error bars 









































































































































Figure 4-6: AMP transcript levels were increased following bacterial infection 
RT-qPCR analysis of 5-7 day old whole fly samples following knockdown of fs(1)h in the fat 
body (c564>fs(1)h-IR, grey bars) and control samples (c564>0, white bars). Injected with PBS, 
as a wounding control, Listeria monocytogenes (L mono) or Francisella novicida (F novi). All 
RT-qPCR data was normalised to the housekeeping gene, α-tubulin. Normalised transcript 
levels of A. Attacin, B. Cecropin A1, C. Defensin, D. Diptericin, E. Drosocin, F. Drosomycin 
and G. Metchnikowin. Unpaired t tests, *p<0.05, **p<0.01, ***p<0.001, no stars indicate lack of 
statistical significance. Data represented as mean of n=5 biological repeats per genotype and 
injected group (3 flies per sample), error bars as SEM.  	
  




























































































































4.4.1. Relish showed increased protein levels when fs(1)h was knocked down in 
the fat body  
NF-κB and IκB proteins have vital roles in the regulation of immunity and inflammation 
in mammals (Baldwin, 1996). Homologues to these proteins have also been shown to 
be conserved in Drosophila and play a similar role in regulating the innate immune 
response (Begun and Whitley, 2000). Relish, the Rel/NF-κB like transcription factor 
plays a key role in the Drosophila humoral immune response and is a key 
transcription factor for AMP gene expression (Hedengren et al., 1999). The activation 
of the Imd pathway, via the peptidoglycan of Gram-negative bacteria, leads to the 
rapid proteolytic cleavage of Relish into two parts by the Caspase-8 homology, Dredd 
(Hetru and Hoffmann, 2009; Kim et al., 2014). The N-terminal fragment, contains the 
DNA-binding domain of Relish, which can translocate to the nucleus where it can 
proceed to bind to κB-sites in DNA and drive the expression of a number of AMPs 
including Drosomycin (Hoffmann, 2003). The IκB-like C-terminal fragment remains in 
the cytoplasm following cleavage (Silverman et al., 2000). The C-terminal of Relish is 
required for endoproteolysis and signal-dependent phosphorylation by the Drosophila 
IκB kinase β (Stöven et al., 2003). Drosophila Relish mutants are extremely sensitive 
to bacterial and fungal infection and have a severe reduction in the induction of 
antimicrobial defence, especially the production of AMPs by the fat body (Stöven et 
al., 2000). Enhanced activation of the Imd pathway and therefore increased activity of 
Relish may result in an induction of AMP production. We detected an increased 
expression of AMPs in flies lacking fs(1)h in the fat body, and due to this, we wanted 
to investigate the activation of the Imd pathway and the transcription factor Relish in 
these flies. 
 Western blot analysis for total Relish protein levels showed that fs(1)h 
knockdown in the fat body led to a significant upregulation of total Relish protein when 
compared to the control flies (Figure 4-7A). However, the C-terminal fragment, which 
remains in the cytoplasm following Relish cleavage and is indicative of Imd pathway 
activation showed no change between the control and fs(1)h knockdown flies (Figure 
4-7A). These data indicated that the increased baseline AMP expression shown 
previously was not due to an overall increase in Imd pathway activation. Interestingly, 
we found an accumulation of total Relish protein in flies with fs(1)h knockdown in the 
fat body, but this did not seem to be directly affecting the activation of the Imd 
pathway or explain the increased AMP expression shown. Following bacterial 
infection with Francisella novicida, there was a further increase of total Relish protein 
in both the PBS injected flies and in the F. novicida infected flies. This increase was 
shown slightly in the control flies, but was heightened further in the fs(1)h fat body 
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knockdown flies. The C-terminal fragment was also increased following injection with 
PBS or F. novicida, however there was no difference between the fs(1)h knockdown 
and the control flies (Figure 4-7B). These data suggested that fs(1)h knockdown in the 
fat body did not cause an increase in Imd pathway activation following bacterial 
infection. Interestingly, we found elevated total Relish protein levels in fs(1)h 
knockdown flies when uninjected, injected with PBS as a wounding control, and 
following bacterial infection. However, as the C-terminal did not alter following fs(1)h 
knockdown, an over-activation of the Imd pathway did not seem to be the reason for 
the elevated AMP expression or the reduction in survival following fs(1)h knockdown 





Figure 4-7: Total Relish levels were increased in fs(1)h fat body knockdown flies 
Western blot analysis of 5-7 day old flies lacking fs(1)h in the fat body (c564>fs(1)h-IR) and 
controls (c564>0) A. Total Relish protein and cleaved C-terminal levels in fs(1)h knockdown 
flies (grey bars) and controls (white bars). Values represented as intensity relative to α-tubulin, 
data shown as mean + SEM, *p<0.05, no stars indicate lack of statistical significance. B. Total 
Relish protein and cleaved C-terminal levels in fs(1)h knockdown flies (grey bars) and controls 
(white bars), in uninjected samples and following injection with PBS or Francisella novicida. 
Data represented as mean or mean + SEM, *p<0.05, no stars indicate lack of statistical 












































































































































4.5. Loss of fs(1)h in the fat body increased cytokine expression 
In addition to the production of AMPs in the humoral immune response, the fat body 
also releases a wide variety of immune-modulatory molecules and cytokines. 
Cytokines are a group of proteins that can help mediate the immune response. In 
Drosophila, cytokines have been shown to play roles in host defence, stress response 
and wound repair (Vanha-aho et al., 2016). Much of the cross-talk between tissues 
and organs in Drosophila, including gut-to-fat body, hemocytes-to-fat body and 
hemocytes-to-muscle, is carried out by cytokines that can respond to an array of 
stimuli and act to initiate local or systemic responses (Vanha-aho et al., 2016). 
 decapentaplegic (dpp), a TGF-β superfamily member, is homologous to the 
mammalian bone morphogenetic protein (BMP) and is essential for many aspects of 
Drosophila development and the immune response. dpp is activated by wounding and 
can help to resolve the antimicrobial peptide response (Clark et al., 2011). It is also an 
inhibitor of the immune response and inflammation following sterile injury and flies 
with non-functioning dpp exhibit strong antimicrobial peptide expression after 
wounding. Due to the role of dpp in the immune response and resolving AMP 
expression, the transcript levels were measured following fs(1)h knockdown in the fat 
body. We found a significant increase following knockdown of fs(1)h in the fat body 
compared to the control group (Figure 4-8A). eiger, the single member of the TNF 
superfamily, is expressed predominantly in the nervous system, is able to induce cell 
death by activating the JNK pathway (Igaki et al., 2002) and acts as a metabolic 
hormone that mediates nutrient response by remotely acting on IPCs (Agrawal et al., 
2016). It also plays an important role as a key inflammatory cytokine of the immune 
system in Drosophila. eiger mutants are sensitive to bacterial infection, suggesting a 
role in the Drosophila innate immune response (Brandt et al., 2004). It has also been 
shown that eiger mutants are sensitive to extracellular bacteria (Schneider et al., 
2007). However, following infection with intracellular bacteria the mutants respond as 
well as, or better than wild-type flies (Schneider et al., 2007). Following knockdown of 
fs(1)h in the fat body there was a significant upregulation in eiger transcript levels 
relative to the control group (Figure4-8B). The Jak/STAT activating ligand, upd3, is an 
important pro-inflammatory cytokine in coordinating the cellular immune response in 
different tissues of Drosophila (Yang and Hultmark, 2016). Following bacterial 
infection, hemocytes produce upd3, which in turn activates the Jak/STAT pathway in 
the fat body (Yang and Hultmark, 2016). Bacterial infection or damage to the gut can 
also lead to the secretion of upd3 to stimulate intestinal stem cell proliferation and 
differentiation (Buchon et al., 2010). Furthermore, lipid-rich diet stimulates hemocytes 
to secrete upd3, systemically impairing glucose homeostasis and reducing lifespan 
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(Woodcock et al., 2015). upd3 levels in the fat body fs(1)h knockdown flies showed a 
significant increase relative to the control group (Figure 4-8C). Taken together, along 
with the increased AMP expression, we also found elevated cytokine levels following 
loss of fs(1)h in the fat body. 
 
Figure 4-8: Cytokine expression was increased following fs(1)h knockdown in the fat 
body 
RT-qPCR analysis of 5-7 day old whole fly samples following knockdown of fs(1)h in the fat 
body (c564>fs(1)h-IR, grey bars) and control samples (c564>0, white bars). All RT-qPCR data 
was normalised to the housekeeping gene, α-tubulin. Normalised transcript levels of A. 
decapentaplegic (dpp), B. eiger, C. unpaired 3 (upd3). Unpaired t tests, **p<0.01, 
****p<0.0001. Data represented as mean of n=8 biological repeats per genotype (3 flies per 








































































4.6. Flies with fs(1)h knockdown in the fat body showed increased gut 
barrier dysfunction but did not alter endogenous bacterial loads 
Ageing is broadly defined by a progressive decline in physiological function and this 
decline includes all biological systems, including molecular interactions, cellular 
function and tissues structure and function (He and Jasper, 2014; López-Otín et al., 
2013).  
 The intestinal epithelium forms a barrier that allows the absorbance of 
nutrients and restricts contact with contaminants from the environment and 
microorganisms (Buchon et al., 2009). Structural and functional impairments of this 
epithelium have been identified in humans and Drosophila during the ageing process 
(He and Jasper, 2014; Rera et al., 2012; Saffrey, 2014). Intestinal barrier dysfunction 
is correlated with reduced lifespan across a number of Drosophila genotypes and in 
various environmental conditions such as dietary restriction (Rera et al., 2012). 
Irrespective of actual age, intestinal barrier dysfunction can be used to predict 
impending death in individual flies and can be used to identify flies with systemic 
metabolic defects including a reduction of AKT activation and FOXO upregulation 
(Rera et al., 2012). Remarkably, age-related increase in AMP expression is tightly 
linked to intestinal barrier dysfunction (Rera et al., 2012). In response to 
microorganisms, the reaction by the gut epithelium of Drosophila is complex and 
diverse (Buchon et al., 2013). However, gut defences include the production of 
reactive oxygen species (ROS), the secretion of AMPs into the hemolymph via the 
Imd pathway and epithelium renewal in response to gut damage, in order to maintain 
homeostasis (Kuraishi et al., 2013). Furthermore, to maintain intestinal homeostasis, 
commensal bacteria must be upheld, whereas pathogens must be eliminated, and 
inflammatory responses must be regulated (Apidianakis and Rahme, 2011). 
Interestingly, regulatory mechanisms such as the down-regulation of the Imd pathway 
in Drosophila ensures the appropriate level of immune reactivity in the gut to 
effectively destroy invading pathogens, but to accommodate the required gut 
microbiota (Buchon et al., 2013). In mammals, acute or chronic dysregulation can 
lead to various diseases including gastrointestinal infection and colorectal cancer 
(Garrett et al., 2010). The smurf assay was used to non-invasively investigate the gut 
integrity of flies with fs(1)h knocked down in the fat body. In this assay, dyed food was 
used to visualise the integrity of the digestive system. An intact gut does not allow the 
dye to leak into the body cavity of the fly, whereas a dysfunctional gut barrier allows 
the dye to leak into the body and the whole fly will become coloured blue. The assay 
showed that following fs(1)h knockdown in the fat body, there was a small increase in 
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the number of flies with gut barrier dysfunction, observed by the blue food dye being 
outside of the digestive tract, relative to the control group, where we did not detect 
any flies with dysfunctional gut integrity (Figure 4-9A). However, we did not detect gut 
integrity dysfunction in all the flies with fs(1)h knocked down in the fat body, indicating 
that the loss of gut integrity was not a hallmark of fs(1)h deficiency in the fat body, 
rather a secondary effect of the early death phenotype observed in these flies. 
 In many organisms, the microbiome is made up of extracellular bacteria and 
endosymbionts, which often play important roles in development, immunity and 
homeostasis (Elgart et al., 2016). In recent years, Drosophila have become an 
important model for studying non-pathogenic host-microbe interactions, along with the 
dynamics and consequences of host-microbe interaction (Chandler et al., 2011). The 
microbiota of the Drosophila gut is relatively simple compared to the complex diversity 
of the microbiota associated with vertebrates (Broderick and Lemaitre, 2012). 
Laboratory stocks of Drosophila are colonised predominantly by Acetobacter and 
Lactobacillus species (Wong et al., 2011) which influence many functions including 
immunity, lifespan and nutritional regulation (Ridley et al., 2012; Ryu et al., 2008; 
Yamada et al., 2015). Furthermore, there is an important interplay between the 
microbiome and the immune response, and immune deficiency or even ageing can 
result in increased bacterial load in the fly (Ren et al., 2007). Bacteria were identified 
through culture-independent assessment of microbial diversity by direct PCR 
amplification and sequencing of bacterial 16S ribosomal DNA extracted from 
Drosophila DNA. The amplified product for 16S ribosomal DNA showed no difference 
between the control flies and fs(1)h fat body knockdown flies (Figure 4-9B). Loss of 
fs(1)h in the fat body did not result in an increase of endogenous bacterial load 
compared to the control group.  
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Figure 4-9: fs(1)h knockdown in the fat body showed a slight change in gut integrity but 
no change in endogenous bacterial load 
Changes in the gut of controls (c564>0) and fs(1)h fat body knockdown flies (c564>fs(1)h-IR) 
were investigated. A. Smurf assays for the gut integrity of 5-7 day old male flies with fs(1)h 
knocked down in the fat body and controls. Data represented as percentage, non-smurfs 
(white bars), and smurf flies (grey bar). B. Amplified product for bacterial 16S ribosomal DNA 
in 5-7 day old male fs(1)h knockdown flies and controls.  
4.7. Fat body knockdown of fs(1)h reduced survival during starvation 
Drosophila are a widely studied model of starvation responses (Gibbs and Reynolds, 
2012). There are three main ways to increase starvation resistance; by storing more 
energy, by consuming that energy at a lower rate or by tolerating the loss of the 
energy stores (Lee and Jang, 2014). The fat body is the main organ for the storage 
and mobilisation of energy, we aimed to investigate whether the loss of fs(1)h in the 
fat body affected the survival and tolerance to starvation stress. Flies with fat body 
knockdown of fs(1)h had a reduced life span on starvation food compared to the 
control flies (Figure 4-10). Half the fs(1)h knockdown flies were dead after 
approximately 10 hours on starvation food, whereas the control flies still had 50% 
survival around 40 hours. Along with the reduction in lifespan under both physiological 
and infected conditions we found previously, we also found a dramatically reduced 











































































































Figure 4-10: Knocking down fs(1)h in the fat body reduced starvation survival 
Starvation survival of 5-7 day old control flies (c564>0, circles) and flies with fs(1)h knockdown 
in the fat body (c564>fs(1)h-IR, squares). Fed flies (closed shapes) and starved flies (open 
shapes). Flies were counted every two hours during the day for deaths and percent survival 
was calculated, n=20 per group. 
4.7.1. Flies lacking fs(1)h in the fat body were unable to utilise their triglyceride 
stores during starvation 
The fat body is not only important in the humoral immune response; it also plays 
fundamental roles in energy storage and utilisation (DiAngelo et al., 2009). Fat body 
cells control the synthesis and use of fat and glycogen, along with the production of 
many proteins and metabolites required in the hemolymph (Arrese and Soulages, 
2010). The fat body is analogous to adipocytes, which are characterised by the 
presence of lipid droplets, made up predominantly of triglycerides (TAG). The 
triglycerides are produced from dietary carbohydrates, fatty acids or proteins (Arrese 
and Soulages, 2010). However, during times of energy demand, Drosophila can 
access their triglyceride stores via lipolysis (Arrese and Soulages, 2010). The process 
of lipolysis is carried out by a number of lipases working together. As there was a 
severe starvation phenotype in the fs(1)h knockdown flies, thin layer chromatography 
(TLC) was used to analyse triglyceride levels within the flies. These data showed that 
fs(1)h knockdown in the fat body showed no difference in the quantity of triglyceride 
present under normal fed conditions (Figure 4-11). However, the fs(1)h knockdown in 
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the fat body limited the ability for the flies to mobilise triglycerides following a 24-hour 
starvation period when compared to controls (Figure 4-11). Control flies completely 
emptied and utilised their triglyceride stores for energy during 24-hours starvation. 
Conversely, flies with fs(1)h knocked down in the fat body only showed a slight 
reduction in triglyceride levels following 24-hours starvation, suggesting they were 
incapable of utilising their stored triglycerides. This inability for the flies to utilise their 
triglyceride stores fits with the observation that they die much earlier than the control 
flies on starvation food. It also indicates why the fs(1)h fat body knockdown flies had a 
significant reduction in starvation tolerance and a deficiency in energy mobilisation. 
 
Figure 4-11: fs(1)h fat body knockdown flies were unable to utilise their triglyceride 
stores during starvation 
Thin layer chromatography (TLC) analysis of 5-7 day old total fly triglyceride levels following 
knockdown of fs(1)h in the fat body (c564>fs(1)h-IR) compared to controls (c564>0). Fed 
conditions (grey bars) and following 24-hour starvation (white bars). The TLC plate shows one 
fed and one starved group for the control, and one fed and two starved groups (represented by 
the mean) for the fs(1)h fat body knockdown. F; fed, S; starved and TG; triglyceride, n.d; non-
detected.  	  

























































4.7.2. Morphological changes to the fat body were not observed following fs(1)h 
knockdown in the fat body 
There are approximately 18,000 fat body cells in the abdomen of adult flies and the 
proportion of lipids and glycogen remain relatively constant throughout adult life 
(Johnson and Butterworth, 1985). However, dense, protein-rich granules can be seen 
in fat body cells of ageing flies (Johnson and Butterworth, 1985). As fs(1)h knockdown 
flies were unable to utilise their triglyceride stores during starvation, we wanted to 
investigate whether removing fs(1)h from the fat body changed the appearance or 
morphology of the lipid droplets. Staining the adult fat body with LipidTOX, a dye 
staining neutral lipids, showed no overt morphological abnormalities in the tissue 
following knockdown of fs(1)h in the fat body compared to the control group (Figure 4-
12). We can conclude that under fed conditions, there were no morphological 
abnormalities in the fat body cells deficient for fs(1)h.  
Figure 4-12: The morphology of lipids remained the same as controls following fs(1)h 
knockdown in the fat body 
Isolated adult fat body tissue aged for 5-7 days from fs(1)h knockdown flies (c564>fs(1)h-IR, 
right) and controls (c564>0, left), stained with LipidTOX (red, neutral lipids) and DAPI (blue, 
nuclei). Scale bar, 20µm. 	  

























































4.7.3. Loss of fs(1)h in the fat body led to a transcriptional reduction in a 
number of key lipid mobilisation genes  
Lipases are hydrolytic enzymes that operate on the surface of lipid substrates to 
break down triglycerides into free fatty acids and glycerol (Pistillo et al., 1998). In 
Drosophila, and numerous other organisms, lipases control the balance between 
triglyceride accumulation and mobilisation (Grönke et al., 2007). There are thought to 
be two modes of lipolysis, firstly basal lipolysis, which balances steady-state 
lipogenesis in lipid storage homeostasis (Kühnlein, 2012). The second mode is 
stimulated lipolysis, which causes TAG to be mobilised during periods of energy 
shortage, for example during starvation (Kühnlein, 2012). Having identified impaired 
utilisation of triglyceride stores upon starvation in the fs(1)h knockdown flies, the 
transcript levels of key lipases involved in lipid metabolism were assayed. 
 Hormone sensitive lipase (Hsl), functions in lipid metabolism, in the fed state 
Hsl does not localise to the lipid droplets, however, during starvation there is an 
accumulation of Hsl on the surface of the lipid droplets (Bi et al., 2012). When fs(1)h 
was knocked down in the fat body, there was no change in the transcript level of Hsl 
between the knockdown in either whole fly (Figure 4-13A) or dissected fat body 
samples (Figure 4-13A’) compared to the control genotype. The brummer (bmm) 
lipase plays key roles in both basal and stimulated lipolysis (Kühnlein, 2012). bmm 
knockdown increases lipid storage in Drosophila tissue culture, whereas over-
expression protects flies against high fat diet-induced TAG accumulation (Grönke et 
al., 2005). Here, we showed that fs(1)h fat body knockdown flies had a decrease in 
bmm transcript levels, but this was not significant in the whole fly (Figure 4-13B). 
However, there was a significant reduction of bmm in the dissected fat body samples 
following fs(1)h knockdown (Figure 4-13B’). The perilipins are members of an 
evolutionarily conserved family of lipid droplet-associated proteins that modulate 
storage lipid homeostasis (Kimmel and Sztalryd, 2016). plin1 increases lipolytic 
activity by recruiting lipases to the lipid surface (Beller et al., 2010) and was 
significantly reduced in the whole fly samples following fs(1)h knockdown in the fat 
body (Figure 4-13C). plin1 was further decreased in the dissected fat body samples of 
fs(1)h knockdown flies (Figure 4-13C’). In contrast to the prolipolytic plin1, plin2 
protects triglyceride stores in a dose-dependant manner (Tsai et al., 2017). plin2 
transcript levels showed no change in the whole fly samples of fs(1)h fat body 
knockdown flies (Figure 4-13D), however a significant reduction was shown following 
fat body dissection (Figure 4-13D’). Overall, these data showed a reduction, but not 
an elimination of bmm, plin1 and plin2 following fs(1)h knockdown in the fat body 
following fat body dissection. These data indicate that the reduction in lipases may be 
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partially influencing the dysfunction in triglyceride mobilisation following the loss of 
fs(1)h in the fat body. 
	
Figure 4-13: Lipid metabolism genes were altered following fat body knockdown of 
fs(1)h in both whole fly samples and dissected fat body 
RT-qPCR analysis of 5-7 day old whole flies and dissected fat body following knockdown of 
fs(1)h in the fat body (c564>fs(1)h-IR, grey bars) and control samples (c564>0, white bars). All 
RT-qPCR data was normalised to the housekeeping gene, α-tubulin. Normalised transcript 
levels of A. Hormone sensitive lipase (Hsl) in whole fly samples, A.’ Hsl in dissected fat body 
samples, B. brummer (bmm) in whole fly samples, B.’ bmm in dissected fat body samples, C. 
perilipin 1 (plin1) in whole fly samples, C.’ plin1 in dissected fat body samples, D. perilipin 2 
(plin2) in whole fly samples and D.’ plin2 in dissected fat body samples. Unpaired t tests, 
*p<0.05, ***p=0.001, ****p<0.0001, no stars indicate lack of statistical significance. Data 
represented as mean of n=8/10 biological repeats per genotype (3 flies per sample), error bars 
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4.8. Flies lacking fs(1)h in the fat body were hypoglycemic   
In many insects, including Drosophila, trehalose, a non-reducing disaccharide, is the 
main circulating hemolymph sugar, along with low levels of glucose also found in the 
hemolymph (Reyes-DelaTorre et al., 2012). Trehalose is produced from glucose, and 
due to its chemical properties has the advantage of protecting Drosophila against 
environmental stresses such as starvation (Matsuda et al., 2015). Glycogen is 
synthesised from glucose, derived mainly from dietary carbohydrates and amino 
acids, it comprises the major form of energy storage for carbohydrates and is stored 
in the Drosophila fat body (Arrese and Soulages, 2010). Additionally, when trehalose 
reaches a certain concentration within the fat body, its production is repressed and 
the glucose present is used for glycogen synthesis (Friedman, 1978). Interestingly, 
with increasing age Drosophila are shown to have a decrease in trehalose and 
glycogen, whereas glucose remains constant (Morris et al., 2012). Drosophila insulin-
like peptides (DILPs) maintain hemolymph sugar levels and the mobilisation of 
hemolymph trehalose to glucose is critical for metabolic homeostasis. However, the 
physiological importance of circulating sugar metabolism following changes in 
nutritional state remain unclear (Yasugi et al., 2017). Flies with defects in energy 
mobilisation from the fat body, are often found to have altered levels of circulating 
sugars and stored carbohydrates (Baker and Thummel, 2007). Flies with fs(1)h 
knocked down in the fat body were hypoglycemic compared to the control group, they 
had reduced circulating sugars, in the form of trehalose and glucose (Figure 4-14A, 
B). The loss of fs(1)h in the fat body also induced a reduction in the stored 
carbohydrates, glycogen, compared to the control group (Figure 4-14C). Interestingly, 
we found decreased levels of circulating and stored carbohydrates in fs(1)h 
knockdown flies. This phenotype is reminiscent of those seen in mice heterozygous 
for Brd2 mutation, which exhibit reduced serum glucose levels (Wang et al., 2009). 
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Figure 4-14: fs(1)h knockdown in the fat body caused hypoglycemia 
Trehalose, glucose and glycogen content in 5-7 day old male flies following knockdown of 
fs(1)h in the fat body (c564>fs(1)h-IR, grey bars) and control samples (c564>0, white bars). 
Circulating sugars of A. Trehalose, B. Glucose, and stored carbohydrate levels of C. 
Glycogen. Unpaired t tests, *p<0.05, **p<0.01, ****p<0.0001. Data represented as mean of 













































4.8.1. Glucose uptake was not impaired when fs(1)h was knocked down in the 
fat body 
In human diseases such as diabetes, there is a failure to increase glucose uptake into 
peripheral tissues in response to insulin, leading to chronically increased levels of 
glucose in circulation, which is known as hyperglycemia (Alfa and Kim, 2016). 
Although the fs(1)h knockdown flies were hypoglycemic, we wanted to assay the 
ability of these flies to take up glucose into their tissues. The fluorescently labelled 
deoxyglucose analog, 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-Deoxyglucose 
(2-NBDG), was used to monitor this glucose uptake. These data showed that there 
was no obvious difference in the way the glucose analog was being taken up by either 
the fs(1)h knockdown or the control group (Figure 4-15). One-hour post injection, we 
found an organism-wide distribution and uptake of 2-NBDG into the tissues, with no 
preference for specific tissues. We concluded from these results that glucose uptake 
and distribution did not seem to be disturbed following the loss of fs(1)h in the fat 
body. It would also be of interest to include a negative control within this experiment, 
perhaps insulin receptor (InR) mutant flies to show their inability to take-up the 2-
NBDG efficiently into the tissues.   
	
Figure 4-15: Flies with a loss of fs(1)h in the fat body were able to take up glucose 
normally 
Images of 5-7 day old males with knockdown of fs(1)h in the fat body (c564>fs(1)h-IR, right) or 
control flies (c564>0, left). 1-hour post injection with the fluorescently labelled deoxyglucose, 












































4.9. Loss of fs(1)h in the fat body reduced the activation of the kinase 
AKT 
The insulin-signalling pathway has conserved roles in regulating growth, metabolism 
and lifespan and can also affect AMP expression (Becker et al., 2010; Taguchi and 
White, 2008). Based on our phenotypic observations thus far, we further aimed to 
assay insulin activity in fs(1)h fat body knockdown flies. AKT is the key effector kinase 
of the insulin-signalling pathway, it is activated at Serine 505 by the activation loop at 
Threonine 308 by phosphoinositide-dependent kinase 1 (PDK1) and the 
phosphorylation within the carboxy terminus at Serine 473 (Alessi et al., 1996; 
Scanga et al., 2000). Analysis showed knockdown of fs(1)h in the Drosophila fat body 
led to a reduction in phosphorylated AKT (pAKT) relative to the control group (Figure 
4-16A). Loss of AKT activity in the fs(1)h knockdown flies under normal, fed 
conditions was indicative of a reduced signalling via the insulin pathway. We further 
aimed to analyse the levels of p70 S6 kinase (S6K) when phosphorylated at threonine 
398, which acts downstream of TOR signalling in response to growth factors and 
nutrients, was also reduced following knockdown of fs(1)h when compared to controls 
(Figure 4-16B). Interestingly, Drosophila deficient in S6K exhibit extreme delays in 
development and a reduction in body size (Montagne et al., 1999), however this was 
not observed following fs(1)h knockdown in the fat body. As mentioned previously, a 
reduction in pAKT is often induced by a reduction in insulin signalling and a loss of 
insulin signalling in a tissue can result in insulin resistance (Rask-Madsen and Kahn, 
2012). We tested if the loss of fs(1)h in the fat body resulted in insulin resistance by 
challenging fs(1)h knockdown flies and controls with either PBS or two different doses 
of human insulin (low and high). However, when the fs(1)h fat body knockdown flies 
were injected with insulin they did not show signs of insulin resistance and were able 
to response in the same manner as the control flies (Figure 4-16C). From these 
results, we could show that the loss of fs(1)h in the fat body led to decreased insulin 
signalling activity, shown by the decrease in activity of the kinase AKT and a reduction 
in p70 S6 Kinase (S6K) activity. However, fs(1)h deficiency in the fat body did not lead 
to the development of insulin insensitivity. 
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Figure 4-16: fs(1)h knockdown flies showed a reduction in pAKT and S6 Kinase but 
were not insulin resistant 
Western blot analysis of 5-7 day old flies following knockdown of fs(1)h in the fat body 
(c564>fs(1)h-IR) and controls (c564>0). A. AKT Ser505 phosphorylation in control (white bars) 
and fs(1)h fat body knockdown (grey bars) flies. Values represented as intensity relative to α-
tubulin, data shown as mean + SEM, **p<0.01. B. p70 S6 Kinase (S6K) in control (white bars) 
and fs(1)h fat body knockdown (grey bars) flies. Values represented as intensity relative to α-
tubulin, data shown as mean + SEM, **p<0.01.  C. To assay insulin sensitivity, AKT 
phosphorylation levels were measured following injection with PBS (white bars) or a high 
(320pg/fly; light grey bars) or low (64 pg/fly; dark grey bars) dose of human insulin. Values 




















































































































4.9.1. Insulin signalling related genes showed transcriptional changes following 
fs(1)h knockdown in the fat body 
There are a number of key genes in the insulin-signalling pathway and their 
dysregulation can be detrimental in both vertebrates and invertebrates (Erion and 
Sehgal, 2013). Several of these key genes are transcriptionally regulated by the 
phosphorylation event of AKT (Liao and Hung, 2010). Here, we wanted to investigate 
the expression levels of several key genes of the insulin pathway to determine 
whether the loss of fs(1)h was affecting their transcript levels. The insulin-like receptor 
(InR) is essential for normal development in Drosophila and is required for the 
formation of the epidermis as well as the central and peripheral nervous systems 
during embryogenesis (Fernandez et al., 1995). Following ligand binding, the InR can 
activate the insulin-signalling pathway. When fs(1)h was knockdown specifically in the 
fat body, expression level of the InR were significantly increased in both the whole fly 
(Figure 4-17A) and in dissected fat body (Figure 4-17A’). The best-characterised 
transcriptional effector downstream of AKT is the transcription factor foxo. FOXO is 
phosphorylated by AKT, promoting its nuclear exclusion and limiting gene 
transcription. In the whole fly, we found no change in transcription levels between the 
control flies and the fs(1)h fat body knockdown flies (Figure 4-17B). However, the 
transcript level of foxo in dissected fat body samples was significantly reduced when 
compared to controls (Figure 4-17B’). Fitting with this observation, when FOXO levels 
are high, it is able to reduce its own expression to stimulate the expression of its 
target genes. 4E-BP, also known as Thor, which is transcriptionally regulated by foxo 
was significantly upregulated in the flies with the fs(1)h knockdown in the fat body in 
both whole fly (Figure 4-17C) and dissected fat body (Figure 4-17C’). Here, we found 
that loss of fs(1)h in the fat body resulted in transcriptional dysregulation of several 
key genes involved in the insulin pathway. In particular, we found elevated levels of 
InR and 4E-BP, which are both FOXO target genes. These data, along with the 




Figure 4-17: Transcript levels of insulin signalling genes were altered following fs(1)h 
knockdown in the fat body 
RT-qPCR analysis of 5-7 day old whole flies and dissected fat body samples following 
knockdown of fs(1)h in the fat body (c564>fs(1)h-IR, grey bars) and control samples (c564>0, 
white bars). All RT-qPCR data was normalised to the housekeeping gene, α-tubulin. 
Normalised transcript levels of A. Insulin-like receptor (InR) in whole fly samples, A.’ InR in 
dissected fat body samples, B. foxo in whole fly samples, B.’ foxo in dissected fat body 
samples, C. 4E-BP (Thor) in whole fly samples and C.’ 4E-BP in dissected fat body samples. 
Unpaired t tests, *p<0.05, **p=0.01, ****p<0.0001, no stars indicate lack of statistical 
significance. Data represented as mean of n=8/10 biological repeats per genotype (3 flies per 

























































































4.9.2. Drosophila insulin-like peptides were increased when fs(1)h was knocked 
down in the fat body 
As in mammals, sugar levels in Drosophila are regulated by the action of two 
endocrine hormones, the Drosophila insulin-like peptides (DILPs) and the glucagon-
like peptide, Akh (Yasugi et al., 2017). In most cases, DILPs signal via the conserved 
InR-PI3K pathway and the best-known transcriptional effect involves the signal-
responsive inactivation of FOXO (Britton et al., 2002). DILP2, 3 and 5 are believed to 
play roles analogous to that played by mammalian insulin in regulating physiology in 
response to changes in nutritional state (Zhang et al., 2009). DILP secretion is 
required for the activation of insulin signalling and to regulate glucose levels within 
tissues and in the hemolymph. Due to the changes in activated AKT levels, as well as 
the changes in carbohydrate levels and changes in the transcript level of various 
insulin signalling genes we observed after the loss of fs(1)h in the fat body, we 
assayed DILP levels following fs(1)h knockdown in the fat body. The insulin-like 
peptides, DILP2, 3 and 5, released from IPCs in the brain were all shown to be 
significantly upregulated following fs(1)h knockdown (Figure 4-18A). DILP6, which is 
released from the fat body itself, was measured in whole fly and dissected fat body 
following fs(1)h knockdown, although there was very little transcriptional change in 
either sets of samples (Figure 4-18B, B’). Additionally, the transcript level of 
phosphoenolpyruvate carboxykinase (Pepck), a key enzyme in gluconeogenesis 
(Quinn and Yeagley, 2005), was significantly upregulated in whole fly samples 
following fs(1)h knockdown in the fat body (Figure 4-18C). However, this observation 
was lost in the dissected fat body samples and the transcript levels were similar in 
both the control group and following fs(1)h knockdown (Figure 4-18C’). We conclude 
that even though there was a reduction in insulin signalling activity following fs(1)h 
knockdown in the fat body, we found elevated levels of DILP2, 3 and 5 in these flies 
which may be an attempted rescue mechanism induced by the fat body to increase 
AKT activation and reduced FOXO levels. 
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Figure 4-18: DILP expression was increased following knockdown of fs(1)h in the fat 
body 
RT-qPCR analysis of 5-7 day old whole fly samples and dissected fat body following 
knockdown of fs(1)h in the fat body (c564>fs(1)h-IR, grey bars) and control samples (c564>0, 
white bars). All RT-qPCR data was normalised to the housekeeping gene, α-tubulin. 
Normalised transcript levels of A. Drosophila insulin-like peptide 2, 3 and 5 (DILP2, 3 and 5) in 
whole fly samples, B. DILP6 in whole fly samples, B’. DILP6 in dissected fat body samples, C. 
Phosphoenolpyruvate carboxykinase (Pepck) in whole fly samples and C’. Pepck in dissected 
fat body samples. Unpaired t tests, *p<0.05, **p<0.01, ****p<0.0001, no stars indicate lack of 
statistical significance. Data represented as mean of n=8/10 biological repeats per genotype (3 















































































































4.10. Fat body-derived nutrient-responsive signals were altered when 
fs(1)h was removed from the fat body  
The fat body plays a central role in the regulation of systemic growth in response to 
nutrients. Nutrient sensors function as detectors of nutrient flux via metabolic 
pathways within cells and in the hemolymph (Miyamoto et al., 2013). The fat body 
senses nutrients via two main mechanisms, firstly by sensing intracellular amino acids 
via TOR signalling (Colombani et al., 2003) or by releasing or initiating the release of 
DILPs from the fat body (DILP6) or from other tissues such as the IPCs in the brain 
(DILP2, 3 and 5) (Owusu-Ansah and Perrimon, 2014). 
 upd1 and upd2, two ligands of the Jak/STAT pathway, both play important 
roles in nutrient sensing (Beshel et al., 2017; Rajan and Perrimon, 2012). upd1, 
considered to be a mammalian leptin homolog, is expressed in the Drosophila brain 
and plays an important role in food intake and food cue attraction (Beshel et al., 
2017).  Interestingly, transcript levels of upd1 were significantly increased in the flies 
lacking fs(1)h in the fat body compared to the control flies (Figure 4-19A). However, 
this significant increase was not shown in the dissected fat body samples, although 
there was a similar increasing trend (Figure 4-19A’). upd2, also considered to be a 
functional analogue of leptin, is sugar- and lipid-sensitive, and acts independent of the 
TOR pathway (Sano et al., 2015). upd2 secretion from the fat body is also associated 
with the release of DILPs from the IPCs in the brain (Rajan and Perrimon, 2012).The 
transcript levels of upd2 following fs(1)h knockdown showed an increasing trend in 
whole fly samples (Figure 4-19B), and following fat body dissection the transcript level 
of upd2 was significantly upregulated compared to the control group (Figure 4-19B’). 
Two other peptides, known as Growth-blocking peptide 1 and 2 (Gbp1, Gbp2) are 
produced by the Drosophila fat body in response to amino acids and TOR signalling 
and are thought to act as nutrient sensing factors (Koyama and Mirth, 2016). Gbp1 
and 2 also, either directly or indirectly, stimulate DILP secretion from IPCs, to increase 
insulin-like growth factor signalling activity (Koyama and Mirth, 2016). Gbp1 regulates 
the immune response and its expression is sensitive to starvation (Koyama and Mirth, 
2016). When we assayed the transcript levels of Gbp1, they remained unchanged in 
whole fly samples following fs(1)h knockdown (Figure 4-19C). Conversely, following 
fat body dissection there was a significant reduction in Gbp1 levels when fs(1)h was 
removed in the fat body (Figure 4-19C’). Levels of Gbp2 were also assayed and were 
significantly reduced following fs(1)h knockdown in the whole fly and in the dissected 
fat body tissue (Figure 4-19D and D’). CChamide-2 (CCHa2), much like upd2, is 
sugar- and lipid-sensitive humoral signal secreted by the fat body to regulate DILP 
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secretion (Sano, 2015). fs(1)h knockdown in the fat body led to a significant reduction 
in CCHa2 transcript levels following knockdown compared to controls in both the 
whole fly samples and the dissected fat body tissue (Figure 4-19E and E’). Another 
regulator of nutrient sensing is ImpL2, the secreted insulin/IGF antagonist is involved 
in the wasting process by decreasing systemic insulin signalling (Kwon et al., 2015). 
ImpL2 was significantly upregulated in whole fly samples following fs(1)h knockdown 
(Figure 4-19F). However, in contrast, when the fat body was dissected there was a 
significant down-regulation of ImpL2 following fs(1)h knockdown in the fat body 
(Figure 4-19F’). Our findings showed that various nutrient sensing factors were 
dysregulated following fs(1)h knockdown in the fat body, including a significant 
increase in the negative regulator of DILPS, ImpL2 and the leptin analogue upd2. 
However, it is unknown whether these changes were primarily caused by an 
insufficiency of fs(1)h in the fat body, or were secondary effects due to the severe 
changes in the insulin-signalling pathway found in fs(1)h fat body knockdown flies. 
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Figure 4-19: Transcript levels of insulin regulatory signals varied following the loss of 
fs(1)h in the fat body 
RT-qPCR analysis of 5-7 day old whole flies and dissected fat body following knockdown of 
fs(1)h in the fat body (c564>fs(1)h-IR, grey bars) and control samples (c564>0, white bars). All 
RT-qPCR data was normalised to the housekeeping gene, α-tubulin. Normalised transcript 
levels of A. unpaired 1 (upd1) in whole fly samples, A.’ upd1 in dissected fat body samples, B. 
unpaired 2 (upd2) in whole fly samples, B.’ upd2 in dissected fat body samples, C. Growth-
blocking peptide 1 (Gbp1) in whole fly samples, C’. Gbp1 in dissected fat body samples, D. 
Growth-blocking peptide 2 (Gbp2) in whole fly samples, D’. Gbp2 in dissected fat body 
samples, E. CCHamide-2 (CCHa2) in whole fly samples, E’. CCHa2 in dissected fat body 
samples, F. Ecdysone-inducible gene L2 (ImpL2) in whole fly samples and F’. ImpL2 in 
dissected fat body samples. Unpaired t tests, **p=0.01, ***p=0.001, ****p<0.0001, no stars 
indicate lack of statistical significance. Data represented as mean of n=8/10 biological repeats 
































































































































































































4.11. The phenotypes observed were reproduced with a second, non-
overlapping fs(1)h RNAi line 
To verify the specificity of the fs(1)h knockdown achieved using the original fs(1)h-IR 
line (KK108662), we wanted to demonstrate the finding with a second non-
overlapping fs(1)h RNAi line. Using a second fs(1)h RNAi line, GD51772 (fs(1)h-IR II), 
we showed a similar reduction in survival compared to controls at both 25°C and 29°C 
(Figure 4-20A). Following infection with L. monocytogenes or F. novicida, again we 
saw a similar reduced lifespan compared to the control flies (Figure 4-20B). 
Furthermore, the second fs(1)h RNAi line showed increased antimicrobial peptide 
transcript levels (Figure 4-20C), and finally it showed a significant reduction in 
activated AKT following knockdown in the fat body (Figure 4-20D). Therefore, we can 
confirm the effects and phenotypes described with the originally RNAi line 
(KK108662) are specific to the loss of the target gene, fs(1)h.  
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Figure 4-20: An alternative fs(1)h RNAi line replicated the data from the original RNAi 
line 
Experiments carried out with another fs(1)h RNAi line, GD51227 at 5-7 days old. A. Survival 
was carried out comparing newly eclosed fs(1)h fat body knockdown flies (c564>fs(1)h-IR II, 
squares) and control samples (c564>0,circles) at 25°C (black lines) and 29°C (grey lines). 
n=20 per genotype. B. Survival was carried out on 5-7 day old male flies following knockdown 
of fs(1)h in the fat body (c564>fs(1)h-IR II, grey lines) and control samples (c564>0, black 
lines) and bacterial infection. Uninjected flies (circles), PBS injected (squares), Listeria 
monocytogenes infected (triangles, OD 0.1) or Francisella novicida infected (diamonds, OD 
0.1). At 29°C, n=20 per genotype. C. RT-qPCR analysis of whole fly samples following 
knockdown of fs(1)h in the fat body (c564>fs(1)h-IR II, grey bars) and control samples 
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Data shown on log10 scale. Normalised transcript levels of Attacin, Cecropin A1, Defensin, 
Diptericin, Drosocin, Drosomycin and Metchnikowin. Unpaired t tests, *p<0.05, no stars 
indicate lack of statistical significance. Data represented as mean of n=6 biological repeats per 
genotype (3 flies per sample), error bars as SEM. D. AKT Ser505 phosphorylation in control 
(c564>0; white bars) and fs(1)h fat body knockdown (c564>fs(1)h-IR II, grey bars) flies. Values 
represented as intensity relative to α-tubulin, data shown as mean + SEM, ****p<0.0001. 
4.12. Chapter 4 overview 
In this chapter, we identified that the bromodomain-containing protein, female sterile 
(1) homeotic (fs(1)h), the sole member of the BET family, is required in the fat body of 
Drosophila for normal immune function and metabolism.  
 fs(1)h is known to be important in Drosophila body planning and development 
(Florence and Faller, 2008), however, its role in the immune response and 
metabolism had not been investigated until now. We have shown in Chapter 4 that the 
loss of fs(1)h in the fat body caused a number of immune and metabolic phenotypes. 
A number of these phenotypes were also confirmed using either a second, non-
overlapping fs(1)h RNAi (GD51227) and a different fat body driver (r4-Gal4). Survival 
assays showed that fat body knockdown of fs(1)h led to a drastic reduction in survival 
following infection, but also under physiological, uninfected conditions. Further 
analysis of these flies also showed an increase in antimicrobial peptide (AMP) 
expression when uninfected or infected with bacteria. The transcription factor Relish, 
an important NF-κB family member of the Imd pathway was upregulated at total 
protein levels, however, the cleaved C-terminal fragment that remains in the 
cytoplasm after Relish activation was not upregulated following fs(1)h knockdown in 
the fat body. Additionally, following the loss of fs(1)h in the fat body, there was an 
upregulation of inflammatory cytokines, which play important roles in controlling 
immune response. Knocking down fs(1)h in the fat body also resulted in a number of 
metabolic phenotypes. When assaying triglyceride levels in the fs(1)h knockdown 
flies, we found no change in the quantity or the morphology of the triglycerides stored 
in fat body cells. However, the flies had an inability to utilise their triglyceride stores 
following 24-hour starvation and a slight reduction in gut integrity when fs(1)h was 
removed from the fat body, but they showed no changes in endogenous bacterial 
load. Furthermore, fs(1)h knockdown flies showed a reduction in a number of 
important lipases, including bmm, plin1 and plin2, which are all involved in lipid 
mobilisation, fitting with the inability for the flies to utilise their triglyceride stores 
effectively. When both circulating and stored sugars were measured it was shown 
these flies were hypoglycemic when fs(1)h was knocked down in the fat body, but 
glucose uptake into the tissues was not impaired or dysregulated by the fat body 
knockdown. Removing fs(1)h in the fat body also led to a reduction in the levels of 
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activated AKT and S6 kinase, though it did not lead to the development of insulin 
resistance as these flies were able to respond as normal to injections of insulin. Along 
with the change in activated AKT, we also saw dysregulation in a number of insulin 
pathway genes, including DILPs, which are released from ICPs in the brain to activate 
the insulin-signalling pathway. Interestingly, there was also an increased expression 
of the foxo target genes, InR and 4E-BP. A number of known fat body-derived insulin-
regulatory and nutrient-sensing signals including Gbp1, Gbp2 and CCHa2 were 
strongly reduced, and upd2 was strongly upregulated following knockdown of fs(1)h in 
the fat body.   
 These data together showed the effects of fs(1)h knockdown in the fat body 
are complex, including both immune and metabolic phenotypes. So far it is unclear 
whether the pathologies observed were due to cell-autonomous effects on insulin 
signalling, or if it was mediated in part by dysregulated endocrine signals, which 
resulted collectively in impairment of normal physiological insulin signalling. The best-
characterised transcriptional effector downstream of AKT in the insulin pathway is 
FOXO. Under normal physiological conditions, AKT phosphorylates FOXO, rendering 
it unable to move into the nucleus to initiate the expression of an array of transcription 
factors. Due to the roles of foxo, our observation of fs(1)h knockdown increasing AMP 
expression and the reducing in AKT activity could suggest there may be an increase 
in FOXO activity. The next chapter in this thesis will further explore the role of FOXO 




Chapter 5  		
The role of foxo in Drosophila with fs(1)h knocked down in 
the fat body 
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5.1. Introduction 
foxo transcription factors are part of a large family of Forkhead proteins; they are 
transcriptional regulators that are characterised by a conserved DNA-binding domain 
(Greer and Brunet, 2005). In humans, there are 39 members of the forkhead family 
that have an array of functions. Within the human forkhead family, the FOXO 
subgroup contains four main groups, FOXO1, FOXO3a, FOXO4 and FOXO6. Foxo1 
mRNA is abundant in adipose tissue (Chakrabarti and Kandror, 2009), Foxo3a, shows 
high mRNA expression in the brain (Kannike et al., 2014) and Foxo4 is highly 
expressed in the heart (Zhu et al., 2015). Foxo6 is expressed highly in the developing 
brain, suggesting it may have an important role in central nervous system (CNS) 
development (Salih et al., 2012). foxo has many varying functions in mammalian cells 
including DNA binding, cell differentiation, cell death, stress resistance and glucose 
metabolism (Fu and Tindall, 2008; Gross et al., 2008; Martins et al., 2016; Obsil and 
Obsilova, 2011; Sunayama et al., 2011). FOXO is a direct substrate for the protein 
kinase AKT in response to stimulation by insulin or growth factors (Greer and Brunet, 
2005). The phosphorylation of FOXO by AKT leads to a change in subcellular 
localisation of FOXO, in the absence of insulin or other growth factors, when insulin 
signalling is inactive, FOXO can localise to the nucleus, bind to DNA and initiate the 
transcription of a range of genes. The degradation of FOXO is mediated by the 
ubiquitin-proteasome pathway and AKT activity is necessary for ubiquitin mediated 
degradation of FOXO1 and FOXO3a (Aoki et al., 2004; Huang et al., 2005; Matsuzaki 
et al., 2003; Plas and Thompson, 2003).  
 In Drosophila, there is a single isoform of foxo, which is most similar to 
nematode daf-16 and FOXO3a in mammals. This single Drosophila isoform is 
responsible for all the roles of the four mammalian FOXO subgroup (Spellberg and 
Marr, 2015). foxo is highly conserved in Drosophila and it plays important roles in 
regulating the size of cells and organs and is a crucial mediator of insulin signalling 
(van der Horst and Burgering, 2007; Jünger et al., 2003). It is also a key regulator in 
stress resistance, ageing and metabolism. Ageing is slowed when insulin signalling is 
reduced and expression of wild-type foxo is adequate to increase longevity in flies 
(Giannakou and Partridge, 2007; Hwangbo et al., 2004). In response to cellular 
stress, such as nutrient deficiency, foxo is activated and inhibits growth through the 
upregulation of target genes such as 4E-BP (Jünger et al., 2003). foxo also provides a 
mechanism for cross-regulation between Drosophila innate immunity and metabolism. 
AMP activation can be achieved by foxo independently of the immunoregulatory 
pathways, Toll and Imd (Becker et al., 2010). In uninfected flies, in response to 
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nuclear foxo activity, the expression of AMP genes can be stimulated during times of 
stress, such as starvation (De Gregorio et al., 2002). Additionally, AMP induction is 
enhanced when foxo is over-expressed. It was further shown that foxo can bind to the 
regulatory region of AMPs including Drosomycin inducing its transcription (Becker et 
al., 2010). Furthermore, independent of pathogen-responsive immunity in Drosophila, 
AMPs can be activated under physiological conditions in response to cell- and tissue-
specific energy fluctuations (Becker et al., 2010).  
 As mentioned previously, the fat body, analogous to adipose tissue and the 
liver in mammals, is a multi-functioning tissue in both immunity and metabolism 
(Azeez et al., 2014). The transcription factor foxo mediates a range of autonomous 
and non-autonomous signals in the fat body. In Drosophila, the insulin-signalling 
pathway down-regulates foxo, however when AKT activation is reduced and foxo 
levels are increased it has been shown to extend lifespan (Giannakou and Partridge, 
2007; Hwangbo et al., 2004). Fat body foxo regulates ageing when activated in the 
pericerebral fat body of adult Drosophila and mediates feedback signalling between 
insulin producing cells (IPCs) and the fat body (Hwangbo et al., 2004). Drosophila 
insulin-like peptides (DILPs) released from the IPCs in the brain can repress foxo in 
the fat body, whilst foxo can regulate DILP expression from the IPCs. foxo is also able 
to regulate the transcription of DILP6 specifically in the fat body (Slaidina et al., 2009). 
Furthermore, in mammals and Drosophila, foxo is involved in regulating lipolysis in 
adipocytes and the fat body by controlling the expression of lipases (Chakrabarti and 
Kandror, 2009). 
5.1.1. Objective and aims 
Following the loss of fs(1)h in the fat body, we found that flies had a reduction in 
survival, dysregulation of AMP production along with several metabolic pathologies, 
including an inability to utilise triglyceride stores and hypoglycemia. We also detected 
a reduction in AKT activity and an increase in the transcript levels of foxo target 
genes, including InR and 4E-BP. To determine the extent in which FOXO 
hyperactivation may be responsible for the observed phenotypes of fs(1)h fat body 
knockdown flies, we combined fs(1)h knockdown with a heterozygous loss-of-function 
mutation in foxo. The objective of this chapter is to investigate whether increased 
FOXO activity may drive the phenotypes observed when fs(1)h is knocked down in 






The aims of this chapter are: 
1. To identify whether removing a single copy of foxo can rescue the reduced 
lifespan and increased AMPs observed following fs(1)h knockdown in the fat 
body. 
2. To further analyse if a reduction in foxo levels can also rescue the metabolic 
defects identified following the knockdown of fs(1)h in the fat body. 
5.2. Confirming the knockdown of fs(1)h and Gal4 expression in flies 
lacking one copy of foxo 
Following the removal of one copy of foxo, we wanted to ensure that fs(1)h was still 
being knocked down efficiently in the fat body and that foxo was not required for the 
expression of Gal4. In whole fly samples, as before, fs(1)h transcript levels were not 
reduced following knockdown in the fat body specifically (Figure 5-1A, also see 4-1A). 
However, when one copy of foxo was removed from the fs(1)h knockdown flies, there 
was a significant upregulation in fs(1)h transcript level (Figure 5-1A). In dissected fat 
body samples, the loss of fs(1)h was observed following fat body knockdown, 
however there was no change in fs(1)h transcript levels in the foxo heterozygous flies 
(Figure 5-1A’). These data, showing an increase in whole fly fs(1)h levels following the 
removal of one copy of foxo suggests there may be a feedback mechanism between 
fs(1)h and foxo. However, as we were unable to detect reduced fs(1)h levels in the 
dissected fat body of heterozygous foxo mutants, we wanted to ensure that the 
increase in fs(1)h was due to the reduction in foxo and not due to a reduction in the 
efficiency of the Gal4 mediating fs(1)h knockdown. Assaying Gal4 expression in 
whole fly and dissected fat body showed that expression of c564-Gal4 was enhanced 
by fs(1)h, but foxo heterozygosity alone had no effect on Gal4 expression (Figure 5-
1B and B’). We can summarise that fs(1)h transcript levels seem to be influenced by 









































Figure 5-1: fs(1)h levels were reduced in dissected fat body samples following 
knockdown 
RT-qPCR analysis of 5-7 day old fly samples following knockdown of fs(1)h in the fat body 
(c564>fs(1)h-IR, light grey bars), control samples (c564>0, white bars), fs(1)h fat body 
knockdowns heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, dark grey bars), and control 
samples heterozygous for foxo (c564>0;foxoΔ/+, grey bars). All RT-qPCR data was normalised 
to the housekeeping gene, α-tubulin. Normalised transcript levels of A. fs(1)h expression in 
whole fly samples with fs(1)h knocked down in the fat body, heterozygous for foxo and 
controls. Unpaired t test, data shown as mean + SEM, **p<0.01, ***p<0.001. A’. fs(1)h 
expression in dissected fat body fly samples with fs(1)h knocked down in the fat body, 
heterozygous for foxo and controls. Unpaired t test, data shown as mean + SEM, ***p<0.001. 
B. Gal4 expression in whole fly samples with fs(1)h knocked down in the fat body, 
heterozygous for foxo and controls. Unpaired t test, data shown as mean + SEM, **p<0.01, 
****p<0.0001. B’. Gal4 expression in dissected fat body fly samples with fs(1)h knocked down 















































































SEM, **p<0.01, ****p<0.0001, n=8 biological repeats per genotype (3 flies per sample), error 
bars as SEM. 
5.3. Removing one copy of foxo rescued the reduced Drosophila survival 
after the loss of fs(1)h in the fat body 
Loss of fs(1)h in the Drosophila fat body led to a severe reduction in lifespan, under 
physiological conditions and following infection. In order to determine whether an 
increase of FOXO was causing the survival phenotype, one copy of foxo was 
removed in flies with fs(1)h knockdown in the fat body. Heterozygosity for the foxo null 
allele rescued the reduced lifespan of fs(1)h knockdown nearly back to that of the 
control group (Figure 5-2A). Removing one copy of foxo alone had no effect on the 
lifespan of the control genotype.  
 Following bacterial infection with Francisella novicida, removing fs(1)h in the 
fat body and one copy of foxo did not rescue the survival effect and the flies 
proceeded to die by day 4 post-infection, the same shortened survival as seen in 
fs(1)h knockdown in the fat body alone (Figure 5-2B). Therefore, we can conclude 
that reducing the level of foxo along with the loss of fs(1)h in the fat body could rescue 
the lifespan of the flies under physiological conditions, but was not sufficient to rescue 
the decreased survival following bacterial infection. 
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Figure 5-2: Uninfected survival was rescued by removing one copy of foxo 
Flies were observed daily for the number of deaths and percent survival was calculated over 
time following knockdown of fs(1)h in the fat body, fs(1)h knockdown flies heterozygous for 
foxo and controls. A. Survival was carried out comparing newly eclosed fs(1)h fat body 
knockdown flies (c564>fs(1)h-IR, squares), fs(1)h knockdowns also heterozygous for foxo 
(c564>fs(1)h-IR;foxoΔ/+, diamonds) and control samples (c564>0, circles; c564>0;foxoΔ/+, 
triangles) at 25°C. n=20 per genotype. B. Survival was carried out on 5-7 day old male flies 
following knockdown of fs(1)h in the fat body (c564>fs(1)h-IR, squares), fs(1)h knockdowns 
also heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, diamonds)  and control samples (c564>0, 
circles; c564>0;foxoΔ/+, triangles) and bacterial infection with Francisella novicida (represented 















































5.4. AMP expression levels were normalised following the removal of one 
copy of foxo 
Antimicrobial peptides (AMPs) are produced predominantly by the Drosophila fat body 
via the Toll and Imd pathways (De Gregorio et al., 2002). As described previously in 
Chapter 4, a loss of fs(1)h in the fat body increased the expression levels of AMPs 
(Figure 4-4 and 4-5). We wanted to further assay the effect of foxo heterozygosity on 
AMP expression in flies with fs(1)h knockdown in the fat body. In line with our 
previous finding of foxo heterozygosity rescuing the uninfected survival, we found that 
AMP expression was nearly completely normalised in uninfected fs(1)h knockdown 
flies also lacking one copy of foxo (Figure 5-3A-G). Loss of one copy of foxo in the 
control flies had little effect on AMP expression. We were also able to observe the 
same reduction in AMP expression when dissected fat body samples were obtained 
(Figure 5-4A-G). We went on to analyse AMP expression in infected flies that had the 
loss of fs(1)h in the fat body along with the reduction in foxo. AMP expression was still 
significantly elevated in these flies following bacterial infection with F. novicida (Figure 
5-5A-G). The elevations in AMP expression levels were also shown following L. 
monocytogenes infection in a number of cases (Figure 5-5A, B, E and F). Reducing 
the level of foxo could not rescue the overproduction of the AMPs analysed after 
bacterial infection when flies are lacking fs(1)h in the fat body. These data indicate 




Figure 5-3: AMP levels of whole fly samples were rescued when one copy of foxo was 
removed from fs(1)h knockdown flies 
RT-qPCR analysis of 5-7 day old whole fly samples following knockdown of fs(1)h in the fat 
body (c564>fs(1)h-IR, light grey bars), control samples (c564>0, white bars), fs(1)h fat body 
knockdowns heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, dark grey bars), and control 
samples heterozygous for foxo (c564>0;foxoΔ/+, grey bars). All RT-qPCR data was normalised 
to the housekeeping gene, α-tubulin. Data shown on log10 scale. Normalised transcript levels 
of A. Attacin, B. Cecropin A1, C. Defensin, D. Diptericin, E. Drosocin, F. Drosomycin and G. 
Metchnikowin. Unpaired t tests, *p<0.05, **p<0.01, no stars indicate lack of statistical 
significance. Data represented as mean of n=8 biological repeats per genotype (3 flies per 























































































































































Figure 5-4: AMP transcript levels of dissected fat body samples were rescued when one 
copy of foxo was removed from fs(1)h knockdown flies 
RT-qPCR analysis of 5-7 day old dissected fat body samples following knockdown of fs(1)h in 
the fat body (c564>fs(1)h-IR, light grey bars), control samples (c564>0, white bars), fs(1)h fat 
body knockdowns heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, dark grey bars), and control 
samples heterozygous for foxo (c564>0;foxoΔ/+, grey bars). All RT-qPCR data was normalised 
to the housekeeping gene, α-tubulin. Data shown on a log10 scale. Normalised transcript 
levels of A. Attacin, B. Cecropin A1, C. Defensin, D. Diptericin, E. Drosocin, F. Drosomycin 
and G. Metchnikowin. Unpaired t tests, *p<0.05, **p<0.01, no stars indicate lack of statistical 
significance. Data represented as mean of n=8 biological repeats per genotype (3 flies per 




































































































































































Figure 5-5: Infected fly AMP expression was not rescued by foxo heterozygosity 
RT-qPCR analysis of 5-7 day old whole fly samples following knockdown of fs(1)h in the fat 
body (c564>fs(1)h-IR, light grey bars), control samples (c564>0, white bars), fs(1)h fat body 
knockdowns heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, dark grey bars), and control 
samples heterozygous for foxo (c564>0;foxoΔ/+, grey bars). Injected with PBS, as a wounding 
control, Listeria monocytogenes or Francisella novicida. All RT-qPCR data was normalised to 
the housekeeping gene, α-tubulin. Normalised transcript levels of A. Attacin, B. Cecropin A1, 
C. Defensin, D. Diptericin, E. Drosocin, F. Drosomycin and G. Metchnikowin. 2-way ANOVA, 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, no stars indicate lack of statistical significance. 
Data represented as mean of n=5 biological repeats per genotype and injection group (3 flies 
per sample), error bars as SEM.  




























































































































5.4.1. foxo heterozygosity normalised total Relish protein levels 
As shown in Chapter 4, Relish, the NF-κB family member responsible for Imd-
dependent antimicrobial peptide expression was increased following fs(1)h 
knockdown in the fat body. Here, we wanted to investigate whether a reduction in foxo 
levels in fs(1)h fat body knockdown flies had an effect on the abundance of the Relish 
protein in the flies following bacterial infection, but also when unchallenged. We found 
the protein levels of Relish were normalised back to the control level by removing a 
single copy of foxo in fs(1)h knockdown flies in uninfected conditions (Figure 5-6A). 
Reducing the level of foxo alone did not affect the abundance of total Relish protein, 
nor did it alter the activation of Relish, shown by the unchanged levels of C-terminal 
fragment of Relish (Figure 5-6A). The normalisation of Relish protein level fitted with 
the normalisation of uninfected AMP expression in the flies with a reduction in foxo. 
 Flies with the loss of fs(1)h in the fat body and one copy of foxo removed had 
normalised levels of total Relish protein following injection with PBS, as a wounding 
control, or following infection with F. novicida (Figure 5-6B). Furthermore, there was 
no change in Relish activation level, indicated by the amount of the C-terminal 
fragment, following the removal of fs(1)h in the fat body and one copy of foxo (Figure 
5-6B). After PBS injection or infection with F. novicida, we detected an increase in the 
level of the C-terminal fragment when fs(1)h was knocked down in the fat body 
compared to controls. These findings fit with the reduced survival and the increased 
AMP levels following bacterial infections. foxo heterozygosity was able to completely 
abolish the overexpression of Relish post-infection, but was unable to rescue the 




Figure 5-6: Protein levels of Relish were rescued following the removal of one copy of 
foxo in fs(1)h knockdown flies 
Western blot analysis of 5-7 day old fly samples following knockdown of fs(1)h in the fat body 
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and control samples (c564>0 and c564>0;foxoΔ/+). A. Relish protein level following fs(1)h 
knockdown in the fat body (light grey bars), fs(1)h fat body knockdowns heterozygous for foxo 
(dark grey bars), control samples (white bars), and control samples heterozygous for foxo 
(grey bars). Values represented as intensity relative to α-tubulin. Data shown as mean + SEM, 
****p<0.0001, no stars indicate lack of statistical significance. B. Relish protein level following 
bacterial infection of fs(1)h knockdown in the fat body (B), fs(1)h fat body knockdowns 
heterozygous for foxo (D), control samples (A), and control samples heterozygous for foxo (C). 
Uninjected samples (white bars), injected with PBS (light grey bars) or injected with Francisella 
novicida (dark grey bars). U; uninjected, P; PBS injected, F.n; F. novicida infected. Values 
represented as intensity relative to α-tubulin, data shown as mean. 
 
5.5. The fs(1)h starvation phenotype was rescued by reducing foxo levels 
The transcription factor foxo plays important roles in insulin signalling particularly 
when energy levels are low (Kramer et al., 2003). Therefore, we wanted to investigate 
if a reduction in foxo levels could also rescue the metabolic phenotypes we found 
following fs(1)h knockdown in the fat body. The reduction in survival that was 
observed when flies were lacking fs(1)h in the fat body were put onto starvation food 
was rescued back to the control genotype level by the removal of one copy of foxo 
(Figure 5-7). This finding may indicate that foxo was playing an important role in the 




Figure 5-7: Removing one copy of foxo in fs(1)h knockdown flies rescued the starvation 
phenotype 
Starvation survival of 5-7 day old flies with fs(1)h knocked down in the fat body (c564>fs(1)h-
IR, squares), fs(1)h fat body knockdowns heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, 
diamonds), and control samples (c564>0, circles and c564>0;foxoΔ/+, triangles). Fed flies 
(closed shapes) and starved flies (open shapes) were counted every 2 hours during the day 

























5.5.1. Flies heterozygous for foxo were able to utilise triglyceride stores  
In both mammals and Drosophila, foxo regulates the transcription of lipases and other 
enzymes and transcription factors in adipose tissue that are required for lipid droplet 
lipolysis (Karpac et al., 2013). Fluctuations in the insulin-signalling pathway are also 
associated with abnormal lipid metabolism (Saltiel and Kahn, 2001). To identify if the 
reduction of foxo can also rescue the defect in lipid storage mobilisation, we assayed 
the quantity of triglycerides in fs(1)h knockdown flies when the level of foxo was also 
reduced. Due to the functional roles of foxo in regulating the expression of lipid 
metabolism genes (Gross et al., 2008), foxo heterozygosity caused an increase in 
total triglyceride level whether fs(1)h was knocked down in the fat body or in 
combination with the control genotype. However, flies lacking fs(1)h in the fat body 
and lacking one copy of foxo regained their ability to utilise their triglyceride stores 
following 24-hours starvation (Figure 5-8). Therefore, we conclude that elevated foxo 
activity was responsible for the defect in energy mobilisation we identified following 







































Figure 5-8: Triglycerides could be utilised by removing one copy of foxo in fs(1)h 
knockdown flies 
Thin layer chromatography (TLC) analysis of 5-7 day old total fly triglyceride levels following  
fs(1)h knockdown in the fat body (c564>fs(1)h-IR, B), fs(1)h fat body knockdowns 
heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, D), and control samples (c564>0, A and 
c564>0;foxoΔ/+, C). Fed conditions (grey bars) and following 24-hour starvation (white bars). 
TLC plate shows one fed and one starved group for each genotype. F; fed, S; starved and TG; 





















c564>0 ; foxoΔ / + Fed
c564>0 ; foxoΔ / + Starved
c564>fs(1)h-IR ; foxoΔ / + Fed
































5.5.2. Transcript levels of lipid metabolism genes were restored to control levels 
when one copy of foxo was removed 
FOXO plays important roles in regulating the transcription of a number of lipid 
metabolism genes (Gross et al., 2008). Following fat body knockdown of fs(1)h, there 
were reductions in the transcript levels of bmm, plin1 and plin2, three genes that are 
known to be important in the mobilisation of triglycerides. Levels of Hsl showed no 
change when fs(1)h was knocked down in the fat body, but was slightly upregulated 
when foxo levels were reduced in flies with fs(1)h knockdown in both whole fly and 
dissected fat body samples (Figure 5-9A and A’). Transcript levels of bmm in whole fly 
samples showed no changes across any of the genotypes measured, whereas the 
reduction of bmm seen in the dissected fat body samples was rescued when one 
copy of foxo was removed (Figure 5-9B and B’). plin1 was significantly upregulated 
when foxo levels were reduced in the fs(1)h knockdown flies in both the whole fly and 
dissected fat body samples (Figure 5-9C and C’), and plin2, similarly to plin1, was 
also upregulated when flies were heterozygous for foxo (Figure 5-9D and D’). Here, 
we show that in flies deficient for fs(1)h in the fat body, removing one copy of foxo 
rescued the reduced levels of genes involved in lipid metabolism back to the same 
level as the control group. This rescue in gene expression may fit with their ability to 




Figure 5-9: Lipid metabolism genes showed variation when one copy of foxo was 
removed 
RT-qPCR analysis of 5-7 day old whole flies and dissected fat body samples following fs(1)h 
knockdown in the fat body (c564>fs(1)h-IR, light grey bars), fs(1)h fat body knockdowns 
heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, dark grey bars), and control samples (c564>0, 
while bars and c564>0;foxoΔ/+, grey bars). All RT-qPCR data was normalised to the 
housekeeping gene, α-tubulin. Normalised transcript levels of A. Hormone sensitive lipase 
(Hsl) in whole fly samples, A.’ Hsl in dissected fat body samples, B. brummer (bmm) in whole 
fly samples, B.’ bmm in dissected fat body samples, C. perilipin 1 (plin1) in whole fly samples, 
C.’ plin1 in dissected fat body samples, D. perilipin 2 (plin2) in whole fly samples and D.’ plin2 
in dissected fat body samples. Unpaired t tests, *p<0.05, **p<0.01, ***p<0.001, no stars 
indicate lack of statistical significance. Data represented as mean of n=8/10 biological repeats 





















































































































































5.6. Circulating sugar levels were restored when one copy of foxo was 
removed in flies lacking fs(1)h in the fat body 
In mammals, foxo is thought to promote hepatic glucose production by a variety of 
mechanism and in turn contribute to glucose homeostasis (Nakae et al., 2008). Flies 
lacking fs(1)h in the fat body showed low levels of the circulating sugars, trehalose 
and glucose and low levels of the stored carbohydrate, glycogen. Levels of trehalose 
and glucose were normalised back to the control level in fs(1)h knockdown flies also 
lacking one copy of foxo (Figure 5-10A, B), while glycogen levels were still reduced in 
these flies (Figure 5-10C). These data imply that a reduction in foxo restores 
circulating sugar levels when fs(1)h was lost in the fat body, but was unable to rescue 
the glycogen level suggesting the glycogen homeostasis may be independent of foxo 
level. 
Figure 5-10: Circulating sugar levels were rescued in flies heterozygous for foxo 
Trehalose, glucose and glycogen content in 5-7 day old male flies following  
fs(1)h knockdown in the fat body (c564>fs(1)h-IR, light grey bars), fs(1)h fat body knockdowns 
heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, dark grey bars), and control samples (c564>0, 
while bars and c564>0;foxoΔ/+, grey bars). Circulating sugars of A. Trehalose, B. Glucose, 
and stored carbohydrate levels of C. Glycogen. Unpaired t tests, *p<0.05, no stars indicate 
lack of statistical significance. Data represented as mean of n=6 biological repeats per 






















































5.7. Activated AKT levels were rescued in flies lacking fs(1)h in the fat 
body and heterozygous for foxo 
The AKT kinase of the insulin pathway has two major known metabolic target 
molecules, FOXO and TOR. AKT phosphorylates FOXO leading to its inactivation, 
while it activates the TOR complex and its downstream targets including S6 kinase 
(S6K), which when phosphorylated activates protein synthesis (Magnuson et al., 
2012). We found decreased phosphorylated AKT and S6 kinase levels following the 
loss of fs(1)h in the fat body. As described previously, we assumed the decrease in 
phosphorylated AKT following fs(1)h knockdown in the fat body resulted in elevated 
foxo levels as indicated by the upregulation of foxo target genes (Figure 4-17). We 
wanted to further investigate whether removing one copy of foxo would also rescue 
the activated AKT and S6K levels. Interestingly, we found that activated AKT (Figure 
5-11A) and S6 kinase (Figure 5-11B) levels were both rescued in fs(1)h knockdown 
flies when they were also heterozygous for foxo. Furthermore, we wanted to ensure 
that the changes in the activity of the insulin-signalling pathway were not causing the 
development of insulin resistance in these flies. Heterozygous foxo mutants with a 
loss of fs(1)h in the fat body did not show any sign of insulin resistance (Figure 5-
11C). These data suggest that a reduction of foxo can rescue the reduced levels of 
activated AKT and S6K in flies deficient for fs(1)h in the fat body. 
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Figure 5-11: Activated AKT and S6 Kinase levels were rescued in foxo heterozygous 
flies with fs(1)h knocked down the fat body 
Western blot analysis of 5-7 day old flies following knockdown of fs(1)h in the fat body 
(c564>fs(1)h-IR), fs(1)h fat body knockdowns heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+), 
and control samples (c564>0 and c564>0;foxoΔ/+). A. AKT Ser505 phosphorylation in control 
(white bars, grey bars), fs(1)h fat body knockdown (light grey bars) and fs(1)h fat body 
knockdowns heterozygous for foxo (dark grey bars) flies. Values represented as intensity 
relative to α-tubulin, data shown as mean. B. p70 S6 Kinase (S6K) in control groups (white 
bars, grey bars), fs(1)h fat body knockdown flies (light grey bars) and flies with fs(1)h fat body 
knockdowns heterozygous for foxo (dark grey bars). Values represented as intensity relative to 







































































































































α-tubulin, data shown as mean. C. To assay insulin sensitivity, AKT phosphorylation levels 
were measured following injection with PBS (white bars) or a high (320pg/fly; light grey bars) 
or low (64 pg/fly; dark grey bars) dose of human insulin. Values represented as intensity 
relative to α-tubulin, data shown as mean. 	
5.8. Expression of upd2 was restored following a reduction in foxo levels 
in fs(1)h fat body knockdown flies 
Expression of secreted insulin-regulatory factors were assayed in flies with fs(1)h 
knocked down in the fat body along with foxo heterozygosity. upd1 and upd2, two 
ligands of the Jak/STAT pathway, are both thought to be analogous to mammalian 
leptin (Beshel et al., 2017; Rajan and Perrimon, 2012). Interestingly, we found the 
increase of upd1 in the fs(1)h knockdown flies was further increased when one copy 
of foxo was removed in whole fly samples (Figure 5-12A). However, in the dissected 
fat body samples there was little change in the transcript level of upd1 (Figure 5-12A’). 
The upregulation of upd2 transcript level that was observed following fs(1)h 
knockdown in the fat body was rescued by the foxo heterozygosity in whole fly (Figure 
5-12B) and dissected fat body (Figure 5-12B’) samples. Here, we show that cytokine 
signals with insulin-regulatory functions in the brain could be rescued back to control 
levels in dissected fat body samples, however upd1 was not rescued in whole fly 
samples. This may indicate that upd2, as a fat body-derived signal, was affected by 
the fs(1)h/FOXO axis. This observation fits with reports showing upd2 is a cytokine 












































Figure 5-12: upd1 and upd2 transcript levels were altered following the reduction of 
foxo in fs(1)h knockdown flies 
RT-qPCR analysis of 5-7 day old whole flies and dissected fat body samples following 
knockdown of fs(1)h in the fat body (c564>fs(1)h-IR, light grey bars), fs(1)h fat body 
knockdowns heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, dark grey bars), and control 
samples (c564>0, white bars and c564>0;foxoΔ/+, grey bars). All RT-qPCR data was 
normalised to the housekeeping gene, α-tubulin. Normalised transcript levels of A. unpaired 1 
(upd1) in whole fly samples, A.’ upd1 in dissected fat body samples, B. unpaired 2 (upd2) in 
whole fly samples and B.’ upd2 in dissected fat body samples. Unpaired t tests, **p<0.01, 
***p<0.001, no stars indicate lack of statistical significance. Data represented as mean of 












































































5.9. Nutrient-responsive signals showed variation in foxo heterozygous 
flies with fs(1)h knocked down in the fat body. 
The Drosophila fat body plays a central role in nutrient sensing mechanisms, in 
response to intracellular amino acids, lipids or sugars, the fat body can regulate 
systemic growth in response to nutritional changes (Colombani et al., 2003). Gbp1 
and Gbp2 are both regulated by amino acid levels, whereas CCHa2 is regulated by 
sugar and lipid levels (Koyama and Mirth, 2016). ImpL2, is a secreted insulin 
antagonist that inhibits DILP activity, is expressed in the ring gland of the brain and 
can sense changes nutritional state (Sarraf-Zadeh et al., 2013). Gbp1, showed no 
change in transcript level in any of the genotypes measured in whole fly samples 
(Figure 5-13A). However, in dissected fat body samples, there was a significant 
reduction in Gbp1 levels when fs(1)h was knocked down in the fat body. Surprisingly, 
Gbp1 was still reduced and not rescued by foxo heterozygosity (Figure 5-13A’). Gbp2 
was significantly reduced following fs(1)h knockdown in the fat body, however, this 
phenotype was rescued by removing one copy of foxo in whole fly samples (Figure 5-
13B) and dissected fat body samples (Figure 5-13B’). CCHa2 levels were significantly 
reduced following fs(1)h knockdown in the fat body, however whole fly sample CCHa2 
transcript levels remained low in foxo heterozygous flies (Figure 5-13C). Interestingly, 
this result was partially rescued in dissected fat body samples (Figure 5-13C’). The 
transcript level of ImpL2 showed no differences in whole fly samples of any genotype 
measured (Figure 5-13D). In dissected fat body samples, fs(1)h knockdown in the fat 
body reduced ImpL2 levels, which was partly rescued by removing one copy of foxo 
(Figure 5-13D’). We found that nutrient sensing gene levels could be partly rescued 
by the reduction in foxo level in the fs(1)h knockdown flies. However, we assume 
Gbp1 may be regulated by another mechanism and the change observed following 
fs(1)h knockdown in the fat body may be foxo-independent. 
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Figure 5-13: Removing a copy of foxo in the fs(1)h knockdown flies regulated insulin-
derived signals 
RT-qPCR analysis of 5-7 day old whole flies and dissected fat body following knockdown of 
fs(1)h in the fat body (c564>fs(1)h-IR, light grey bars), fs(1)h fat body knockdowns 
heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+, dark grey bars), and control samples (c564>0, 
white bars and c564>0;foxoΔ/+, grey bars). All RT-qPCR data was normalised to the 
housekeeping gene, α-tubulin. Normalised transcript levels of A. Growth-blocking peptide 1 
(Gbp1) in whole fly samples, A’. Gbp1 in dissected fat body samples, B. Growth-blocking 
peptide 2 (Gbp2) in whole fly samples, B’. Gbp2 in dissected fat body samples, C. CCHamide-
2 (CCHa2) in whole fly samples, C’. CCHa2 in dissected fat body samples, D. Ecdysone-
inducible gene L2 (ImpL2) in whole fly samples and D’. ImpL2 in dissected fat body samples. 
Unpaired t tests, *p<0.05, **p<0.01, ****p<0.0001, no stars indicate lack of statistical 
significance. Data represented as mean of n=8/10 biological repeats per genotype (3 flies per 



















































































































































5.10. Knockdown of fs(1)h in the fat body increased FOXOGFP levels and 
caused potential ubiquitin-proteasome dysfunction  
Due to the phenotypes observed, we wanted to investigate whether fs(1)h was 
regulating FOXO protein levels. Therefore, we used a transgenic fly line carrying a 
FOXOGFP fusion protein regulated by the endogenous foxo locus. We combined this 
fly line with fs(1)h knockdown in the fat body to measure the amount of FOXO in flies 
with fs(1)h knockdown in the fat body. We wanted to assay the amount of FOXOGFP in 
flies with fs(1)h knocked down in the fat body, here we could show there was an 
increased amount of FOXOGFP  (Figure 5-14A). However, in these samples there was 
also a genotype specific dysregulation of α-tubulin, which was used as the loading 
control. A second loading control, GAPDH, showed a similar dysregulated pattern 
(data not shown). Therefore, we assumed that fs(1)h knockdown may be affecting the 
abundance of proteins in the flies and possibly regulating the degradation process of 
proteins within the cells.  
 One mechanism that regulates protein degradation is ubiquitination of proteins 
that are targeted to the proteasome and degraded (Lecker et al., 2006). Ubiquitin is a 
highly conserved protein present in all eukaryotes as a free polypeptide or joined to a 
range of cytoplasmic, nuclear and cell surface proteins (Lee et al., 1988). 
Ubiquitination is a post-translational modification involved in regulating functions such 
as protein degradation and signal transduction (Taylor and Jobin, 2005; Wilkinson, 
1987) by ubiquitin attachment to other cellular proteins, thus changing the stability, 
localisation or activity of a target protein (Pickart and Eddins, 2004). The ubiquitin 
proteasome pathway is required to degrade most short-lived proteins, for example 
proteins unable to fold within the endoplasmic reticulum (Araki and Nagata, 2011) or 
cell cycle proteins, whose destruction at the correct time is vital during cell division 
(Reed, 2006). A specific ubiquitin complex has been shown to regulate the NF-κB 
pathway, NF-κB is vital for inflammatory and immune responses and abnormal NF-κB 
signalling is implemented in many diseases (Tokunaga, 2013). Here, we could show 
that flies with fs(1)h knockdown in the fat body also displayed an increase in protein 
ubiquitination compared to the control groups (Figure 5-14B). In line with this, 
Coomassie staining showed there were variations in the proteins detected and the 
quantity of these proteins in samples containing the fs(1)h knockdown (Figure 5-14C). 
We could conclude that the loss of fs(1)h in the fat body led to elevated levels of the 
FOXO protein. We also found a potential increase in ubiquitination and protein level 

















































Figure 5-14: Using FOXOGFP to investigate an interaction between FOXO and fs(1)h 
Western blot analysis of 5-7 day old flies following knockdown of fs(1)h in the fat body 
(c564>fs(1)h-IR), fs(1)h fat body knockdowns heterozygous for foxo (c564>fs(1)h-IR;foxoΔ/+), 
and control samples (c564>0 and c564>0;foxoΔ/+). A. GFP protein level and α-tubulin in 
controls, fs(1)h fat body knockdown and fs(1)h fat body knockdowns heterozygous for foxo 
flies. B. Ubiquitin protein level in controls, fs(1)h fat body knockdown and fs(1)h fat body 
knockdowns heterozygous for foxo flies. C. Coomassie stain for controls, fs(1)h fat body 

















































5.11. fs(1)h transcript levels were elevated in FOXO homozygous null 
flies  
Due to the phenotypes observed using the foxo heterozygous flies, we were 
interested to see whether completely removing foxo had an effect on fs(1)h levels by 
using foxo homozygous null flies. In whole fly samples, we could confirm that foxo 
homozygous null flies had almost no foxo transcript level present (Figure 5-15A) and 
in these samples we could also show the foxo homozygous null flies had a significant 
upregulation in the transcript level of fs(1)h (Figure 5-15B). In the dissected fat body 
samples, we could again show there was no foxo present in the dissected fat body of 
the foxo homozygous null flies (Figure 5-15C), and we could also see a trend for an 
increase in fs(1)h transcript level in the foxo homozygous null flies (Figure 5-15D). 
After identifying increased foxo levels in fs(1)h knockdown flies, we could also show 
that fs(1)h transcript levels may be regulated by foxo expression levels. These data 
suggest that fs(1)h may be able to control FOXO protein abundance, but the 



































Figure 5-15: Confirming the loss of foxo and fs(1)h levels in foxo homozygous null flies 
RT-qPCR analysis of 5-7 day old whole fly samples and dissected fat body samples of w1118 
controls and foxo homozygous null flies (foxoΔ). All RT-qPCR data was normalised to the 
housekeeping gene, α-tubulin. Normalised transcript levels of A. foxo in whole fly samples, B. 
fs(1)h in whole body samples, C. foxo in dissected fat body samples and D. fs(1)h in dissected 
fat body samples. Unpaired t tests, ****p<0.0001, no stars indicate lack of statistical 
significance. Data represented as mean of n=10 biological repeats per genotype (3 flies per 































































5.12. Chapter 5 overview 
In this chapter, we have identified that the biological consequences of fs(1)h loss-of-
function in the fat body are largely dependent on the elevated levels of the 
transcription factor foxo. We were able to show this by producing flies that were 
heterozygous for foxo in the fs(1)h fat body knockdown flies. Heterozygosity is the 
presense of two different alleles of a gene, in this case we were removing one copy of 
foxo. The heterozygous genotype with a functional foxo allele and a non-functional 
allele is usually expected to produce 50% of the standard activity of the gene (Wang 
et al., 2010). However, the phenotype of the heterozygote will depend on the 
haplosufficiency of the single functional allele, suggesting that the gene activity may 
be higher, or lower than the expected 50% activity (Deutschbauer, 2005).  
 Previously we showed fs(1)h, the sole BET protein in Drosophila, has critical 
functions in both immunity and metabolism. Remarkably, it appears that almost all 
these functions were due to a loss of AKT signalling and increased foxo levels. 
Removing a single copy of foxo completely rescued the reduced lifespan of fs(1)h 
knockdown flies, but did not reduce the survival when infected with F. novicida. foxo 
heterozygosity also restored the expression levels of uninfected AMPs, but did not 
rescue AMP expression following bacterial infection, while total Relish protein levels 
were normalised in both uninfected and infected individuals. The reduced starvation 
survival phenotype seen in fs(1)h fat body knockout flies was rescued along with the 
ability for flies heterozygous for foxo to utilise their triglyceride stores following 24-
hour starvation. However, foxo heterozygosity does increase the baseline triglyceride 
level, due to the role foxo plays in regulating fat cell storage in steady state (DiAngelo 
and Birnbaum, 2009). The transcript levels of important lipid metabolism genes 
including bmm, plin1 and plin2, were also restored in foxo heterozygous flies. 
Following foxo heterozygosity in the fs(1)h knockdown flies the reduced circulating 
sugar levels, of trehalose and glucose, were rescued. However, glycogen, the stored 
carbohydrate, remained low when flies were both heterozygous for foxo and lacking 
fs(1)h in the fat body. The impaired levels of activated AKT and S6 kinase found in 
fs(1)h knockdown flies were restored to control levels when a copy of foxo was also 
removed. A number of nutrient-responsive signals, including upd2, Gbp2, CCHa2 and 
ImpL2 were dysregulated following the loss of fs(1)h in the fat body, however 
removing a copy of foxo rescued the transcriptional changes seen in these genes. 
upd1, a leptin-like factor, and Gbp1, an important gene in the regulation of the 
immune response (Koyama and Mirth, 2016) were not rescued following foxo 
heterozygosity. An increase in FOXOGFP protein level was identified following the loss 
of fs(1)h in the fat body, suggesting higher FOXO protein levels following the loss of 
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fs(1)h in the fat body. Furthermore, we identified first indications that flies with fs(1)h 
knocked down in the fat body may have ubiquitination dysfunction with changes in the 
proteins present and the quantity of some of the proteins. All these findings suggested 
there may be a defect in protein degradation upon ubiquitination when fs(1)h was 
removed from the fat body. Interestingly, this degradation defect seemed to be 
independent of foxo levels. This may suggest the elevated FOXO levels were due to a 
protein degradation fault developing in flies lacking fs(1)h in the fat body. Finally, our 
data showed that foxo homozygous null flies had an increased expression of fs(1)h, 
indicating there may be direct regulation between fs(1)h and foxo at a transcript level.  
 These data together suggest that fs(1)h knockdown may participate in a 
pathophysiological feedback loop via the dysregulation of FOXO and AKT activity, 
leading to altered expression of a number of endocrine signalling factors and in turn a 
reduction in systemic insulin activity. The reduction in insulin signalling and AKT 
activity may drive high FOXO activity, further disrupting the expression of insulin 
regulatory factors. Furthermore, these data could suggest that fs(1)h may directly 
affect foxo, which in turn leads to insulin pathway dysregulation. The use of foxo 
heterozygous flies may have reduced the increased level of FOXO and weakens this 
feedback loop back to a more physiologically normal homeostasis.    
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Chapter 6  		
Removing BET proteins from the human immune cell line, 
THP-1 	  
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6.1. Introduction 
Epigenetic changes and histone modifications have been of great interest in recent 
years as abnormalities in the process can alter chromatin structure and ultimately lead 
to dysregulated gene expression and the development of disease (Kanherkar et al., 
2014). In mammals, chromatin plays an important role in the regulation of 
inflammation by activating a cohort of inflammatory cytokines (Bernstein et al., 2007; 
Medzhitov and Horng, 2009; Smale, 2010). The process of acetylation, predominantly 
carried out by histone acetyltransferases (HATs), controls various inflammatory genes 
(Bayarsaihan, 2011). Furthermore, the promoters of several pro-inflammatory 
cytokines, including interleukin-1 (IL-1), IL-2, IL-8 and IL-12, are rapidly acetylated by 
CBP/p300 leading to transcriptional activation (Villagra et al., 2009). In contrast, the 
recruitment of histone deacetylase (HDACs) causes histone deacetylation and gene 
repression, HDACs also have the ability to regulate the transcription of various pro- 
and anti-inflammatory cytokines and transcription factors including FOXP3, STATs 
and NF-κB (Villagra et al., 2009). Acetylation of histones has many functional roles 
and the detection of these groups by epigenetic readers is extremely important for the 
control of transcriptional regulation. 
  Bromodomain-containing proteins (BCPs) are an important class of histone 
modification proteins that recognise acetylated lysine residues in histones to alter 
transcriptional regulation (Josling et al., 2012). The human genome encodes 46 
BCPs, each of which contain from one to six bromodomains (BDs), creating a total of 
61 unique human BCPs (Filippakopoulos et al., 2012). Structurally, BDs consist of a 
left-handed, four-helix bundle consisting of alphaZ, alphaA, alphaB and alphaC 
helices containing both hydrophilic and hydrophobic regions (Dhalluin et al., 1999). 
The architecture of the BD suggests it could act as an independent functional unit until 
it interacts with other proteins (Arrowsmith et al., 2012).  
Gene expression is under the control of epigenetic mechanisms and several 
small-molecule inhibitors to target these processes have been developed (Tough et 
al., 2016). These tools have further revealed the importance of epigenetics in guiding 
cell fate during immune responses and have highlighted a new role as a treatment of 
inflammation and immune-mediated disease (Tough et al., 2016). Recent years have 
seen the development of therapeutic intervention for treating inflammation using a 
synthetic compound that targets the bromodomain and extraterminal domain (BET) 
family. The BET proteins, BRD2, BRD3, BRD4 and BRDT, are a family of epigenetic 
readers of acetylated lysine residues in histones, specifically at the amino-terminal 
tails (Schaefer, 2014). Acetylated histone tails are usually associated with 
transcriptionally active chromatin regions, and BET proteins play roles as effector 
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molecules, via the association and recruitment of various factors including 
transcription factors (Schaefer, 2014). Selective inhibitors of BET proteins are able to 
repress transcription by blocking their ability to recognise acetylated lysine residues 
(Filippakopoulos and Knapp, 2014). Small molecule BET inhibitors such as JQ1 
(developed by the James Bradner Laboratory, Brigham and Women’s Hospital) and I-
BET (developed by GlaxoSmithKline) mimic acetyl moieties, occluding the 
bromodomains acetyllysine-binding pocket and displacing the BET protein from the 
chromatin (Zhang et al., 2016b).  
JQ1 is a small molecule inhibitor that specifically targets BET proteins and 
acts by blocking the proteins ability to bind to chromatin (da Motta et al., 2017). In 
turn, this impairs the recruitment of numerous transcription factors to their target gene 
promoters (da Motta et al., 2017). Studies using JQ1 have shown its potential 
therapeutic role, with strong inhibitory effects on tumour growth and survival (Shao et 
al., 2014), cell cycle arrest and differentiation, along with the ability to alter hypoxia 
response, exerting an anti-tumour effect (da Motta et al., 2017). Furthermore, JQ1 
inhibits mesenchymal stem cell (MSC) growth by influencing cellular processes 
including the cell cycle and signal transduction (Alghamdi et al., 2016).  
I-BET, another small molecule BET inhibitor, binds selectively to the acetyl-
recognising BET pocket with nanomolar affinity (Nicodeme et al., 2010). It leads to 
disruption of chromatin complexes that are responsible for the expression of 
inflammatory genes (Nicodeme et al., 2010). Initially, the first molecule, I-BET762 was 
used in an inflammatory disease model, showing that it potently inhibited expression 
of LPS inducible genes in macrophages in vitro and suppresses inflammation in a 
severe sepsis mouse model (Nicodeme et al., 2010). Another molecule, 
GSK1210151A (I-BET151) specifically inhibits the binding of bromodomain-containing 
proteins (BRD2, BRD3, BRD4 and BRD9) (Dawson et al., 2011) and exhibits potent 
selectivity over a range of protein types including PI3K-γ and G-protein coupled 
receptors (GPCRs) (Galdeano and Ciulli, 2016). Furthermore, it is an effective 
inhibitor of IL-6 production in LPS-stimulated peripheral blood mononuclear cells 
(PBMC) (Seal et al., 2012), osteoclastogenesis and inflammatory bone resorption 
(Park-Min et al., 2014). In rheumatoid arthritis (RA), I-BET151 suppresses TNF-α, IL-
1β and TLR ligand induced expression of cytokines, chemokines and matrix 
metalloproteinases (MMPs) in the synovial fluid that normally contribute to the disease 
pathology (Klein et al., 2016). The development of inhibitors has revealed novel 
insights into the physiological and therapeutic functions of BET proteins and beneficial 
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effects of these inhibitors have been shown in a number of inflammatory conditions 
and cancer (Belkina and Denis, 2012). 
In mammals, innate immune cells such as myeloid cells, including monocytes, 
macrophages and dendritic cells respond to environmental signs of pathogenic 
infection (Mogensen, 2009). Monocytes and macrophages are important cells of the 
immune response and they have three main roles; recognise foreign pathogens via 
pattern recognition receptors (PRRs) and phagocytose them, proliferate to increase 
the number of cells that are able to eliminate invading microorganisms and produce 
pro- and anti- inflammatory cytokines and chemokines to clear the site of infection and 
to keep the infection under control, respectively (Si-Tahar et al., 2009). THP-1 cells 
are a spontaneously immortalised human monocyte-like cell line, derived from the 
peripheral blood of an acute monocytic leukaemia patient (Tsuchiya et al., 1980). The 
THP-1 cell line is a simplified and reliable model to study monocyte and macrophage 
functions as well as macrophage differentiation (Chanput et al., 2014). Early studies 
demonstrate that THP-1 cells are similar to primary monocytes and macrophages 
both morphologically and functionally, including the presence of differentiation 
markers (Chanput et al., 2014). The cell line is used to study immune response while 
cells are in both a monocytic state and a macrophage-like state (Daigneault et al., 
2010). THP-1 cells in the monocytic state can be differentiated into a macrophage-like 
cell using 1α, 25-dihydroxyvitamin D3 (vD3), phorbol-12-myristate-13-acetate (PMA) 
or macrophage colony-stimulating factor (M-CSF), usually in combination with IFN-γ 
(Aldo et al., 2013). A number of macrophage-like phenotypes have already been 
observed morphologically following differentiation, including adhering to culture plates 
and altering their morphology into flat, amoeboid cells (Tsuchiya et al., 1982). 
Following stimulation with LPS, THP-1 macrophages express myeloid differentiation 
protein-2 (MD-2), CD14 and MyD88 genes, which are also required for LPS signalling 
in vivo (Chanput et al., 2014). Furthermore, genetically modifying THP-1 cells by 
using small interfering RNAs (siRNAs) to knockdown the expression of specific 
proteins is relatively simple in this cell line (Qin, 2012).  
6.1.1. Objective and aims 
The objective of this chapter is to investigate whether the effects on insulin signalling 
following the loss of fs(1)h in the fat body of Drosophila, can be reproduced in a 





The aims of this chapter are: 
1. To investigate the effects on pAKT and FOXO in THP-1 cells following 
treatment with the bromodomain inhibitor, I-BET151. 
2. To use siRNA to knockdown Brd2, Brd3 and Brd4 in THP-1 cells to investigate 
the roles they have individually on pAKT and FOXO levels. 
6.2. Treating THP-1 cells with IBET-151 reduced AKT activity and 
increased FOXO levels 
The human monocytic, THP-1, cell line was used to investigate if the effects we saw 
on the insulin signalling pathway when we knocked down fs(1)h in Drosophila fat body 
were conserved in human immune cells. Instead of genetically manipulating the 
bromodomain-containing protein, we used I-BET151 to inhibit the binding of the 
bromodomain to acetylated lysine residues in histones. THP-1 cells were treated for 
24-hours with the bromodomain inhibitor, IBET-151. The treated cells showed a 
reduction in phosphorylated AKT protein levels (Figure 6-1A) and increased levels of 
FOXO3a protein (Figure 6-1B) when compared to THP-1 cells that had been treated 
with DMSO alone. Therefore, we could confirm a potential conserved role of BET 





Figure 6-1: Treating THP-1 cells with I-BET151 showed changes in the insulin-signalling 
pathway 
Western blot analysis of THP-1 cells following 24-hour treatment with the BET inhibitor, I-
BET151, or DMSO as a control. A. Phosphorylated AKT (pAKT) protein level in I-BET151 
treated cells (grey bars) and DMSO treated control cells (white bars). Values represented as 
intensity relative to Actin, data shown as mean + SEM, *p<0.05. B. FOXO3a protein level in I-
BET151 treated cells (grey bars) and DMSO treated control cells (white bars). Values 
represented as intensity relative to Actin, data shown as mean + SEM, **p<0.01. +; presence 




































































6.3. A knockdown of Brd2 by siRNA showed no change in insulin 
signalling 
The BRD2 protein is a member of the BET family, which associates with transcription 
complexes and acetylated chromatin during mitosis (Nakamura et al., 2006). Brd2 
consist of four chromatin interacting domains that regulate gene expression, two N-
terminal bromodomains, which recognise acetylated lysine residues, a protein-protein 
interaction domain at the C-terminal and an extraterminal (ET) domain that is highly 
conserved among BET proteins (Webby et al., 2009). The two bromodomains and the 
C-terminal domain are equally important in regulating transcription (Hnilicová et al., 
2013). The first bromodomain (BD1) of BRD2 recognises H4K5ac or H4K8ac, 
whereas second bromodomain (BD2) interacts preferentially with H4K12ac or H4K5ac 
(Filippakopoulos et al., 2012; Huang et al., 2007; Umehara et al., 2010). Additionally, 
the bromodomains of BRD2 have a much higher affinity for tetraacetylated histone 
marks (H4K5ac, H4K8ac, H4K12ac and H4K16ac) rather than single acetylation 
marks (Hnilicová et al., 2013). BRD2 associates with E2 factor (E2F) family of 
transcription factors and helps to recruit TATA-binding protein (TBP) to promoter 
regions (Peng et al., 2007). Several experiments using mice have shown that the loss 
of Brd2 is detrimental. Brd2-deficient mice have developmental defects of the neural 
tube, abnormal brain structures and die during embryogenesis (Gyuris et al., 2009; 
Shang et al., 2009). Heterozygous Brd2-deficient mice are viable but develop 
spontaneous seizures and have a low number of inhibitory neurons in the brain 
(Velíšek et al., 2011). Furthermore, it was shown that mice with lower levels of Brd2 
are extremely obese, but protected from type 2 diabetes (Wang et al., 2009). In 
transgenic mice, where Brd2 is constitutively expressed in B-cells, Brd2 upregulates 
cyclin A, destabilises the cell cycle and leads to B-cell over proliferation and 
malignancy (Belkina et al., 2014; Blanton et al., 2008; Greenwald et al., 2004). In 
humans, BRD2 has been implicated in a number of diseases including cancer (Fu et 
al., 2015), chronic inflammation (Belkina et al., 2013) and epilepsy (Layouni et al., 
2010; Pal et al., 2003). It has also been shown to be involved in the regulation of a 
number of signalling pathways including Wnt and Hedgehog (Engelke and 
Chinnaiyan, 2015; Tang et al., 2014).  
We wanted to assay the role of BRD2 on the insulin-signalling pathway by 
looking specifically at the activation of the main kinase AKT and the downstream 
transcription factor FOXO3a in a human immune cell line. We used siRNA to 
knockdown Brd2 in THP-1 cells and assayed the efficiency of the knockdown three 
days after siRNA treatment. We were able to show a significant reduction in BRD2 
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protein level compared to the control DMSO treated cells (Figure 6-2A). However, 
analysis of phosphorylated AKT (pAKT) in these cells showed no change in the 
protein level of activated AKT compared to the DMSO treated cells (Figure 6-2B). 
Furthermore, we could not detect a reduction in FOXO3a protein level following Brd2 
knockdown (Figure 6-2C) when compared to the cells treated with DMSO. In 
conclusion, we were able to show an efficient knockdown of Brd2 using siRNA in 
THP-1 cells but we were unable to show an effect on insulin signalling in these cells, 
indicated by unaltered pAKT and FOXO3A protein levels.   
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Figure 6-2: Using siRNA to knockdown Brd2 did not show changes in the insulin-
signalling pathway 
Western blot analysis of THP-1 cells following Brd2 siRNA or non-targeting siRNA as a control. 
A. Level of BRD2 protein following siRNA treatment, Brd2 siRNA treated cells (grey bars) and 
non-targeting siRNA controls (white bars). Values represented as intensity relative to Actin, 
data shown as mean + SEM,*p<0.05. B. Phosphorylated AKT protein level following siRNA 
treatment, Brd2 siRNA treated cells (grey bars) and non-targeting siRNA controls (white bars). 
Values represented as intensity relative to Actin, data shown as mean + SEM, no stars 
indicate lack of statistical significance. C. FOXO3a protein level following siRNA treatment, 
Brd2 siRNA treated cells (grey bars) and non-targeting siRNA controls (white bars). Values 
represented as intensity relative to Actin, data shown as mean + SEM, no stars indicate lack of 





























































































6.4. Brd3 knockdown in THP-1 cells showed no difference in insulin 
signalling 
Bromodomain-containing protein 3 (BRD3) is a member of the BET protein family, 
and much like the other BET family members it associates with acetylated lysine 
residues in histones to regulate transcription (Lamonica et al., 2011). The first 
bromodomain (BD1) of BRD3 interacts with the GATA1 transcription factor and 
enhances the expression of GATA1-dependent genes (Gamsjaeger et al., 2011; 
Lamonica et al., 2011). BRD3 has also been shown to interact with acetylated lysine 
residues on the N-terminal of H2A, H2B, H3 and H4 (LeRoy et al., 2008). Additionally, 
Brd3 promotes LPS-triggered IL-6 production by promoting the recruitment of CREB-
binding protein (CBP) to the IL-6 promoter and enhancing the amount of acetylation of 
histone 3 close to the IL-6 promoter region (Ren et al., 2017). Knockdown of Brd3 
affects the expression and activation of signalling pathways involved in IL-6 
expression, including NF-κB and mitogen-activated protein kinase (MAPK) pathways 
(Ren et al., 2016). Defects involving BRD3 are found in rare, aggressive and lethal 
carcinomas arising from midline organs including the intestine, bladder and pancreas 
(French, 2010). Furthermore, Shao et al (2016) found that an isoform of Brd3, known 
as Brd3 with Reprogramming activity (Brd3R) positively regulates mitosis during 
reprogramming. It is shown to upregulate a large set of mitotic genes during early 
reprogramming stages and associates with mitotic chromatin (Shao et al., 2016). 
Interestingly, depleting BRD3 levels has also been shown to slow cancer growth in 
mouse models of prostate cancer and medulloblastoma (Henssen et al., 2013; Wilting 
and Dannenberg, 2012).  
We used siRNA to knockdown Brd3 in THP-1 cells and found almost a 
complete loss of BRD3 protein in the three-day siRNA treated cells, compared to 
those treated with DMSO as a control (Figure 6-3A). However, there was no 
detectable change in the protein level of activated AKT (Figure 6-3B) or FOXO3a 
protein level (Figure 6-3C) when we compared the siRNA treated cells to the DMSO 
treated control THP-1 cells.  	
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Figure 6-3: Using siRNA to knockdown Brd3 did not show changes in the insulin-
signalling pathway 
Western blot analysis of THP-1 cells following Brd3 siRNA or non-targeting siRNA as a control. 
A. Level of BRD3 protein following siRNA treatment, Brd3 siRNA treated cells (grey bars) and 
non-targeting siRNA controls (white bars). Values represented as intensity relative to Actin, 
data shown as mean + SEM.*p<0.05. B. Phosphorylated AKT protein level following siRNA 
treatment, Brd3 siRNA treated cells (grey bars) and non-targeting siRNA controls (white bars). 
Values represented as intensity relative to Actin, data shown as mean + SEM, no stars 
indicate lack of statistical significance. C. FOXO3a protein level following siRNA treatment, 
Brd3 siRNA treated cells (grey bars) and non-targeting siRNA controls (white bars). Values 
represented as intensity relative to Actin, data shown as mean + SEM, no stars indicate lack of 













































































































6.5. Insulin signalling was not affected by Brd4 knockdown using siRNA 
Bromodomain-containing protein 4 (BRD4) is another member of the BET family, 
consisting of two tandem bromodomains and an extraterminal (ET) domain. BRD4 is 
an important chromatin binding protein that binds the acetylated lysine residues of 
histone H3 and H4 to activate transcription (Chiang, 2009). Additionally, BRD4 has a 
C-terminal domain that has been implicated in promoting gene transcription via the 
recruitment of the active positive transcription elongation factor (P-TEFb) and inducing 
the phosphorylation of RNA polymerase II (Devaiah et al., 2012; Hargreaves et al., 
2009; Jang et al., 2005; Yang et al., 2005). BRD4 is essential for cellular growth, cell 
cycle control, DNA replication and gene rearrangement (Wu and Chiang, 2007), it has 
been suggested to function in ‘transcriptional memory’ to maintain the correct gene 
expression patterns during cell division (Bisgrove et al., 2007). TGF-β can induce the 
formation of an NF-κB-BRD4 complex and recruit BRD4 to epithelial-mesenchymal 
transition (EMT) transcription regulators (Tian et al., 2016). In a fibrosis mouse model, 
inhibiting BRD4 with small-molecule inhibitors can also reduce lung fibrosis following 
repetitive TGF-β challenge (Tian et al., 2016). BRD4 also seems to play a critical role 
in renal cell carcinoma (RCC). Inhibition of BRD4 activity results in supressed cellular 
proliferation and induces apoptosis in RCC (Wu et al., 2017). In addition, changes in 
BRD4 function can affect osteoblast differentiation at early stages as well as during 
mineralisation by regulating expression of skeleton or extracellular matrix-specific 
genes (Najafova et al., 2017). BRD4 is also involved in a number of stages and 
processes of the viral life cycle of Human Papillomavirus (HPV) and Human 
Immunodeficiency virus (HIV). The E2 protein targets the C-terminus of BRD4 to 
regulate HPV and HIV transcription (Bisgrove et al., 2007; Lee and Chiang, 2009; 
McKinney et al., 2016). 
Again, we used siRNA to knockdown Brd4 in THP-1 cells, three-days after 
siRNA treatment we analysed the BRD4 protein levels in the cells, but it was not as 
efficient as the siRNA for BRD2 or BRD3. We found only a slight reduction of BRD4 
protein abundance following treatment with the siRNA compared to the DMSO treated 
cells (Figure 6-4A). There was also no change in the protein level of activated AKT 
(Figure 6-4B) or FOXO3A protein level (Figure 6-4C) when we compared the siRNA 
treated cells to the DMSO treated THP-1 cells. 	
	 191 
	
Figure 6-4: Using siRNA to knockdown Brd4 showed no change in the insulin-signalling 
pathway 
Western blot analysis of THP-1 cells following Brd4 siRNA or non-targeting siRNA as a control. 
A. Level of BRD4 protein following siRNA treatment, Brd4 siRNA treated cells (grey bars) and 
non-targeting siRNA controls (white bars). Values represented as intensity relative to Actin, 
data shown as mean + SEM, no stars indicate lack of statistical significance. B. 
Phosphorylated AKT protein level following siRNA treatment, Brd4 siRNA treated cells (grey 
bars) and non-targeting siRNA controls (white bars). Values represented as intensity relative to 
Actin, data shown as mean + SEM, no stars indicate lack of statistical significance. C. 
FOXO3a protein level following siRNA treatment, Brd4 siRNA treated cells (grey bars) and 
non-targeting siRNA controls (white bars). Values represented as intensity relative to Actin, 
data shown as mean + SEM, no stars indicate lack of statistical significance. A; non-targeting 






























































































6.6. Chapter 6 overview  
In this chapter, we have identified that the loss of BET proteins in the human immune 
cell line, THP-1, had similar effects on the insulin signalling pathway, as described 
previously when fs(1)h, the only BET protein in Drosophila, is removed from the fat 
body. 
 Bromodomain and extraterminal domain (BET) proteins play a crucial role in 
regulating gene transcription through an interaction between the bromodomains and 
acetylated lysine residues found predominantly in histone tails (Taniguchi, 2016). In 
recent years, the BET protein family have become a new therapeutic target in 
diseases including cancer, neurological disorders and inflammation (Padmanabhan et 
al., 2016). In Drosophila, we observed changes in the insulin signalling pathway when 
we knocked down fs(1)h, the sole Drosophila BET protein, in the fat body. We were 
able to detect a reduction in the activity of AKT, one of the main kinases of the insulin 
pathway and an increase in the level of FOXO following fat body knockdown of fs(1)h. 
The insulin-signalling pathway is highly conserved from Drosophila to humans, and 
we wanted to determine whether the results found in Drosophila were reproducible in 
a human immune cell line. THP-1 cells were used for these experiments; they are a 
widely used and a well characterised cell line used to investigate the function and 
regulation of monocytes and macrophages (Qin, 2012).  
 We found that when we treated the THP-1 human cell line with I-BET151, a 
small molecule inhibitor of the BET family of proteins, we were able to show a 
reduction in activated AKT levels (pAKT), similar to the reduction shown following 
knockdown of fs(1)h down in the fat body of Drosophila. We were also able to detect 
an increase in the protein level of FOXO in the THP-1 cells following 24-hour 
treatment with I-BET151. These data suggested there may be an important and 
conserved role for BET proteins in the regulation of the insulin-signalling pathway of 
immune cells. We also wanted to try and dissect these results further by using specific 
siRNA against the BET proteins (Brd2, Brd3, Brd4) and investigate whether one of 
these proteins was having a specific effect on the insulin-signalling pathway. Although 
the siRNA worked successfully for two out of the three BET protein knockdowns, we 
were unable to identify any changes in either activated AKT or FOXO3a levels. These 
data may suggest that the other BET proteins, which are still present after knockdown 
of one individual BET protein in the THP-1 cells, may be able to compensate for the 
loss of an individual BET proteins. It would be interesting to test the combined siRNA 
knockdown of Brd2, 3 and 4 in the THP-1 cell line. This may also suggest why the 
fs(1)h phenotype observed in Drosophila may be so strong, as there isn’t another BET 
protein to recognise acetylated lysine residues and regulate transcription following 
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knockdown in the fat body. We were only able to test the conservation of this 
regulatory effect in the insulin-signalling pathway in one cell line. The regulation of the 
insulin pathway by BET proteins should be further tested on other human immune 
cells, but also in hepatocytes of the liver and adipocytes, as they share many 
properties with the fat body of Drosophila.   
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The objective of this thesis was to investigate the role of bromodomain-containing 
proteins (BCPs) and jumonji domain-containing proteins (JDCPs) in the Drosophila 
immune cells, hemocytes and fat body, following bacterial infection. The survival 
screen resulted in the identification of female sterile (1) homeotic (fs(1)h) to be 
required in the fat body. 
In this thesis, we showed for the first time that fs(1)h, the sole Drosophila 
member of the bromodomain and extraterminal (BET) protein family, was essential for 
both immunity and metabolism. fs(1)h had critical functions in the fat body to enable 
normal lifespan, restrain the expression of antimicrobial peptides (AMPs) and for 
normal utilisation of triglyceride stores. Knockdown of fs(1)h in the Drosophila fat body 
also led to significant reductions in baseline AKT phosphorylation and hypoglycemia 
(Figure 7-1). It appeared that almost all of these functions were due to effects on 
signalling via AKT and FOXO. Removing a single copy of foxo, along with the 
knockdown of fs(1)h in the fat body, was able to rescue the reduced lifespan, 
normalise AMP expression levels when uninfected, and restore their ability to utilise 
triglyceride stores following starvation. Phosphorylated AKT levels, S6 Kinase levels 
and circulating sugar levels were also rescued by foxo heterozygosity. Importantly, 
following bacterial infection, survival and AMP expression levels were not rescued by 
the loss of one copy of foxo, indicating that not all the fs(1)h phenotypes were 
attributed to FOXO hyperactivation. Interestingly, we also found the first indication for 




Figure 7-1: Summary of findings following fs(1)h knockdown in the Drosophila fat body 
An overview of the data obtained in this thesis, showing changes that occurred in various 
signalling pathways, in various tissues following fs(1)h knockdown in the fat body. Green 
arrows indicate an increase in transcript or protein level, red arrows indicate a decrease in 
transcript or protein level. Striped arrows indicate differing results depending on whether whole 
fly or dissected fat body samples were analysed. LD; lipid droplet.  
7.2. fs(1)h expression in the fat body is required for survival 
Initially, we identified that Drosophila with a deficiency of fs(1)h in the fat body showed 
a reduction in survival following bacterial infection. Interestingly, fs(1)h knockdown in 
the fat body also led to a dramatically shortened lifespan under physiological 
conditions and during starvation. Ageing is accompanied by cellular damage, changes 
in repair and detoxification processes, and a shift in homeostatic balance, leading to 
dysregulation of various signalling pathways (Rubinstein and Kimchi, 2012). Human 
ageing and age-related disease is often associated with increases in inflammatory 
markers and insulin resistance (Chung et al., 2009; Lusis et al., 2008). In Drosophila, 
similarly to humans, ageing is associated with an increased expression of immunity-
related genes (Landis et al., 2004; Pletcher et al., 2002) and changes in insulin 
signalling (Morris et al., 2012). fs(1)h knockdown in the fat body led to an over-
expression of the antimicrobial peptides (AMPs) measured as well as severe changes 
in the insulin-signalling pathway, these are two pathological changes that may 
account for the decreased survival observed in the fs(1)h knockdown flies. Functional 
decline of organs and signalling pathways of individuals links both physiological 

















































and the changes in the insulin-signalling pathway may have induced dysregulated 
organ function following fs(1)h knockdown in the fat body.  
 The intestinal epithelium is a regenerative, permeable membrane that interacts 
with normal microflora and pathogens to maintain homeostasis and elicit an immune 
response when needed (Ayyaz et al., 2015). In ageing mammals and Drosophila, 
structural and functional damage of the intestinal epithelium have been reported 
(Biteau et al., 2008; Kirkwood, 2004; Rera et al., 2011). This suggests maintaining gut 
integrity is an important indicator of organism health and viability (Rera et al., 2012). 
Furthermore, intestinal barrier dysfunction is correlated with lifespan of Drosophila 
and regardless of chronological age, gut barrier dysfunction has been reported as a 
predictor of death in flies dying of old age (Rera et al., 2012). Following knockdown of 
fs(1)h in the fat body, a decline in gut barrier function was observed in a small number 
of the flies, which may be another indication of their decreased viability. Although the 
main reason for the reduction in survival seems to be due to the reduction in AKT and 
the increase in FOXO levels following fs(1)h knockdown, there are also a number of 
other factors that may have contributed to the early death phenotype including toxic 
levels of antimicrobial peptides, hypoglycemia and dysregulation in endocrine 
signalling.  
7.3. Expression of antimicrobial peptides and cytokines  
Drosophila have a multi-layered immune system consisting of various defence 
mechanisms that can be used to help fight infection including physical barriers, along 
with a cellular and a humoral immune response. The cellular response is driven 
predominantly by hemocytes, to phagocytose and encapsulate intruding pathogens, 
and the humoral response, which produces the majority of the molecules to help kill 
the microbes (Brennan and Anderson, 2004; Hoffmann, 2003; Hultmark, 2003). 
Antimicrobial peptides (AMPs) are an important aspect of the humoral response and 
host defence in Drosophila. The AMPs are grouped on their biological targets, such 
as Gram-positive, Gram-negative bacteria or fungi (Imler and Bulet, 2005). These 
peptides are produced predominantly by the fat body, an organ analogous to adipose 
tissue and the liver in mammals, but can also be expressed by phagocytes of the fly 
known as hemocytes, as well as epithelial cells (Lemaitre and Hoffmann, 2007). In the 
initial survival screen, knocking down fs(1)h in hemocytes did not lead to a decreased 
survival following bacterial infection, unlike the dramatic reduction in survival observed 
following knockdown in the fat body. These data suggest fs(1)h expression may be 
important for the regulation of the humoral immune response in the fat body, but may 
be redundant for the cellular immune response in hemocytes. The upregulation of 
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AMPs may also indicate further that fs(1)h could be involved in the pathways 
prompting AMP expression in the fat body. Upon infection, two major immune 
signalling pathways, Toll and Imd, can be activated via members of the NF-κB family 
known as Dif, Dorsal and Relish (Tanji et al., 2007). Infection-induced AMP 
expression is due to strong signalling via NF-κB and MEF-2 combined with tissue 
identity signals from GATA transcription factors (Clark et al., 2013; Petersen et al., 
1999; Senger et al., 2006). However, following fs(1)h knockdown in the fat body there 
was an increase in total Relish protein level, but there was no increase in activated 
Relish under physiological or infected conditions. These data suggest fs(1)h may 
affect total Relish levels, NF-κB signalling or their targets in the Drosophila fat body 
but not directly affect the activation of the Imd pathway.  
 It was previously described that under uninfected conditions, a subset of 
AMPs can be directly activated by the transcription factor, foxo depending on the 
metabolic state of the fly (Loch et al., 2017). However, foxo is not believed to be an 
important regulator of AMPs in the fat body during infection (Becker et al., 2010). 
These observations suggest there is cross-talk between the innate immune response 
and metabolism (Becker et al., 2010; Varma et al., 2014). The data suggested fs(1)h 
may be a key regulator of AKT and FOXO signalling, and could regulate AMP 
expression by controlling the level of foxo. In uninfected conditions, the elevated AMP 
expression following the loss of fs(1)h in the fat body seems to foxo dependent, as 
foxo heterozygosity is able to rescue the phenotype. Although total Relish protein was 
upregulated, the increase in AMPs did not seem to be due to an increase in Imd 
pathway activation. Interestingly, removing one copy of foxo during infection was 
unable to rescue the survival phenotype or the increased AMP expression in fs(1)h 
knockdown flies. These observations fit with the data showing that foxo may only 
control AMP expression under uninfected conditions (Becker et al., 2010). 
Furthermore under normal conditions, fs(1)h may play a role in constraining foxo 
activation to a low enough level that it does not activate AMPs. Infection-induced AMP 
expression was increased in fs(1)h knockdown flies independent of foxo, suggesting 
that under normal conditions fs(1)h may supress AMP loci. fs(1)h may be an 
endogenous negative regulator of AMP expression, in the presence or absence of 
infection.  
 Along with the role of AMPs in the innate immune response, they also help to 
maintain a steady state of microflora in the gut (Lehrer and Ganz, 1999), play an 
important role in tolerance to oxidative stress and are induced under non-infectious 
stress (Zhao et al., 2011). In the immune response of Drosophila, the NF-κB family 
member, Dif is dedicated to the antifungal defence elicited by fungi and Gram-positive 
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bacteria (Rutschmann et al., 2000). Dif mutant flies, much like Toll pathway mutants, 
are susceptible to fungal but not bacterial infections (Rutschmann et al., 2000). 
Whereas, Imd mutant flies are susceptible to bacterial but not fungal infections 
(Lemaitre et al., 1996), the ability to express Drosomycin is not affected in Imd 
mutants, but the expression of the other AMPs is impaired (Rutschmann et al., 2000). 
Loss of fs(1)h in the fat body resulted in a reduction of survival, but interestingly, these 
flies showed a hyperactivation of the immune response, rather than a down-
regulation. In many organisms, a dysregulation of the immune response can result in 
severe pathologies and can contribute to tissue damage (Dionne and Schneider, 
2008). Mutations in negative regulators of the Imd pathway disposes Drosophila to 
toxic levels of AMPs, resulting in reduced lifespan, neurodegeneration and locomotor 
defects (Kounatidis et al., 2017). The over-expression of AMPs in fs(1)h knockdown 
flies may be inducing tissue damage and a pathology that could explain the severely 
reduced lifespan. Additionally, during bacterial or viral infection, prolonged immune 
activation has been associated with metabolic dysregulation, mainly due to alterations 
insulin signalling (Dionne et al., 2006). In humans and Drosophila, excessive immune 
activation can drive metabolic disruption and the loss of metabolic stores (Dionne, 
2014) and MEF2 in the fat body can act as a switch between both immune and 
metabolic functions (Clark et al., 2013). Furthermore, chronic activation of the immune 
response due to an over-expression of AMPs in neurons and glia of adult flies is 
sufficient to promote neurodegeneration (Cao et al., 2013; Kounatidis et al., 2017; 
Petersen et al., 2012; Sudmeier et al., 2015). Continuous upregulation of AMPs can 
be detrimental to host tissues (Bischoff et al., 2006; Zaidman-Rémy et al., 2006), 
following fs(1)h fat body knockdown the increased expression levels of AMPs may 
also be harmful to the flies.  
 In addition to the drastically elevated AMP expression, a number of cytokines 
were also elevated in unchallenged conditions following the loss of fs(1)h in the fat 
body. TGF-β family signals play roles in regulating tissue repair and inflammation in 
mammals (Li et al., 2006). dpp, a TGF-β family member in Drosophila is activated 
following wounding and is important for repressing the production of AMPs (Clark et 
al., 2011). This may explain the transcriptional increase in dpp expression observed 
following fs(1)h knockdown in the fat body as a rescue mechanism to reduce the 
increase in AMP expression during uninfected and infected conditions. In mammals, 
the TNF superfamily plays essential roles in regulating infection, inflammation and 
tissue homeostasis (Locksley et al., 2001). In Drosophila, eiger, is a TNF ligand that 
induces cell death by the activation of the JNK pathway (Igaki et al., 2002). Removing 
fs(1)h in the fat body of Drosophila caused an increase of eiger, which may be highly 
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expressed to try and help regulate and reduce the expression of AMPs and cytokines. 
The Jak/STAT pathway and one of its ligands, upd3, are involved in maintaining 
tissue homeostasis and tissue repair during times of infection and acute stress by 
controlling stem cell proliferation (Singh et al., 2007) and inhibiting apoptosis (Betz et 
al., 2008). upd3 is produced as a pro-inflammatory cytokine by hemocytes in 
response to infection (Agaisse et al., 2003), but also in midgut epithelial cells, where it 
plays essential roles in gut infection and homeostasis (Buchon et al., 2009; Jiang et 
al., 2009; Osman et al., 2012). The production of upd3 is induced in hemocytes 
following high fat diet and controls insulin sensitivity and lifespan in Drosophila 
(Woodcock et al., 2015). Over-activation of the Jak/STAT pathway can leads to 
persistent immune activation, inflammation and tissue damage (Shen-Orr et al., 
2016). Therefore, increased upd3 levels in fs(1)h knockdown flies could also play a 
part in causing the reduced survival phenotype.  
7.4. Insulin signalling in the fat body 
The insulin-signalling pathway is highly conserved in Drosophila and has many 
functional similarities to the mammalian insulin pathway (Papatheodorou et al., 2014). 
In response to sugars in the hemolymph, Drosophila insulin-like peptides (DILPs) bind 
to the insulin-like receptor (InR) and activate a signalling cascade via the 
phosphorylation of the main kinase, AKT. The activation of AKT controls the nuclear 
localisation of the transcription factor FOXO; following activation of AKT, FOXO 
remains inactive in the cytoplasm (Hay, 2011). AKT is also able to inhibit the 
TSC1/TSC2 complex, leading to the inhibition of Rheb and activation of TOR (Huang 
and Manning, 2009). Independently of DILPs and the InR, the TOR pathway can be 
regulated by amino acids, which are imported into cells via the amino acid transporter, 
Slimfast (Britton et al., 2002; Dann and Thomas, 2006). Insulin regulates growth of all 
tissues during the larval stage but in adults its effects are focused on lifespan, 
fecundity, metabolic homeostasis and resistance to stress (Broughton et al., 2005; 
Grönke et al., 2010). Mutations in single genes encoding insulin signalling 
components result in increased lifespan, reduced activity of the insulin pathway 
extends lifespan in the worm, fly and mouse (Kenyon, 2010), it also slows the ageing 
process (Hwangbo et al., 2004). Life expectancy in Drosophila is extended when the 
InR or chico are mutated. Conversely, the loss of fs(1)h in the fat body resulted in a 
reduction in AKT activity but also a decrease in survival. These observations 
suggested other phenotypes associated with fs(1)h knockdown in the fat body may be 
responsible for the reduction in lifespan, such as the increased AMP expression, their 
inability to utilise triglyceride stores or hypoglycemia. Ablating IPCs in Drosophila 
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larvae causes developmental delay, problems with growth and elevated carbohydrate 
levels (Rulifson et al., 2002). However, ablation of IPCs in the adult stage prolongs 
lifespan, increases storage of triglycerides and sugars, reduces fecundity and 
heightens resistance to starvation (Broughton et al., 2005).  
 Dietary restriction, where food intake is reduced without causing malnutrition, 
extends lifespan in many organisms from yeast to mammals (Anderson et al., 2003; 
Chippindale et al., 1993; Colman et al., 2009; Houthoofd et al., 2003; McCay et al., 
1935; Partridge et al., 1987). In Drosophila, dietary restriction is applied by modifying 
the amount of yeast and diluting the nutrients in the food (Chapman and Partridge, 
1996). Interestingly, the extension in lifespan is much greater in females than males, 
but also leads to reduced fecundity in C. elegans, Drosophila and rodents (Chapman 
and Partridge, 1996; Klass, 1977; Selesniemi et al., 2008). Given that a reduction in 
insulin signalling can increase Drosophila lifespan (Clancy et al., 2001; Tatar et al., 
2001); this pathway may also help to mediate the response to dietary restriction. In 
mice, deletion of the insulin receptor in white adipose tissue results in lean, long-lived 
adults (Kenyon, 2005) and in Drosophila, the insulin receptor controls growth by 
regulating the size and number of cells and organs in response to nutrient availability 
(Brogiolo et al., 2001). The beneficial effects of reduced insulin signalling are evidently 
redundant in flies with fs(1)h knocked down in the fat body.  
 The loss of fs(1)h in the fat body also led to a reduction in lipolytic activity 
following starvation and a down-regulation of several lipid metabolism genes involved 
in energy mobilisation. Disruption of metabolic homeostasis often leads to the 
development of insulin resistance, a hallmark of type II diabetes (Morris et al., 2012). 
In mammals, hepatic deletion of AKT causes glucose intolerance and insulin 
resistance in hepatocytes (Yuan et al., 2012). However, fs(1)h knockdown in the fat 
body led to a reduction of activated AKT but the flies did not develop insulin 
resistance. In addition, disruption of Brd2 in mice causes severe obesity, 
hyperinsulinemia and hepatosteatosis (Wang et al., 2009). Furthermore, much like 
fs(1)h knockdown flies, mice lacking Brd2 experience elevated proinflammatory 
cytokines and reduced blood glucose (Wang et al., 2009). These data suggest fs(1)h 
in the Drosophila fat body and Brd2 in the mouse may serve a similar function. 
Furthermore, S6 Kinase, a downstream effector of the PI3K signalling pathway 
(Dennis et al., 1999), which regulates ribosomal protein production and cell size, not 
cell number, in a cell-autonomous manner in Drosophila and in mammals (Montagne 
et al., 1999). Drosophila deficient in S6K have an extreme delay in development and a 
severe reduction in body size (Lambertsson, 1998), and flies dominant negative for 
S6K show lifespan extensions (Kapahi et al., 2004). Flies with fs(1)h reduction in the 
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fat body also showed a reduction in S6K, however, there were no morphological 
changes in the fat body tissue, suggesting the reduction in S6K was not causing a 
reduction in cell size or altering lifespan. The decrease in S6K activity may be caused 
by the reduction in AKT activity in fs(1)h knockdown flies, as its been previously 
described that AKT triggers S6K signalling via TOR and a reduction in pAKT levels 
can result in reduced S6K activity (Lizcano et al., 2003; Miron et al., 2003). 
 The forkhead box O (FOXO) family of transcription factors are key regulators 
of metabolism, ageing, stress resistance, independent of the immunoregulatory 
pathways. The reduction of pAKT in flies with fs(1)h knocked down in the fat body was 
accompanied by an increase in the transcript levels of foxo target genes, all which can 
be rescued by reducing the level of foxo in these flies. These findings suggest fs(1)h 
may be playing an important and direct role in regulating signalling via AKT and 
FOXO. Expression of foxo in early Drosophila development causes inhibition of larval 
growth and changes to feeding behaviour (Kramer et al., 2003). High levels of FOXO 
expression in early larval stages can cause developmental arrest and the inhibition of 
growth can be rescued when foxo expression is reduced (Kramer et al., 2003). In 
many organisms, FOXO is negatively regulated by AKT in response to insulin and 
insulin-like growth factors binding to insulin receptors. As mentioned previously, 
reducing insulin signalling and inducing the expression of FOXO in the fat body in the 
adult increases Drosophila lifespan (Hwangbo et al., 2004), although fs(1)h 
knockdown in the fat body displayed the opposite effect on survival. In mammals, 
hypoglycemia and a reduction in circulating insulin leads to FOXO1 localisation in the 
nucleus of hepatocytes, which drives gene expression to activate gluconeogenesis 
and lipid catabolism (Zhang et al., 2006). In line with these findings, knocking down 
fs(1)h in the fat body resulted in an increase in Pepck transcript, a major enzyme 
mediating gluconeogenesis. In non-infected flies, AMP genes are activated in 
response to nuclear FOXO activity when induced by starvation. AMP induction is lost 
in foxo null mutants, but enhanced when FOXO is over-expressed (Becker et al., 
2010). Furthermore, over-expressing FOXO in flight muscles delays the accumulation 
of misfolded protein aggregates in muscle and non-autonomously in other tissues 
(Demontis and Perrimon, 2010). foxo also plays a functional role in response to 
stress, and a protective role during nutritional stress in larval development (Tettweiler 
et al., 2005). Interestingly, foxo upregulates transcript levels of 4E-BP, a translational 
repression (also known as Thor in Drosophila), under conditions of low insulin (Jünger 
et al., 2003). FOXO and its target 4E-BP also regulate the expression of various 
autophagy genes and protein homeostasis. In Drosophila, foxo mutants show 
proteostatic dysfunction and both foxo and 4E-BP delay muscle function and extend 
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lifespan (Demontis and Perrimon, 2010). Knocking down fs(1)h in the fat body 
suggests that disturbed expression of endocrine factors resulted in low systemic 
insulin activity, which in turn drove high FOXO activity, further disrupting the 
expression of insulin and energy mobilisation regulatory factors.  
7.5. Utilisation of triglycerides and sugar regulation  
In humans, obesity is associated with many health implication including type II 
diabetes, cardiovascular disease and cancer (Lee and Mattson, 2014). However, 
under-storage, or an inability to utilise fat stores are also problematic particularly 
during periods of food deprivation. The main functions of lipids are to store energy in 
the form of triglycerides, compose cellular membranes and serve as precursors for a  
range of hormones (Liu and Huang, 2013). In Drosophila, storage lipids in the form of 
triglycerides are stored in lipid droplets in the fat body. Signalling pathways and major 
metabolic enzymes involved in lipid metabolism are conserved between Drosophila 
and mammals, including a number of genes that regulate lipid uptake, storage and 
mobilisation. When energy is required, lipids undergo lipolysis by lipases and 
hydrolases, releasing fatty acids, as energy, into the hemolymph (Moghadam et al., 
2015). The mobilisation of lipids is regulated by hormonal signals and carried out by 
lipases produced by the fat body. The metabolic pathways and the lipases play 
essential roles in maintaining lipid homeostasis (Moghadam et al., 2015). In 
Drosophila, there are four main lipases that operate at the surface of lipids to 
breakdown triglycerides (TAG) into free fatty acids and glycerol (Pistillo et al., 1998). 
Hormone-sensitive lipase (Hsl) and brummer (bmm, homolog of human adipose 
triglyceride lipase; ATGL) are involved in the mobilisation of TAG. Chronic over-
expression of bmm or lack of food depletes fat stores in vivo, and like ATGL knockout 
mice, bmm mutants have impairments in fat mobilisation and have increased TAG 
storage (Grönke et al., 2007). Drosophila Hsl mutants are partially defective in fat 
mobilisation, especially during starvation. Furthermore, Hsl;bmm double mutants are 
extremely obese (Grönke et al., 2005). The recruitment of Hsl or bmm to lipid droplets 
can be either supported or blocked by the perilipins (plin1 and plin2) that are 
expressed primarily by the fat body and localise to the surface of lipid droplets (Bi et 
al., 2012). Interestingly, plin1 and plin2 mutant mice are lean, as they are thought to 
store less fat (Tansey et al., 2001), whereas Drosophila plin1 mutants have large lipid 
droplets and an inability to mobilise lipids during starvation (Bi et al., 2012). fs(1)h 
knockdown in the fat body led to a reduction, but not an elimination, of bmm, plin1 and 
plin2, which may have contributed to the defect in energy mobilisation and the 
reduction in survival following starvation.  
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To maintain metabolic homeostasis, organisms have to coordinate the 
mobilisation of lipids, proteins and sugars to ensure energy levels across all tissues 
are adequate. Glucose metabolism in mammals is regulated predominantly by insulin 
signalling, and key metabolic pathways have been shown to be evolutionarily 
conserved from Drosophila to humans (Owusu-Ansah and Perrimon, 2014). In 
Drosophila, much like in mammals, circulating sugars are regulated by two endocrine 
hormones, insulin-like peptides (ILPs) and a glucagon-like peptide, Adipokinetic 
hormone (Akh) (Yasugi et al., 2017). Dietary sugars quickly change the levels of 
circulating sugars (Ugrankar et al., 2015), elevated glucose levels initiate insulin 
signalling, while starvation can cause glycogen breakdown and lipid mobilisation 
(Hietakangas and Cohen, 2009; Teleman, 2009). Trehalose is the main circulating 
sugar in invertebrates (Elbein et al., 2003; Shukla et al., 2015). In Drosophila, 
trehalose is produced from glucose in the fat body and degraded to glucose by 
trehalase (Yasugi et al., 2017). Much like in humans, an imbalanced diet can disrupt 
metabolic homeostasis in adult Drosophila and promote insulin resistance. Drosophila 
fed a high-fat diet are characterised by increased triglycerides, inflammation, 
metabolic imbalance (as hyperglycemia and insulin insensitivity) and a reduction in 
lifespan (Woodcock et al., 2015). Additionally, a high-sugar diet also elicits 
hyperglycemia and insulin resistant phenotypes (Musselman et al., 2011). However, 
the loss of fs(1)h in the fat body did not cause insulin resistance or obesity. 
Conversely, hypoglycemia and an increase in DILP expression are suggestive of 
increased insulin signalling (Flatt et al., 2008b). Genetic alterations in DILPs or Akh 
changes levels of trehalose and glucose circulating in the hemolymph and flies 
lacking Akh-producing neurons display a drop in trehalose levels (Lee and Park, 
2004). Removing fs(1)h from the Drosophila fat body resulted in increased DILP 
secretion from the IPCs in the brain and hypoglycemia. The disturbance of endocrine 
factors regulating nutrient sensing and DILPs may account for the changes in insulin 
signalling and hypoglycemia shown in fs(1)h knockdown flies. Similarly to fat body 
knockdown of fs(1)h in Drosophila, mice deficient in Sirtuin-6 (SIRT6), a NAD-
dependent protein deacetylase, which deacetylates lysines in histones and non-
histone proteins (Ramakrishnan et al., 2014), have low insulin levels, are severely 
hypoglycemic, age prematurely and leads to the activation of NF-κB signalling (Xiao 
et al., 2010). Furthermore, Brd2 knockout mice, much like fs(1)h knockdown flies are 
shown to have lowered blood glucose levels (Wang et al., 2009).  
The Drosophila genome encodes eight Drosophila insulin-like peptides 
(DILPs), which are expressed by various organs including the IPCs in the brain, fat 
body, midgut and ventral nerve cord (VNC) (Kannan and Fridell, 2013). DILP2, 3 and 
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5, are secreted from the IPCs in the brain, which are homologous to pancreatic beta 
cells in vertebrates and are shown to be nutrient responsive (Shim et al., 2013). 
Increasing the level of circulating DILPs systemically increases growth and 
metabolism (Lee et al., 2008b). DILP2 is a potent growth regulator and is important in 
regulating the longevity of the adult fly (Morris et al., 2012), while DILP3 and 5 are 
thought to control growth and development (Grönke et al., 2010). Ablating IPCs in 
Drosophila larvae result in a hyperglycemic phenotype that persists into adulthood 
(Broughton et al., 2008). Adult Drosophila with ablated IPCs in the brain are shown to 
be hyperglycemic and have impaired glucose tolerance, however they remain insulin 
sensitive (Haselton et al., 2010). This ablation of the IPCs would suggest a loss of 
DILP2, 3 and 5 secretions from the brain. Conversely, fs(1)h knockdown flies 
exhibited the opposite of these observations, with a hypoglycemic phenotype and a 
transcriptional increase in DILP2, 3 and 5. These data suggest fs(1)h may play a role 
in regulating DILP secretion and sugar levels. The fat body-derived peptide, DILP6, 
acts indirectly, by stimulating the release of DILPs from other tissues. DILP6 has been 
shown to activate insulin signalling in oenocytes during starvation and promotes 
metabolic alterations when needed (Chatterjee et al., 2014). DILP6 upregulation in the 
fat body during fasting or over-expression of foxo can repress secretion of DILP2 from 
IPCs in the brain (Bai et al., 2012). Over-expression of DILP6 in the fat body causes 
traits associated with decreased insulin signalling, including lifespan extension and 
increased triglyceride levels (Bai et al., 2012). It is unknown whether upd2 and DILP6 
work in parallel or in concert to regulate DILP secretion from IPCs (Owusu-Ansah and 
Perrimon, 2014). Interestingly, DILP6 is also able to repress the secretion of DILP2 
from IPCs in the brain (Bai et al., 2012) however, knocking down fs(1)h in the fat body 
had little effect on the transcript levels of DILP6. 
In mammals, phosphoenolpyruvate carboxykinase (Pepck) is a key enzyme 
for gluconeogenesis and glyceroneogenesis (Okamura et al., 2007), it has also been 
shown to play a key role in lipid homeostasis in white adipose tissue (Reshef et al., 
2003). Mice expressing Pepck in adipose tissue displayed larger adipocytes and fat 
mass (Franckhauser et al., 2002). Conversely, mice with Pepck knockdown in 
adipose tissue exhibited lower triglyceride levels under both fed and fasted conditions 
(Olswang et al., 2002). In Drosophila, Pepck also plays an important role in 
gluconeogenesis and glyceroneogenesis and ATF-2 of the p38 pathway has been 
shown to regulate Pepck transcript level. Furthermore, the expression of Pepck is 
reduced following ATF-2 knockdown (Okamura et al., 2007). fs(1)h knockdown flies 
are shown to have increased Pepck transcript level, which may be associated with 
generating circulating sugars, to try and reduce their hypoglycemia. There may also 
	 206 
be an increase in ATF-2 and a stress-response via the p38 pathway, which is 
upregulating Pepck levels. This was not investigated following fs(1)h knockdown in 
the fat body. However, Pepck is also upregulated upon starvation (Zinke et al., 1999), 
which would fit with fs(1)h knockdown flies dramatically responding to starvation, and 
being unable to utilise triglyceride stores.  
7.6. Nutrient sensing  
Hormonal signalling ensures organ-to-organ communication, and failure to regulate 
this cross-talk in humans can lead to diseases including obesity and diabetes. Insulin-
like growth factors (IGFs) and insulin in vertebrates, and insulin-like peptides (ILPs) in 
insects help to coordinate nutritional state and the control of growth (Okamoto and 
Yamanaka, 2015). In Drosophila, endocrine mechanisms and signals regulate 
carbohydrate and lipid metabolism and organs including the fat body, gut and brain 
can functions as nutrient sensors to coordinate growth depending on the nutritional 
conditions.  
unpaired 1 (upd1), an endogenous ligand of the Jak/STAT pathway, is a 
mammalian leptin homolog expressed in the Drosophila brain, unlike upd2, which is 
also thought to be a human leptin homolog, expressed in the Drosophila fat body 
(Beshel et al., 2017). upd1 acts through the dome receptor found on neuropeptide F 
(npf)-positive neurons, the upd1-dome signalling suppresses npf activity to regulate 
food-related behaviour including food intake, cues and weight (Beshel et al., 2017). 
Manipulation of upd1 function in neurons impacts on feeding behaviour and 
responsiveness, leading ultimately to weight gain (Beshel et al., 2017). A decline in 
nutrient availability may contribute to a decrease in upd1 expression and secretion 
(Beshel et al., 2017). Interestingly, fs(1)h fat body knockdown flies showed increased 
upd1 transcript levels, suggesting that they were not exhibiting a reduction in nutrient 
availability. Although, upd1 and upd2 both activate the Jak/STAT pathway, they have 
different binding affinities for their receptor dome, suggesting different roles in 
Drosophila nutrient sensing. As mentioned previously, unpaired 2 (upd2), a type I 
cytokine and a ligand of the Jak/STAT pathway, was found to be induced in the fat 
body during the fed state in Drosophila (Rajan and Perrimon, 2012). upd2 activates 
Jak/STAT in GABAergic neurons relieving the inhibitory effect of IPCs, leading to the 
secretion of DILPs into the hemolymph to promote growth and energy storage (Rajan 
and Perrimon, 2012). This induction of upd2 in the fat body is also associated with the 
release of DILPs from IPCs in the brain (Rajan and Perrimon, 2012). Following fs(1)h 
knockdown in the fat body, transcript levels of upd2 and DILP2, 3 and 5 were 
upregulated. The induction of DILP expression may be upregulated by the increased 
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upd2 expression in fs(1)h knockdown flies to try and rescue the dysregulated insulin-
signalling pathway, independent of nutritional status. Much like in Drosophila, 
vertebrate leptin is secreted from adipose tissues in mammals during nutritional 
surplus (Zhang et al., 1994). Human leptin can function as a ligand to the dome 
receptor of the Jak/STAT pathway and has been shown to rescue upd2 mutant 
phenotypes, suggesting upd2 is a homolog of leptin (Rajan and Perrimon, 2012). 
Knocking down upd2, but not upd1 or upd3, in the larval fat body resulted in smaller 
flies, suggesting upd2 alone plays a fat body specific role in regulating systemic 
growth depending on nutrient availability (Rajan and Perrimon, 2012). Much like the 
knockdown, upd2 null mutants are also smaller in size, have reduced triglyceride 
levels and accumulate lipid droplets in oenocytes. Over-expression of upd2 can 
suppress lipid storage breakdown under conditions of starvation, suggesting it signals 
a fed condition even when flies are lacking nutrient (Rajan and Perrimon, 2012). In 
fs(1)h knockdown flies, there may be a feedback loop to increase upd2 levels, as a 
stress signal, to try and induce DILP secretion from the IPCs in the brain to increase 
DILP binding to the InR and increase the amount AKT activation, in turn reduce 
FOXO level. The idea of a feedback loop was also supported by the loss of fs(1)h in 
the fat body leading to an increased expression of InR, which may be induced by 
FOXO in order to rescue the diminished AKT activity. Furthermore, the increased 
upd2 transcript level following fs(1)h knockdown in the fat body may also be 
influencing the inability to utilise triglyceride stores, particularly following starvation.  
Growth-blocking peptide (Gbp) was identified in butterflies and moths as a 
growth regulator, low levels of Gbp enhance growth, whereas high concentrations 
suppress it (Hayakawa and Noguchi, 1998; Matsumoto et al., 2003). In insects, Gbp is 
a potent cytokine that regulates stress-induced AMP expression, which does not 
require Toll or Imd related genes, and an over-expression of Gbp in Drosophila leads 
to elevated levels of AMPs (Tsuzuki et al., 2012). The larval fat body of Drosophila 
secretes epidermal growth factor-like peptides known as Gbps (Koyama and Mirth, 
2016). Gbp1 and Gpb2 are produced by the fat body, secreted into the hemolymph 
and are able to stimulate DILP2 and DILP5 secretion, either directly or indirectly from 
IPCs in the brain (Koyama and Mirth, 2016), the stimulation of DILP secretion can 
lead to an increase in insulin signalling. Additionally, Gbp1 and Gbp2 transcript levels 
are sensitive to the protein content in the Drosophila diet and TOR signalling in the 
larval fat body, suggesting they work downstream of TOR (Koyama and Mirth, 2016). 
Reducing Gbp1 and Gbp2 expression in the Drosophila fat body leads to smaller body 
size due to reduced growth rate (Koyama and Mirth, 2016). Data suggests Gbp1 and 
Gbp2 do not play equal roles in regulating DILP secretion as the accumulation of 
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DILP2 was not enhanced by Gbp2 knockdown, but increased when both Gbp1 and 
Gbp2 were reduced in the fat body (Koyama and Mirth, 2016). Furthermore, Gbp1 
regulates immune response and its expression is sensitive to starvation and TOR 
signalling in Drosophila (Fujikawa et al., 2009; Koyama and Mirth, 2016; Nelson et al., 
2005). Interestingly, fs(1)h knockdown flies had reduced levels of Gbp1 and Gbp2, but 
increased levels of AMPs suggesting foxo levels may be impacting on the AMP 
expression directly. Moreover, the transcript levels Gbp1, which regulates immune 
response, could not be rescued by foxo heterozygosity. These data further suggest 
fs(1)h knockdown may play two distinct roles in the fat body (Figure 7-2); a metabolic 
role that is foxo-dependent that could be rescued by removing one copy of foxo, and 
an immune role, predominantly following bacterial infection, that is foxo-independent, 
























Figure 7-2: The distinct metabolic and immune roles of fs(1)h in the Drosophila fat body  
fs(1)h seems to play two distinct roles in the Drosophila fat body. Left: A metabolic role that 
was dependent on foxo and many of the phenotypes observed following fs(1)h knockdown 
could be rescued by a reduction in foxo levels. Right: An immune role that is foxo-independent 
and a reduction in foxo levels in fs(1)h knockdown flies could not rescue some of the observed 
phenotypes. 
CCHamide-2 (CCHa2), a peripheral tissue derived peptide hormone, is 
thought to be a nutrition-dependent regulator of DILPs in Drosophila larvae (Sano et 
al., 2015). CCHa2 and its receptor, CCHa2-R, a G-protein coupled receptor (GPCR) 
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found in the brain, form a direct link between peripheral tissues and the brain. CCHa2 
has been identified as a sugar- and lipid-sensitive humoral signal secreted from the 
fat body, similarly to upd2 (Sano et al., 2015). In larvae, genetic disruption of CCHa2 
or CCHa2-R causes expression of DILP5 and the release of DILP2 and 5 to be 
severely reduced (Sano et al., 2015). Interestingly, when CCHa2 is expressed in the 
fat body of CCHa2 mutants the level of DILP5 is restored in the brain. Transcriptional 
levels of CCHa2 are altered in response to nutritional levels, particularly glucose 
(Sano et al., 2015). In the fs(1)h knockdown flies, both CCHa2 levels and glucose 
levels were reduced suggesting fs(1)h may also play a role in fat body-derived 
nutrient sensing and regulation. However, other studies suggest CCHa2 is not 
regulating DILP secretion in the brain via the larval fat body, as no expression of 
CCHa2 was identified in the fat body (Ren et al., 2015). It may be produced in the gut 
(Li et al., 2013; Ren et al., 2015; Veenstra and Ida, 2014) and signals to the CCHa2-R 
in the brain to plays important roles in controlling developmental timing (Ren et al., 
2015), feeding behaviour (Li et al., 2013; Ren et al., 2015) and as a major regulatory 
peptide in the midgut (Veenstra and Ida, 2014). Possible signals from the gut lumen 
may communicate information, potentially regarding nutritional status and availability, 
to other organs in the fly by releasing CCHa2 into the hemolymph (Li et al., 2013). 
Both larval and adult CCHa2 mutants show a delayed development, significant 
reduction in feeding, decreased locomotion and a severe down-regulation of DILP2 
and 3 mRNA levels (Ren et al., 2015). It is uncertain whether glucose sensing takes 
place in CCHa2-expressing gut cells or in the fat body. Although fs(1)h knockdown in 
the fat body showed a significant reduction in CCHa2 transcript, they did not seem to 
show any developmental delay or a reduction of DILP2 or 3. fs(1)h knockdown flies 
should be investigated further to identify whether the reduction in CCHa2 is affecting 
their feeding behaviour.  
The secreted protein, Ecdysone-inducible gene L2 (ImpL2), is induced by the 
molting hormone 20-hydroxyecdysone (20E, ecdysone) and is a neural/ectodermal 
development factor in Drosophila (Honegger et al., 2008). Genetic disruption of ImpL2 
results in embryonic lethality (Garbe et al., 1993). Furthermore, ImpL2 is an insulin-
binding antagonist able to bind to DILP2 and DILP5 in Drosophila adults and is 
involved in a feedback circuit with DILP2, 3 and 5 (Alic et al., 2011). Removing DILP2, 
3 and 5 leads to a down-regulation of ImpL2 transcript (Alic et al., 2011). Conversely, 
increasing the expression of ImpL2 results in phenotypic changes consistent with the 
down-regulation of insulin signalling, including increased lifespan (Alic et al., 2011). 
Forced expression of ImpL2 results in the induction of 4E-BP, a marker of insulin 
repression, causes non-autonomous growth inhibition and triggers phenotypes 
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associated with reduced insulin signalling (Honegger et al., 2008). Over-expression of 
ImpL2 in the Drosophila eye results in reduced eye size, a reduction in the size of the 
whole fly and a developmental delay (Alic and Partridge, 2008), whereas loss of 
ImpL2 function results in increased body size (Honegger et al., 2008). Accumulations 
of trehalose and organ-wasting processes are dependent on ImpL2, which is 
specifically upregulated in the proliferating midgut (Kwon et al., 2015). In Drosophila, 
ImpL2 is a mediator necessary for wasting (Kwon et al., 2015). Tumour specific 
inhibition of ImpL2 is sufficient to significantly ameliorate wasting phenotypes 
(Figueroa-Clarevega and Bilder, 2015; Kwon et al., 2015). Furthermore, a reduction in 
insulin signalling is responsible for mycobacterial infection induced wasting, however 
it is unknown if ImpL2 is the relevant mediator in this case (Dionne et al., 2006; 
Figueroa-Clarevega and Bilder, 2015). In fs(1)h knockdown flies, ImpL2 transcript 
levels were increased in whole fly samples, which may suggest ImpL2 levels were 
being increased due to the increased DILP transcript levels and in turn may be 
causing wasting and playing a role in their reduced survival. Conversely, in dissected 
fat body there was a significant reduction in ImpL2 transcript level following fs(1)h 
knockdown, the reason for this remains unknown. However, there may be a signal 
down-regulating ImpL2 in the fat body to prevent lipid metabolism. There seems to be 
a range of nutrient-sensing mechanisms and pathways in both larval and adult 
Drosophila (Nässel and Vanden Broeck, 2016). fs(1)h may be detrimental in 
regulating some of these endocrine signals from the fat body and regulating energy 
availability.  
7.7. An interaction between fs(1)h, FOXO and AKT?  
The transcription factor foxo is a crucial mediator of insulin signalling and in response 
to cellular stresses, such as nutrient deprivation; FOXO is activated and inhibits 
growth through the activation of target genes including 4E-BP. It has been shown that 
fs(1)h may regulate AKT activity and the level of FOXO. Reducing the level of foxo in 
fs(1)h fat body knockdown flies rescued many of the phenotypes observed. This may 
also suggest that fs(1)h could engage in a pathophysiological feedback loop, in which 
disturbed endocrine factors result in low insulin activity, and drive high FOXO activity. 
An interaction between AKT, foxo and fs(1)h is yet to be identified, however, the data 
obtained suggest there may be a feedback mechanism between fs(1)h, foxo and AKT 
in the insulin pathway (Figure 7-3). The possibility of an interaction between fs(1)h 
and foxo was strengthened further when fs(1)h transcript levels were increased in 
foxo homozygous null flies compared to wild-type flies.  
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Figure 7-3: A potential interaction between fs(1)h, FOXO and AKT? 
A proposed model for the role of fs(1)h in the fat body. A. Under physiological conditions, 
when fs(1)h is present in the fat body, the insulin-signalling pathway can function as normal. 
Dotted line; potential feedback mechanism and red solid line: a feedback mechanism or a 
potential physical or transcriptional interaction. B. When fs(1)h is lost in the fat body, the 
insulin signalling pathway becomes dysregulated, leading to the phenotypes observed in this 
thesis.  
7.8. Ubiquitination dysregulation  
Ubiquitin is a highly conserved, small modifier molecule that specifically labels 
proteins, in both physiological and pathological cellular processes (Hoeller and Dikic, 
2009). The process of ubiquitination is started by ubiquitin-activating enzymes (E1), 
which activate and transfer ubiquitin to ubiquitin-conjugating enzymes (E2), and finally 
the conjugation of target proteins with ubiquitin is mediated by ubiquitin ligases (E3) 
(Lee et al., 2008a). Initially, ubiquitination was described as the process to label 
proteins for degradation by the proteasome (Hershko and Ciechanover, 1998). 
However, there has been an increase in functions given to different types of ubiquitin 
modification, such as signal transduction, assembly of protein signalling complexes, 
the activation or inactivation of enzymes and the regulation of protein trafficking 
(Bennett and Harper, 2008; Haglund and Dikic, 2005; Mukhopadhyay and Riezman, 
2007). The Ubiquitin pathway has been implemented in various processes including 
development, the immune response and programmed cell death (Hershko and 



































including cancer and neurodegenerative disorders (Ciechanover and Schwartz, 
2004). Following the loss of fs(1)h in the fat body, alterations in the abundance of 
proteins were observed along with a dysregulation in the ubiquitination of the whole fly 
proteins present.  
Many proteins that are regulated by ubiquitination play roles in cellular 
processes including gene transcription, cell-cycle progression and apoptosis, which 
can all become processes involved in cancer progression and tumourigenesis (Chen 
and Dou, 2010; Tu et al., 2012). Additionally, ubiquitin-mediated signalling is 
important for activating and restricting the activity of NF-κB during the innate immune 
response, and dysregulation can lead to chronic inflammation and cancer (Chen and 
Chen, 2013). Following infection, pattern recognition receptors (PRRs), such as Toll-
like receptors (TLRs) and Nod-like receptors (NLRs) trigger the activation of NF-κB by 
a number of signal transduction pathways (Jiang and Chen, 2011; Tigno-Aranjuez 
and Abbott, 2012). After the activation of NF-κB, PRRs coordinate with ubiquitination 
machinery to regulate NF-κB activation, deubiquitinating enzymes also allow for tight 
control of NF-κB (Chen and Chen, 2013). Pathogens can also counteract host 
defence by taking over the ubiquitin system to repress NF-κB signalling (Chen and 
Chen, 2013). fs(1)h knockdown in the fat body resulted in an increase in the 
abundance but not the activity of the NF-κB family member, Relish. This increase in 
abundance may result from a degradation defect, and in turn an accumulation of 
ubiquitinated protein. Therefore, fs(1)h may also effect processes involved in protein 
degradation, including autophagy or ubiquitination itself. In Drosophila, there is only 
one E1, known as Uba1, the E2 ubiquitin-conjugating enzyme is known as ubcD1 and 
E3 is known as DIAP1. Trabid (Trbd) was originally identified as a positive regulator of 
the Wnt pathway in both Drosophila and mammals (Tran et al 2008). It has more 
recently been identified as a negative regulator of the Drosophila NF-κB pathway and 
interacts with Tak1, which activates the Imd pathway and apoptosis, to reduce 
immune signalling output and ubiquitination (Fernando et al., 2014). The loss of 
Trabid, much like the loss of fs(1)h in the fat body, results in constitutive immune 
activation and a dramatic reduction in lifespan in the absence of infection (Fernando 
et al., 2014). In the absence of infection, Trbd mutants also show a systemic increase 
in the expression of AMPs leading to a chronic response (Fernando et al., 2014). 
Furthermore, in mice E3 ubiquitin ligase is responsible for FOXO1 polyubiquitination 
and proteasome degradation in response to insulin (Huang et al., 2005). As fs(1)h 
knockdown may cause some ubiquitination dysregulation, this may also impact on 
increasing FOXO levels as it could not be ubiquitinated and degraded efficiently.  
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7.9. Human relevance 
Bromodomain-containing proteins (BCPs) recognise and bind acetylated lysine 
residues in histone tails to alter gene expression. In recent years, the bromodomain 
and extraterminal domain (BET) family of BCPs have become of great interest; using 
small molecule pharmaceuticals to inhibit members the BET family have been 
extremely beneficial in the treatment of inflammation, autoimmune disease and 
cancer (Smith and Zhou, 2016). However, the broader in vivo roles of BET proteins in 
immunity and metabolic regulation are not entirely clear in humans or Drosophila. Our 
data from the fly suggest that BET inhibition in vivo may have significant metabolic 
consequences via AKT-FOXO signalling. Using the human monocytic cell line, THP-1, 
and treating with the small molecule inhibitor, I-BET151, also showed a reduction in 
activated AKT and an increase in FOXO levels suggesting there may be a conserved 
BET function in insulin signalling. 
In humans, the ability for BRD2, 3 and 4 to acetylated lysine residues play a 
wide variety of roles in regulating chromatin function and transcription, along with their 
roles in cell development and cell-cycle control (Padmanabhan et al., 2016). 
Interestingly, when each BET protein was knocked down individually using siRNA in 
THP-1 cells there was no effect on AKT activation or FOXO levels, suggesting that 
there may be some compensation mechanism between each of the BCPs 
(Stonestrom et al., 2015), however this would need further investigation. This may 
also suggest why when fs(1)h is knocked down in the fat body there is such a strong 
phenotype as there isn’t another BET protein to take over the role. 
7.10. Summary 
Loss of fs(1)h, the sole BET protein, in the Drosophila fat body exhibited a range of 
immune and metabolic phenotypes that have been shown, in most cases, to be due to 
the detrimental effects on AKT signalling and FOXO. Removing a single copy of foxo 
could rescue much of the uninfected metabolic phenotype, which seemed to be 
initiated by foxo-dependent dysregulation. However, during bacterial infection it could 
be shown that not all the fs(1)h phenotypes can be elucidated by FOXO 
hyperactivation, indicating there was also a foxo-independent component to the 
function of fs(1)h. We also suggest the phenotypes observed following fs(1)h 
knockdown in the fat body are a complex combination of developmental and 
physiological effects. The dysregulation of insulin signalling identified in Drosophila 
following fs(1)h knockdown could also start to be shown in the human THP-1 cell line 
following treatment with the BET inhibitor, I-BET151. 
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7.11. Future work 
The role of fs(1)h in immunity or metabolism have not been previously reported. In 
order to further investigate the roles, mechanism and function of fs(1)h in the 
Drosophila fat body there are a number of experiments that could be carried out.  
Firstly, to determine the transcriptional and epigenetic roles of fs(1)h in the 
Drosophila fat body experiments such as chromatin immunoprecipitation (ChIP) to 
determine where the fs(1)h protein is binding to DNA could be carried out. ChIP is a 
powerful tool for analysing histone modification and proteins that bind either directly or 
indirectly with DNA (Milne et al., 2009). fs(1)h is a BET protein, which recognises and 
binds acetylated lysine residues in histones tails, it consists of two bromodomains and 
an extraterminal (ET) domain involved in protein-protein interactions. Due to the 
known function of BET proteins and its close interaction with DNA, ChIP may provide 
more information as to where the bromodomains of fs(1)h are recognising acetylated 
lysine residues and binding to DNA. Furthermore, RNA sequencing (RNA-seq) is an 
approach to transcriptome profiling, widely used for analysing gene expression and 
measuring the quantities of RNA (Wang et al., 2009). RNA-seq may provide more 
information regarding other pathways that may be involved leading to the fs(1)h 
phenotype that has been observed. Investigating the idea of a feedback loop between 
fs(1)h and foxo would be extremely interesting, many of the phenotypes observed 
were dependent on AKT-FOXO signalling and suggest fs(1)h may also be playing a 
part in regulating insulin signalling and nutrient sensing. Additionally, foxo 
homozygous null flies had a significant upregulation of fs(1)h transcript level.   
Using co-immunoprecipitation (Co-IP) to pulldown fs(1)h and analysing the 
protein-protein interactions may provide further information as to the role of fs(1)h in 
the fat body of Drosophila and identify potential interaction partners. It would be 
particularly interesting to look for a physical interaction between fs(1)h and FOXO, as 
this is currently unknown, however the finding in this study strongly suggest a possible 
interaction between them. Furthermore, cell culture and fluorescence imaging could 
be used to try and visualise a protein-protein interaction between fluorescently 
labelled fs(1)h and FOXO. Literature also suggests fs(1)h may interact with 
phosphatidylinositol 5-phosphate 4-kinase (PIP4K) (Rhee et al., 2014), which 
regulates TOR signalling and growth during Drosophila development (Gupta et al., 
2013), so investigating that interaction further may also provide more information 
about fs(1)h. Looking into the role of TOR signalling following knockdown of fs(1)h in 
the fat body may provide further insight into its role. Our data showed reduced levels 
of S6 Kinase, which in mammalian cells is deactivated when amino acid availability is 
low (Hara et al., 1998).    
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Interestingly, much of our data has focused on the metabolic role of fs(1)h 
under physiological conditions and that removing one copy of foxo is adequate to 
rescue most the phenotypes observed. However, our data also showed that following 
infection, survival and AMP expression levels could not be rescued by foxo 
heterozygosity. Further investigation into the role of fs(1)h following infection with a 
range of pathogens may provide a further insight into its role in immunity.  
Previous studies have shown that fs(1)h plays an important role in Drosophila 
development and body planning, and mutations in fs(1)h can cause segmental 
abnormalities. As the known role of fs(1)h is predominantly developmental, it would be 
interesting to use temperature sensitive Gal80 (Gal80ts) in combination with the 
Gal4/UAS system to knockdown fs(1)h specifically in the adult fat body to decipher 
between developmental and non-developmental metabolic and immune phenotypes 
that have been observed. Although no reproducible survival phenotype was observed 
following the knockdown of fs(1)h in the hemocytes, investigating the role of fs(1)h in 
other tissues, such as the brain, gut or muscle, may provide informative and 
interesting results into the functions of fs(1)h in Drosophila. To further explore the role 
of fs(1)h in the immune response of the fly it may be interesting to carry out a double 
knockdown of fs(1)h in both hemocytes and the fat body. It may also be of interest to 
knockdown fs(1)h ubiquitously or use fs(1)h mutants to explore the total loss of fs(1)h 
in Drosophila compared to tissue specific knockdowns.  
Drosophila lacking fs(1)h in the fat body appear to show dysfunction in 
ubiquitination, which may cause some of the phenotypes observed. Further 
investigation into how fs(1)h is affecting ubiquitination would be of interest. This could 
be done by looking at transcript levels of the ligase and proteases involved in 
ubiquitination in Drosophila and trying to rescue any of the observed phenotypes by 
over-expressing Trabid, which plays important roles in ubiquitination and reducing 
immune signalling output. 
Finally, Drosophila are a robust model in therapeutic drug discovery and 
chemical screening, feeding or injecting BET inhibitors into the flies to try and 
reproduce the fs(1)h phenotypes observed following RNAi knockdown in the fat body 
would be interesting. Carrying out more experiments using BET inhibitors, to treat 
THP-1 cells and other human cell lines may provide insightful information about the 
conservation of BET proteins between in Drosophila and humans, along with 
increasing the knowledge for treatment of human disease. 
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